Org. age Ohio . 711 - College of Pharmacy

Transcription

COLLEGE OF
PHARMACY
Dr. Robert W. Brueggemeier
Dean, College of Pharmacy
Executive Publications Editor
[email protected]
Dr. Sylvan Frank
Associate Dean for
Professional Programs
[email protected]
Dr. William Hayton
Associate Dean for Graduate Studies and Research
and Interim Pharmaceutics Chair
[email protected]
Dr. Kenneth Hale
Assistant Dean for
Student Affairs
[email protected]
Dr. Tom Li
Medical Chemistry and
Pharmacognosy Chair
[email protected]
Dr. Milap Nahata
Pharmacy Practice and
Administration Chair
[email protected]
Dr. Lane Wallace
Pharmacology Chair
[email protected]
Shannon Weiher
Director of Development
[email protected]
Lou Marcy
Director of Alumni Affairs
[email protected]
Barbara Hegler
Publication Editor
[email protected]
Mike Conrad
Graphic Design
Conrad Graphic Design
[email protected]
Every effort has been made to ensure the accuracy of
the information included in this report. If an error has
been made, we apologize and encourage you to
contact us at (614) 688-3643.
Table of Contents
Welcome from Dean Robert W. Brueggemeier . . . . . . . . . . . . . . . . . . . . . . . . .2
Vision and Mission Statements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .3
Education and Academics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .4
Doctor of Pharmacy Programs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .4
Entry-Level PharmD Program . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .4
Non-Traditional PharmD Program . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .12
Undergraduate Program . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .14
Bachelor of Science in the Pharmaceutical Sciences . . . . . . . . . . . . . . . . .14
Graduate Programs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .18
Pharmacy Practice and Administration . . . . . . . . . . . . . . . . . . . . . . . . . . .18
Pharmaceutical Sciences . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .18
Summary of Student Enrollment and Graduates, 2005-06 . . . . . . . . . . . . . . .20
Faculty . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .21
Faculty Awards and Recognitions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .23
Faculty National Honors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .23
Division of Medicinal Chemistry and Pharmacognosy . . . . . . . . . . . . . . .25
Division of Pharmaceutics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .26
Division of Pharmacology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .27
Division of Pharmacy Practice and Administration . . . . . . . . . . . . . . . . . .28
Department of Pharmacy, The OSU Medical Center . . . . . . . . . . . . . . . . . . .30
Administrative and Professional Staff . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .31
Research and Scholarship . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .34
List of Publications, 2005 and 2006 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .37
Grants (NIH and other) Awarded FY 2005 . . . . . . . . . . . . . . . . . . . . . . . . . . .55
Outreach and Engagement . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .58
Alumni Affairs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .59
Pharmacy Alumni Society Governing Board Roster 2005-2006 . . . . . . . .60
Development . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .62
College of Pharmacy Honor Roll, Donors 2005 . . . . . . . . . . . . . . . . . . . .63
Dean’s Corporate Council . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .67
Financial Report . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .68
Photos courtesy of Jonathan Gladden and Brad Stansell
Welcome
I
am pleased to present the 2005-06 Annual
Report from the College of Pharmacy at The Ohio
State University. The 2005-06 year has certainly
been a dynamic year for academic pharmacy and for
the pharmacy profession. We in the College have
seen a continued expansion of our educational
programs and research activities and the pharmacy
profession has experienced significant changes with
the implementation of Medicare Part D. The 200506 report highlights the vast array of academic,
educational, research, and outreach activities that
have transpired during this period.
Our Doctor of Pharmacy programs are vibrant
and strong. All four classes in the entry-level
PharmD program are near the program capacity of
approximately 115-120 students per class per year.
Dean Robert W. Brueggemeier
Our Non-Traditional PharmD program, 91
students in Autumn 2005, will enter its final class
in Winter 2007. Academic programming for undergraduate students has never been
stronger in the BS in Pharmaceutical Sciences program, 421 students enrolled as
majors in Autumn 2005. Our graduate programs continue the tradition of excellence,
100 students enrolled in Autumn 2005 in the areas of medicinal chemistry and
pharmacognosy, pharmaceutics, pharmacology, and pharmaceutical administration.
Total student enrollment in the College stands at 1,054, the highest number ever in
our College’s history. Pharmacy faculty and staff responded in an exemplary fashion to
meet the academic and professional needs of all our students.
Exciting disciplinary and interdisciplinary research in drug discovery, drug action,
drug delivery, and drug development are being led by our faculty. Faculty also engage
in innovative practice models of medication therapy management. Faculty, PharmD
students and residents participate in training and delivery of therapeutic services in
various area hospitals, clinics, and ambulatory/community practice settings. Faculty
and staff also serve the University and the profession at both the regional and national
levels and are involved in stimulating outreach and engagement activities.
The College of Pharmacy Alumni Society continues to support our students and
faculty in many significant ways, especially as preceptors, and the Dean’s Corporate
Council provides important feedback on the College’s
strategic initiatives and directions. We all come together with
a common mission and our collective efforts to maintain The
Ohio State University College of Pharmacy among the top
ranked pharmacy schools in the country.
I invite you to review highlights from this period and I
remind you that, in this dynamic academic environment, we
use a snapshot in time, (Autumn Quarter 2005), to present a
picture of our College to you. I thank you for your
contributions to our College mission and look forward to
working with you to ensure future success in all our
endeavors; academic, research and service.
Robert W. Brueggemeier
Dean
2
Vision and Mission Statements
Our Mission:
The overall mission of the College of Pharmacy is to improve
medications and medication-related health outcomes for the
people of Ohio and the global community through our
teaching, through our research and through our service.
The College will provide high quality education in the
pharmaceutical sciences and pharmacy practice to
professional, undergraduate, graduate and postgraduate
students through teaching, research, practice and related
service activities including outreach and engagement.
Our Core Values:
We value innovation, teaching, learning and the
advancement and sharing of knowledge.
We value research and its application toward improving
the use of medications in society.
We value patient-centered pharmacy services and professionalism.
We value our students, faculty, staff, alumni and friends.
We value diversity in all of its forms.
Our Overarching Goal:
The Ohio State University College of Pharmacy will be among
the world's truly great institutions of pharmacy education.
Our Vision and Indicators of Success:
We envision The Ohio State University College of Pharmacy as
being among the top ranked institutions of pharmacy education
in the world. This vision encompasses a robust pharmaceutical
science and clinical research enterprise with emphases in
interdisciplinary scholarship. Our faculty will be
viewed as leaders in the discovery, development,
delivery and use of drugs, which will translate into
innovations in health care. We will prepare an
outstanding cadre of graduate-research students who
are fully engaged in our educational and research
enterprises. We will offer a strong patient-centered,
evidence-based curriculum for our graduateprofessional students which develops exceptional
medication therapy specialists. Our combined degree
programs will be viewed as hallmarks of excellence.
We expect to lead the country in post-doctoral
residency and fellowship training. We will offer high
quality undergraduate education enhanced through
didactic, research and extracurricular experiences. Our
student services will be regarded as a model within the University.
Through partnerships in outreach and engagement, we will
effectively translate our scholarship toward improving health
outcomes for the people of Ohio and beyond. Our alumni will
be viewed as leaders in pharmacy practice, in pharmaceutical
science, and within their communities.
3
Education and Academics
T
he College of Pharmacy currently offers degree programs
at the undergraduate, graduate professional, and graduate
levels.
Doctor of Parmacy Programs:
Entry-Level PharmD Program:
P
harmacists place an emphasis on medication therapy
management, a patient-focused orientation to pharmacy practice,
which entails a shared responsibility between the patient,
pharmacist, and other health care professionals toward achieving
positive therapeutic outcomes. The entry-level PharmD program
prepares students for licensure as a pharmacist and prepares them
to embrace this mission of a patient-focused orientation. The
program consists of four years of study. Three years of didactic
course work cover principles of pharmaceutical, administrative,
and clinical sciences, with some pharmacy practice experiences
included in the first and third years. The fourth year is devoted
to full-time professional experience. New interprofessional
combined degree programs were established in 2004. These are
the PharmD/Master in Business Administration (PharmD/MBA)
and the PharmD/Master in Public Health (PharmD/MPH).
Two hundred and eight professional pharmacy students, our
fourth and fifth entry-level PharmD classes, received their Doctor
of Pharmacy degrees at two commencements, June 2005 and
June 2006. Of this number 35 graduated cum laude, 25 magna
cum laude, and 4 summa cum laude. Following graduation,
100% of our PharmD program graduates passed the pharmacy
licensure exam, NAPLEX, and 98% passed the MPJE on their
first attempt. Our students graduate from Ohio State prepared to
accept positions in hospitals, community/ambulatory pharmacies,
managed care and other interesting pharmacy professions. Many
elect to continue their studies through residencies and
fellowships (see Figure 1). Of those PharmD
graduates of the Class of 2005 who reported
starting salaries, 56% reported salaries higher
than $80,000 and 41% reported salaries
higher than $90,000.
We completed the “phase in” of our
PharmD program in Autumn 2005 and
currently have 442 Entry-Level PharmD
students and 91 Non-Traditional PharmD
students in the College.
PharmD1, PharmD2 and PharmD3
classes are enrolled in didactic courses and
Sylvan Frank
Figure 1. Positions accepted by the 2005
PharmD Graduates
4
each class is near the program capacity of approximately 120
students per year. The class that entered in Autumn Quarter
2005 consisted of 122 students from 12 different states and
37 different undergraduate institutions. Two-thirds of the
entering class had a BS or MS degree prior to enrolling in
our graduate professional PharmD program and the average
GPA of the incoming class for Autumn 2005 was 3.5. The
distribution by gender of the incoming class was 71% female
and 29% male. Thirty-three percent of this class are nonOhio residents.
Figure 2 illustrates the trends in the quality markers for
the incoming classes from 1998 (first ELPD class) to the
2006 class.
Ninety-six students in their final year are engaged in
clerkship rotations locally, nationally, and internationally.
Currently, over 775 experiential preceptors are approved and
registered with our College. Students are engaged in experiential
rotations in Ohio, USA and one international rotation at Guys
Ken Hale
Figure 2. Quality measures of incoming PharmD classes, 1998 - 2006
and St. Thomas Hospital in London, England. The distribution
of our students on rotations is shown in Figure 3. Our valued
preceptors are honored at an annual event. “Preceptor of the Year
Awards” 2005 and 2006 were presented to Vinita Pai, OSU and
Children's Hospital; Ann Segraves, VA Columbus; Tom Bechtel,
OSU Medical Center; Ryan Glaze, Target; Tony Gerlach and
Jennifer Shamp, OSU Medical Center, and Mark Friedman,
Riverside Methodist Hospital.
We offer an Early Admissions Pathway to our PharmD
program for Honors students. Twenty EAP students have
successfully matriculated into the PharmD program. We
currently have 80 students in this program, most living in
Pharmacy House, our Living Learning Program. We welcomed
41 new first-quarter freshmen into the Pharmacy Scholars
Program for the 2005-06 academic year and now boast 104
Pharmacy Scholars. Participation in our Pre-Pharmacy Club
5
remains strong with students coming from a
variety of majors including the pharmaceutical
sciences.
The high-quality and the maturity of
the students in our PharmD program
are not only reflected in their
incoming academic records.
PharmD students are also
excelling in a variety of other
activities, such as practice
settings, student professional
organizations, and community
outreach. In 2005, PharmD
students completed a total of over
1600 hours in community service
activities such as brown-bag medicine
reviews, Katy’s Kids, diabetes screenings,
Figure 3. PharmD Professional Experience Sites
health fairs, immunizations and tutoring.
Several of our students traveled away from Ohio
State in outreach and engagement activities; 32
undergraduate and professional students to Merced, California,
to learn more about cultural competency in health care at
Healthy House, a clinic primarily serving the Hmong
population; 10 undergraduates to Puerto Rico to study pharmacy
in that region. Two of our students were selected to participate in
the Brazil Research Exchange Program.
Involvement in student professional organizations, Academy of
Students in Pharmacy (ASP), Student Society of Health-System
Pharmacists (SSHP), student affiliate of the Academy of
Managed Care Pharmacy (AMCP), and the Student National
Pharmaceutical Association (SNPhA) continues to increase since
2004.
Diversity in our entry-level professional and undergraduate
programs remains strong, with studentsof-color representing 11% of the
graduate student body, 17.3% of the
professional student body, and 21.5% of
the undergraduate student body. We
remain strong in our commitment to
enhance diversity and made significant
progress toward our diversity goals. We
6
completed climate assessments, conducted significant diversity
events, implemented a College diversity enhancement award,
established relationships with minority institutions, and are
implementing a cultural competence curriculum.
Figure 4 shows the diversity composition of our PharmD
classes over the last five years. Female to male ratios remained
relatively constant over the past few years, approximately 2/3 to
1/3 in Autumn 2005.
Figure 4. Professional Student Class Composition
T
he total amount of student financial aid awarded to our
students increased by 25.9% over 2004 to $12,003,208 in 2005.
The College held the first annual Endowed Scholarship Donors
and Student Recipient Reception focusing
on acknowledging our generous
scholarship donors and bringing them
together with the student scholarship
recipients and their families.
7
Doctor of Pharmacy Graduates (2005)
8
Name
AmAdams, Katherine M
Aladesanmi, Ayoola O
Aranke, Sarang
Bailey, Rachel
Blozy, Allison Kirsten
Bollinger, Jessica Eileen
Carpenter, Dianne Christine
Carpenter, Kristina A
Chen, Aiun
Christianson, Loren Allen
Clark, Colleen Ann
Colla, Nicholas Patrick
Corwin, Danielle Nicole
Cottle, Kristy Nicole
Cummings, Peter Trevor
Dimechele, Edward Anthony
Doukoure, Yasmine Melissa
Dula, Joseph M III
Durell, Amy Lynn
Durica, Briana Marie
Fernandez, Bahati Aisha
Franklin, Steven James
Hometown
Dublin, OH
Columbus, OH
La Palma, CA
Deerfield, OH
Parma, OH
Nashport, OH
Johnstown, OH
Bexley, OH
Brunswick, OH
Ft. Atkinson, WI
Akron, OH
Youngstown, OH
Dayton, OH
Portsmouth, OH
Heighland Hts, OH
Garfield Hts, OH
Cote D'Ivoire
Euclid, OH
Kalida, OH
Parma, OH
Oak Park, IL
Westerville, OH
Franz, Thaddeus Tyler
Garver, Matthew Allan
Geurink, Melinda Ann
Gralton, Elizabeth Mary
Hackett, Tara Lynn
Hall, Derrick Phillip
Hanudel, Dana Lynn
Ironton, OH
Columbus, OH
Brunswick, OH
Columbus, OH
Canfield, OH
Akron, OH
Fairlawn, OH
Hawkins, Melanie Nicole
Hixenbaugh, Elaine Marie
Hodapp, Charles Thomas
Hoffmann, Christa Fern
Holliday, Kristie J
Hollis, Ian Bruce
Hord, Amanda J
Huang, Hsuan-Hsiu Claire
Jackson, Joshua Lynnale
Jackson, Lauren Ann
Johnson, Amber Alice
Johnson, Michele Theresa
Joy, Coleen
Kelly, Angela D
Kroustos, Cynthia I
Krug, Kelley Anne
Kuhlen, Cheryl A
Kullgren, Justin Garret
Laymon, Andrew Scott
Lee, Sae Jin
Lehn, Genevieve Ann
Limperos, Maria M
Aurora, OH
Cortland, OH
Sydney, OH
Columbus, OH
Bellefontaine, OH
Vermillion, OH
Fremont, OH
Concord, OH
Robbins, IL
Cincinnati, OH
St. Mary's, OH
Youngstown, OH
Dublin, OH
South Shore, KY
N. Olmstead, OH
Springfield, OH
Dayton, OH
Millford, OH
Hartville, OH
Seoul, South Korea
Hillsboro, OH
Canton, OH
Honors
Awards
Cum Laude
Summa Cum Laude
Cum Laude
Benjamin Balshone; Rho Pi Phi
Cum Laude
George B. Kauffman Mem Award
GlaxoSmithKline Patient Care
Magna Cum Laude
Roche Pharmacy
Communications
Cum Laude
Cum Laude
ASHP Student Leadership
Magna Cum Laude
Leadership
Cum Laude
Magna Cum Laude
Phi Lambda Sigma
Cum Laude
Magna Cum Laude
Mylan Excellence in Pharmacy
APhA-ASP Mortar & Pestle
Cum Laude
Magna Cum Laude
Cum Laude
Cum Laude
Magna Cum Laude
Merck Award
Perrigo Award
Lok-Mayo Award for Excellence in
Pharm
Name
Maughan, Evan Lewis
Mazza, Amy Elizabeth
McClellan, Charles
McHughes, Mary
Meekins, Melissa D
Hometown
Boulder, CO
N. Canton, OH
Columus, OH
Honors
Awards
Barberton, OH
Cum Laude
Miller, Mark Shawn
Mills, Jennifer Lynn
Musser, Thomas Paul
Oelrichs, Kyle F
Parker, Christine Elizabeth
Parker, David Earl
Patel, Nimesh
Patel, Rupesh
Pieratt, Emily
Summa Cum Laude
Magna Cum Laude
Merck Award
Protus, Bridget
Risko, Pamela Lea
Robbins, Mark
Ross, Mary M
Russell, Joshua Thomas
Samant, Meeta B
Schneider, Jacqueline Kay
Schuler, Patricia Michele
Searles, Brynn Elizabeth
Shieh, Suzanna
Skrtic, Zeljko
Soja, Stacie Lynne
Stauffer, Elizabeth Anne
Sullivan, Meghan Marie
Sung, Jennifer
Tang, Sai-Chiu
Toma, Meredith Brennan
Galena, OH
Reynoldsburg, OH
Fremont, OH
Cole Camp, MO
Las Vegas, NV
Las Vegas, NV
London, England
Reynoldsburg, OH
Washington, Court
House, OH
Austin, MN
Kuala Lumpur,
Malaysia
Pickerington, OH
Vandalia, OH
Dublin, OH
Westlake, OH
Chesapeake, OH
Centerville, OH
Napoleon, ND
Canfield, OH
Grove City, OH
Westerville, OH
Eastlake, OH
Olmstead Falls, OH
Cincinnati, OH
Warren, OH
Centerville, OH
Sacramento, CA
Charleston, WV
APhA-ASP Recognition for
Outstanding Service; Stephen W.
Birdwell Student Award; Anne L.
Burns Award; Ohio Pharmacists
Association Award
Harris Leadership Award
Ungham, Brandy Nicole
Ungham, Michael David
Voth, Laura Ann
Walker, Kembre Leigh
Wells, Elizabeth Anne
Williams, Jacquelyn Janine
Lorain, OH
N. Olmstead, OH
Centerville, OH
Cincinnati, Oh
Kettering, OH
Columbus, OH
Playle, Scott
Poi, Ming Jye
Wirth, Corey Anne
Woo, Eujin Michelle
Zarandi, Raya Karami
Loveland, OH
Seoul, South Korea
Westerville, OH
Zayas-Aiken, Carmen
Zgonc, Timothy Matthew
Zhang, Yuan
Laurenceville, GA
Stow, OH
Hilliard, OH
Cum Laude
Magna Cum Laude
Teva Company Student Award
Magna Cum Laude
Lilly Achievement Award
Magna Cum Laude
Cum Laude
Cum Laude
Merck Award
Magna Cum Laude
Summa Cum Laude
Claude E. Altenburg, Jr. Award
Faculty Award
Cum Laude
Magna Cum Laude
Council of Ohio Colleges of
Pharmacy; Student Leadership
Award
Magna Cum Laude
Student National Pharmaceutical
Association Award
Cum Laude
Magna Cum Laude
Magna Cum Laude
Facts & Comparisons Award of
Excellence Excellence in
Clinical Communication
9
Doctor of Pharmacy Graduates (2006)
Name
Adams, Alysia Niccole
Adams, Bettina Jovan
Ahmed, Abdurahman
Argaw, Lissanu
Barchanowicz, Vincent E III
Barszcz, Todd James
Baughman, Melissa Ann
Bellar, James Robert
Bhatt, Anand Jagdish
Blake, Nancy Henricks
Brown, Sesame Luba
Burris, Austin Albert
Cabrera, Kristina Alex
Cerepnalkoski, Kristina
Closson, Julie Renee
Cooney, Jeffrey Michael
D'Andrea Anastacia Happy
Desai, Anuja
Dipalma, Allison Nicole
Donahue, Thomas J
Dreslinski, Jonathan Arnaud
Duncan, Jessica Erin
Dura, Jillian Valerie
Edris, Tigist H
Ferguson, Melissa Anne
Fisher, Tara Lynn
Fleskes, Stephanie Nicole
Gerber, Mary Clare
Giancola, Jessica Marie
Giang, Jen
Grinder, Nicholas Lee
Grossman, Jarrod Warren
Grundman, Laurel Ann
Grutza, Jill Elizabeth
Hammad, Eman H
Hatch, Jacob Brian
Heitz, Ronald Douglas
Herrera, Julian A
Hughes, Pamela Howard
Hurless, Nathan P
Hwang, Jessica Heejin
Jackson, Deidre Change
10
Javorsky, Brian Joseph
Jewell, Amanda Kay
Judin, Heather Marie
Keller, Kristen L
Lampe,
Christopher Lawrence
Larrick, Jennifer Leigh
Lenchak, Laureen Marie
Leo, Ming Y
Macchiarella, John S
Mahoney, Jessica Ann
Makii, Jason Michael
Martinez, David Zaragoza
McDade, Cara Danielle
Hometown
Hilton, NY
Jackson, MS
Columbus, OH
Columbus, OH
Jefferson, OH
Cleveland, OH
Worthington, OH
Bloomfield Village, MI
Cincinnati, OH
Chillicothe, OH
Dublin, OH
Coshocton, OH
Sofia, Bulgaria
Columbus, OH
Ada, OH
Concord, OH
Huslin, Alaska
Westchester, OH
Gahanna, OH
Marysville, OH
Brighton, MI
Circleville, OH
North Tanawanda, NY
Columbus, OH
Columbus, OH
Elida, OH
Kettering, OH
Huron, OH
Chesterton, OH
Skokie, IL
Canal Fulton, OH
Upper Sandusky, OH
Euclid, OH
LaSalle, IL
Dublin, OH
Columbus, OH
Westerville, OH
El Paso, TX
Paris, KY
Wooster, OH
Mentor, OH
Steubenville, OH
Columbus, OH
Toledo, OH
Poland, OH
Barberton, OH
Columbus, OH
Caldwell, OH
Olmsted Falls, OH
Bucyrus, OH
Tallmadge, OH
Copley, OH
Avon Lake, OH
Amherst, OH
Pittsburgh, PH
Honors
Awards
Cum Laude
Cum Laude
Anne L. Burns Award
Cum Laude
Magna Cum Laude
Magna Cum Laude
George B. Kauffman Memorial Award
Cum Laude
Magna Cum Laude
Cum Laude
Cum Laude
Cum Laude
Magna Cum Laude
Cum Laude
Harris Leadership Award
Student National Pharmaceutical
Association Award
Cum Laude
Magna Cum Laude
Magna Cum Laude
Stephen W. Birdwell Student Award
Faculty Award (Doctor of Pharmacy)
Name
McElroy, Adam Neil
McGill, Barron Hartford
Meyer, Christopher Stephen
Micu-Stan, Dominique Danielle
Miles, Randal Corey
Mills, Jason Robert
Moore, Tamara Yvette
Nasipak, Nicole Leigh
Noll Baker, Kelly A
Oinonen, Laura Lynn
Olexia, Michael Allen
Orosz, Christina Michelle
Patel, Sapna S
Payton, Harold Junior
Peters, Jeremy Ross
Picha, Jennifer Janell
Plogsted, Scott Michael
Prater, Shannon Leigh
Purtee, Audrey A
Randall, Kimberly Ann
Reardon, Joshua Thomas
Redley, Joseph Leroy
Reid, Kacey Warren
Reinhard, Heather Alyse
Ridenour, Amber Marie
Rider, Kevin Patrick
Rodden, Leah Abigail
Runyeon, Christopher Scott
Samnijlenko, Gregory George
Schlitt, John Henry
Schmid, Elizabeth A
Schultz, Martin Joseph
Scott, Rochelle Ann
Seggerson, Sara Elizabeth
Singh, Shaleen
Sinkovich, Stephanie Ann
Smiley, Fadi Rada
Smith, Jennifer Lynn
Speeg, Melinda Dawn
Steininger, Megan Dee
Stewart, John Charles
Stillwagon, Electra
Stingel, Erica Faye
Stojak, April Marie
Sukul, Ilina
Sweeney, Lynn Marie
Thompson, Nathaneal Mbaya
Trinh, Julie Diep
Vyhnalek, Amy Marie
Walker, Cristen Nicole
Warsame, Liban
Watkins, Jennifer
Wilkinson, Steven David
Williams, Johathan Paul
Windon, Erin Elizabeth
Wu, Kunyi
Yee, Jennifer Florence
Zaw, Myo Thet
Hometown
Pleasant City, OH
Mobile, AL
Vermillion, OH
Columbus, OH
Sterling Heights, MI
Columbus, OH
Cedar Rapids, IA
Lexington, OH
Somerset, OH
Painesville, OH
Kalamazoo, MI
Lancaster, OH
Westerville, OH
Williamston, WV
Maumee, OH
Canton, OH
Dublin, OH
Quincy, IL
Honors
Gahanna, OH
Poland, OH
Galloway, OH
McArthur, OH
Millersburg, OH
Wapakoneta, OH
Ashtabula, OH
Mt. Vernon, OH
Centerville, OH
Brunswick, OH
Norton, OH
Columbus, OH
Miamisburg, OH
Rootstown, OH
Lima, OH
N. Royalton, OH
Youngstown, OH
North Canton, OH
Columbus, OH
Westerville, OH
Fairborn, OH
Cum Laude
Awards
Cum Laude
Magna Cum Laude
Summa Cum Laude
Cum Laude
Magna Cum Laude
Cum Laude
Cum Laude
Summa Cum Laude
Rho Phi Award
Marvin and Geraldine Faeges Award
Claude E. Altenburg, Jr. Award
Cum Laude
Cum Laude
Columbus, OH
New Philadelphia, OH
Aurora, OH
Columbus, OH
Troy, OH
Nigeria
San Jose, CA
Cleveland, OH
Blacklick, OH
Cum Laude
Columbus, OH
Hubbard, OH
Beavercreek, OH
Powell, OH
Magna Cum Laude
Lithopolis,OH
Cum Laude
Shanghai, P. R. China
N. Royalton, OH
Yangon, Myanmar
Phi Lambda Sigma
Benjamin Balshone Student Award
11
Non-Traditional Doctor of Pharmacy Program:
O
ur Non-traditional Doctor of Pharmacy Program (NTPD) provides licensed pharmacists at the
baccalaureate level the opportunity to enhance their skills and credentials to provide high quality patientoriented pharmaceutical care by obtaining the PharmD degree. The program is an on-line professional doctoral
degree program which requires and supplements a five-year Bachelor of Science degree in pharmacy. Applicants
to the program must hold a B.S. in Pharmacy degree from an Accreditation Council for Pharmacy Education
(ACPE) accredited institution, be a resident of Ohio or contiguous states, and be a licensed pharmacist. The
general capabilities of the PharmD graduate include patient physical assessment relative to attainment of
pharmacotherapeutic endpoints, assessment of drug response, clinical evaluation of a broad range of adverse
drug reactions, general therapeutic consultative services to physicians, and pharmacokinetic and toxicological
interpretations of drug concentrations in blood and tissues.
The first NTPD class entered in January 2001 and the final class will do so in January 2007. The faculty of
the College voted recently to end the NTPD program based on a number of factors, but most importantly, that
we have accomplished the intended mission of the program. By the end of the 2005-06 academic year 54
Doctor of Pharmacy degrees will have been earned by students in the NTPD program. At that point we will
have 113 active students remaining in the program.
The NTPD program was designed primarily to meet the professional needs of our B.S. in Pharmacy alumni
to enhance their education and clinical skills to the doctoral level. Indeed, pharmacists from ambulatory,
hospital, and long-term care practice settings; and industry, responded to the opportunity. We are very proud of
our unique and innovative program and especially of our students who have made major commitments of time
and energy. Given the six-year time limit to complete the program, the NTPD Class of 2007 will run until
December 2012. Hence we will fully support the program to the highest
degree until the last student graduates. The
comprehensiveness and excellence of our NTPD
Program will not be compromised in any way as
it is phased out. In addition, the Office of
Professional Experience Programs will
continue to provide their outstanding
services in arranging and monitoring
experiential rotations.
We are also proud of the fact that
this program was the first degreegranting, distance education program
at Ohio State. The distance education
technology we developed and tested, the
Figure 5: Distribution of our Non-Traditional PharmD
unique needs of non-traditional students
students in their professional settings.
we have dealt with, and the multitude of
other experiences we have had should assist the
University in future endeavors in on-line education.
12
Non-Traditional Doctor of Pharmacy Gradutes (2005)
Name
Agbaji, Tami
Al-Ghamedi, Najwa
Brown-Chang, Claudia
Burgess, Simone D
Byers, Theresa
Groubert, Gary Jr.
Hudson-DiSalle, Sarah
Johnson, Shawn
Ludlow, Steven Paul
McAllister, Diane
Myint, Sanda
Papouras-Volakis, Maria
Roten, Jessica Louise
Shammis, Yana
Sill, Bruce
Simons, Lisa Ann
Stevens, Mitali
Straughn, Angela
Tannous, Mona
Taylor, Tracie D
Wijaya, Aida
Hometown
Westerville, OH
Riyadh, Saudi Arabia
Grand Cayman
Kingston, Jamaica
Carroll, OH
Lisbon, OH
Columbus, OH
Pickerington, OH
Toledo, OH
Pickerington, OH
Yangon, Myanmar
Columbus, OH
Hamilton, OH
Ontario, Canada
Glastonbury, CT
Cleona, PA
Solon, OH
Troy, OH
Westlake, OH
Columbus, OH
Beaverton, OR
Honors
Magna Cum Laude
Summa Cum Laude
Magna Cum Laude
Summa Cum Laude
Summa Cum Laude
Magna Cum Laude
Magna Cum Laude
Summa Cum Laude
Magna Cum Laude
Magna Cum Laude
Summa Cum Laude
Summa Cum Laude
Summa Cum Laude
Cum Laude
Magna Cum Laude
Magna Cum Laude
Non-Traditional Doctor of Pharmacy Gradutes (2006)
Name
Ferrell, Matthew
Fiorito, John A.
Goetz, Diana R.
Peterman, Mary
Shah, Tej S.
Yiu, Wai Chun
Hometown
Delaware, OH
Cincinnati, OH
Cincinnati, OH
North Wales, PA
Dublin, OH
Rutherford,NJ
Honors
Summa Cum Laude
Magna Cum Laude
Magna Cum Laude
Magna Cum Laude
13
Undergraduate Program:
Bachelor of Science in the Pharmaceutical Sciences:
O
ur undergraduate programming remains very strong, experiencing
a sizeable increase in enrollment during the period 2005-06. The
students in the Bachelor of Science in the Pharmaceutical Sciences
(BSPS) program study the exciting areas of drug discovery, drug
delivery, drug action, drug distribution and pharmacoeconomics. This
introduction to the major areas of the pharmaceutical sciences, as well
as a general education, encompasses the disciplines of medicinal
chemistry, pharmacognosy, pharmaceutics, pharmacology, toxicology,
and pharmaceutical administration. The program, initiated in 2000 as a
four year undergraduate curriculum, builds a strong science foundation,
develops essential laboratory skills, and provides the experience and
training necessary for graduate education, graduate professional
education, or a health-related career.
We graduated 97 BSPS students in the
2005-06 academic year, a 34% increase
from the previous year. The program
currently has 421 students (Autumn
Quarter 2005), a 27% increase from the
previous year. The mean cumulative gradepoint average was 3.17 for all BSPS
students, and 66.6% of the students had a
cumulative grade-point average above 3.0,
a significant increase (63% ) from the
previous year. Twenty nine BSPS students
are currently participating in undergraduate
research projects. Many of our top students
in this program entered our PharmD
program in the fall, while others have gone
on to medical school, graduate school, or
one of many career options.
Figure 6: Enrollment Growth in the BSPS Program
14
Bachelor of Science in Pharmaceutical Sciences Graduates (2005)
Name
Adomako, Richard
Aimiuwu, Josephine
Bahler, Heidi
Bakos, Matthew Ryan
Barie, Gretchen Lynn
Barker, Stephanie Michelle
Baughman, Aylin
Beachy, Susanna
Beyer, Andrew Paul
Bickar, Amy Lynn
Boakye, Isaac
Campbell, Paul Robert
Chaudhry, Bushra
Cool, Nichole Karista
Cox, Leslie Ann
DeLuco, Nicole Elizabeth
Dev, Punam
Dews, Jennifer Y
Diluciano, Jessica Lynn
Doan, Thomas
Endres, Emily Jo
Engelhardt, Katherine Ann
Funk, Jason Allen
Gembala, Kelly Diane
Gonzalez, Luis Alejhandro
Grosser, Heather Danielle
Hamper, Justin Patrick
Hawk, Nathan Allen
Hinman, Ryan Warren
Jones, Kristina Francine
Kang, Yun-Sung
Kharofa, Jordan Raed
Kidd, Scott Robert
Kim, Hyun Jung
Kox, Leslie Ann
Langford, Scott
Lee, Yongchu An
Li, Kong H
Li, Susana Shuting
Lupfer, April Elise
Marshall, Olga A
Mayo, Armond Miguel
McClain, Barry Michael II
Mean, Kemhorn
Mellott, Michelle Renee
Merhi, Sarah A
Miker, Daniel L
Mitchell, Lindsay Nicole
Nguyen, Stephanie Thuy
Pham, Nancy Gar
Tincher, Laurie Ann
Moracco, Greggory Lee
Nguyen, Amy To
Nicols, Lisa A
Parbhoo, Shirish Kishor
Parmar, Jeniel
Patel, Jyoti H
Patel, Vishal R
Pham, Lynn Thao
Quisno, Adam Michael
Reeves, Kevin Charles
Riser, Brooke Ann
Hometown
Kumasi, Ghana
Columbus, OH
Alliance, OH
Youngstown, OH
Hilliard, OH
Columbus, OH
Columbus, OH
Sugarcreek, OH
Maineville, OH
Imperial, PA
Kumasi, Ghan
Columbus, OH
Cincinnati, OH
Massillon, OH
Willard, OH
Boardman, OH
Middleburg Hts, OH
Cincinnati, OH
Elyria, OH
Cincinnati, OH
Mt. Sterling, OH
Cincinnati, OH
Marietta, OH
N. Olmsted, OH
Columbus, OH
Grove City, OH
Marion, OH
Lynchburgh, OH
Wilmington, OH
Baltimore, OH
Seoul, South Korea
Toledo, OH
Alliance, OH
Seoul, South Korea
Vandalia, OH
Tae-Gu, Korea
Macomb, MI
N. Potomac, MD
Groveport, OH
Mayfield Hts, OH
Washington, DC
Westerville, OH
Grove City, OH
Baltimore, OH
Westlake, OH
Maineville, OH
Nashport, OH
Columbus, OH
Richmond Hts, OH
Westerville, OH
Canfield, OH
Columbus, OH
Lancaster, OH
Powell, OH
Wapakoneta, OH
Mt. Porspect, IL
Hilliard, OH
Cleveland, OH
Oak Harbor, OH
Canfield, OH
Zanesville, OH
Honors
Distinction and Honors
Cum Laude with Distinction and Honors
Magna Cum Laude
Cum Laude
Cum Laude
Cum Laude
Magna Cum Laude with Distinction and Honors
Cum Laude
Cum Laude
Distinction
Distinction
Cum Laude
Cum Laude
Magna Cum Laude with Distinction and Honors
15
Name
Ross, Timothy Travis
Rudy, Jennifer Joyce
Shafto, Adam Keith
Shroll, Joshua Timothy
Siedenberg, Laurie R
Sinharoy, Ronojit
Sohn, Hae Jin Ester
Strelnikova, Natalya
Symonds, Natalie Ann
Thomas, Michelle Ashlee
Truong, Jennifer
Uhas, Adam A
Weber, Charlene M
Williams, Sarah Lindsay
Wilson, Kelly Elaine
Wilson, Tierra Camille
Young, Christopher A
Zidan, Samia Mansour
Hometown
Springfield, OH
Lancaster, OH
Massillon, OH
Bucyrus, OH
Jefferson, WI
Dublin, OH
Saipan, MP
Beachwood, OH
Lima, OH
Dublin, OH
Cleveland, OH
Columbus, OH
McClure, OH
Westerville, OH
Columbus, OH
Trotwood, OH
Youngstown, OH
Haifa, Israel
Honors
Summa Cum Laude
Magna Cum Laude
Honors
Bachelor of Science in Pharmaceutical Sciences Graduates (2006)
16
Name
Adkins, Kelly Ann
Ali, Ibrahim
Arfaoui, Hafid
Atwal, Gagandeep
Awadallah, Shadi M
Balase, Huglyn Dayon
Bayan, Semirra Lynn
Hometown
Columbus, OH
Columbus, OH
Columbus, OH
Parma, OH
Green, OH
Schaumburg, IL
Beavercreek, OH
Beachy, Susanna
Bercovitz, Courtney Rebecca
Brackney, Shawna Lee
Bradley, Nicholas A
Brown, Megan Marie
Bui, Ben Van
Cha, Eungjig
Choksy, Achint V
Cline, Dustin Joseph
Cooper, Andrea Rose
Corbett, Lindsey J
Dellaquila, Matthew James
DelRe, Jessica Lyn
Donahue, Kevin Robert
Espinas, Sebastian S
Ferkins, Amanda Jane
Forman, Joanna, Marie
Gehers, Anna
Glen, Stephanie Nicole
Grapentine, Morgan Rochelle
Grutza, Gabriel Robert
Guttenberg, Eric
Haas, Megan
Harper, Keyonnna
Hassan, Nasir A.
Sugarcreek, OH
Columbus, OH
West Chester, OH
Houghton, MI
Morral, OH
Westerville, OH
Seoul, South Korea
Fairborn, OH
Galena, OH
Stow, OH
Mentor, OH
St. Mary's, PA
Bellebrooke, OH
Akron, OH
Dover, OH
Columbus, OH
Uniontown, OH
Hassen, Eric James
Hasty, Stephanie Leigh
Havens, Karen Jean
Honors
Awards
Magna Cum Laude
with Distinction and
Honors
Magna Cum Laude
Summa Cum Laude
Magna Cum Laude
Magna Cum Laude
Cum Laude
Magna Cum Laude
Summa Cum Laude
Cum Laude
Springfield, OH
Cleveland, OH
Maysville, KY
New Washington, OH Cum Laude
Westerville, OH
Columbus, OH
Columbus, OH
Magna Cum Laude
Honors
Toledo,OH
Avon Lake, OH
Magna Cum Laude
Findlay, OH
Pharmacognosy Award
Name
Holmes, Kandice Rochelle
Hout, Justin Elmer
Huang, Christine
Jindal, Nikunj S
Karakasis, Tammy Marie
Keys, Shannon Catherine
Kiptum, Jane
Kish, Kara Lynn
Kopeck, Rachel Elizabeth
Hometown
Northfield, OH
Mansfield, OH
Columbus, OH
Dublin, OH
Highland Hts, OH
Dublin, OH
Columbus, OH
Powhatan Point, OH
Pemberville, OH
Lambrinides, Christina Marie
Linebaugh, Katherine Ann
Marker, Beth Heather
Mattox, Lauren
McCabe, Ashley Elaine
McEldowney, Jessica Lynn
Miglesz, Dawn Marie
Cincinnati, OH
Columbus, OH
Ashland, OH
Miller, Paul Thomas
Newcomer, Tiffany
Nixon, Dania M
Olayanju, Ahmed
Parnell, Timothy J
Patel, Mitul R
Patel, Niyati
Wheelersburg, OH
Lima, OH
Columbus, OH
Nigeria
Ironton, OH
New Dehli, India
N. Brunswick, NJ
Patel, Roshni
Roberts, Gary Ray
Rozewski, Darlene Marie
Russo, Renee
Saint Germain, Neil Thomas
Schechter, Amy Lauren
Schell, Kylie
Schmidt, Ryan
Schnelle, Brandon J
Sherman, Bradley
Shrader, Kelly Clarke
Sillah, Saffiatu Barry
Sohn, Esther Haejin
Steward, John
Sylvester, Michael Allen
Lima, OH
Hamilton, OH
Mentor, OH
Canal Winchester, OH
Crystal Lake, IL
Cincinnati, OH
Caldwell, OH
Antioch, IL
Van Wert, OH
Monclova, OH
Worthington, OH
Columbus, OH
Columbus, OH
Milford, OH
Columbus, OH
Thomas, Matthew S
Truong, Trang
Galloway, OH
Columbus, OH
Turakhia, Samir
Turner, Kirsten Renee
Van Sant, Elizabeth
Vo, Trinh T
Williams, Anne Elise
Williams, Bethany Marie
Williams, Doris Margaret
Winkhart, Ashley Nicole
Woldemariam, Siem M
Yee, Roger
Yu, Marie
Zink, Andrew R
Zuchowski, Beverly Anne
Solon, OH
Kent, OH
Cincinnati, OH
Parma, OH
Marion, OH
Marion, OH
Wadsworth, OH
Navarre, OH
Worthington, OH
Parma, OH
Columbus, OH
St. Marys, OH
Rossford, OH
Miamisburg, OH
Ansonia, Oh
Hilliard, OH
Honors
Awards
Cum Laude
Cum Laude
Magna Cum Laude
Honors
Cum Laude
Magna Cum Laude
Honors
Magna Cum Laude
Magna Cum Laude
Cum Laude
Magna Cum Laude
Honors
Cum Laude
Magna Cum Laude
Distinction
Cum Laude with
Magna Cum Laude
Honors
Cum Laude
Cum Laude
Cum Laude
Magna Cum Laude
Summa Cum Laude
Faculty Award
17
Graduate Programs in Pharmacy:
T
he MS and PhD programs in pharmacy offer advanced education
in all aspects of pharmaceutical sciences. Pharmaceutical sciences
include all aspects of the discovery, development, and use of
medicines. Thus, the graduate program in pharmacy includes courses
and research associated with discovery and evaluation of new drugs,
determination of the mechanisms by which medicines exert both
beneficial and harmful effects, and optimization of drug delivery to
specific organs requiring treatment. It also includes studies and
research on the ways in which human behavior influences the
purchase and consumption of medicines and seeks to improve the
William Hayton
delivery of medicine and health care information to all patients, with
particular emphasis on those who are currently serviced inadequately.
The goal of the pharmaceutical sciences is to improve health through the use of medicinal
agents. This includes finding and developing new and better drugs and drug delivery systems,
using existing drugs more efficiently, and lowering cost of therapy by improving production,
distribution, and marketing. These goals are accomplished through research in industrial,
academic, and hospital settings and by training of health care providers. Graduates of MS and PhD
programs in pharmacy have integral roles in these functions.
Because the scope of pharmaceutical sciences is so broad, our graduate program has five
specialty areas of emphasis:
The pharmaceutical administration discipline focuses on issues related to the pharmaceutical
care delivery system, pharmacoeconomics, drug distribution and public policy, strategic planning
for pharmaceutical organizations, and drug use behavior and evaluation. A subspecialty within
pharmaceutical administration is the master of health-system pharmacy administration. The
major focus of this program is to educate and train pharmacists to conceptualize, plan,
coordinate and evaluate pharmaceutical care in organized health care settings.
The medicinal chemistry discipline focuses on the interdisciplinary application of chemical,
biochemical, and molecular principles to the identification and development of therapeutic
agents. This includes both synthesis of new chemical entities and isolation of medicinal agents
from natural sources (pharmacognosy).
The pharmaceutics area focuses on pharmacodynamics and pharmacokinetics, with a special
emphasis on drug delivery and targeting systems.
Pharmacology involves identification of new therapeutic targets through multidisciplinary
approaches that exploit emerging molecular biological, biochemical, and biophysical tools to
uncover disease-relevant signal transducton pathways in cells, tissues, and whole animals,
including transgenic models.
18
Our graduate programs in the College of Pharmacy remain strong, with approximately 100
students enrolled this fall in areas of medicinal chemistry and pharmacognosy, pharmaceutics,
pharmacology, and pharmacy administration. The College also offers combined PharmD and
graduate degrees in pharmaceutical sciences: the PharmD/MS and the PharmD/PhD combined
degrees.
Fourteen PhD degrees and twelve MS degrees were awarded this past academic year. Six
graduates received the professional MS degree in Health Systems Pharmacy Administration. Three
graduate students received fellowships from the American Foundation for Pharmaceutical
Education (AFPE), and one student received a University Presidential Fellowship. Graduate
students from three interdisciplinary graduate programs (Ohio State Biochemistry Program,
Molecular Cellular and Developmental Biology, Neurosciences) work with pharmacy faculty
advisors.
MS and PhD Graduates in 2005:
Name
Bohl, Casey Edward
Chen, Jiyun (Sunny)
Chen, Kuen-Feng
Chiu, Shih-Jiuan
Dai, Guowei (David)
Diaz-Cruz, Edgar S.
Huang, Jui-Wen
Hu, Leijun
Hurh, Eunju
Joshi, Mandar Shankar
Lin, Ho-Pi
Lu, Qiang
Lyness, Greg
Pierson, Shawn Michael
Rose, Jane L. (McIntosh)
Salem, Manar
Shaw, Yeng-Jeng
Shiau, Chung-Wai
Stevens, Phillip J.
Tseng, Ping-Hui
Walsh, Colin
Wang, Jie (Jack)
Yang, Jun
Zhu, Jiuxiang (Julie)
Degree
Ph.D.
Ph.D
Ph.D.
Ph.D.
Ph.D.
Ph.D
Ph.D.
Ph.D.
Ph.D.
Ph.D.
Ph.D.
Ph.D.
Ph.D.
Ph.D.
Ph.D.
Ph.D.
Ph.D.
Ph.D.
Ph.D.
Ph.D.
Ph.D.
Ph.D.
Ph.D.
Ph.D.
Area
Pharmaceutics
Pharmaceutics
Medicinal Chemistry
Pharmaceutics
Pharmaceutics
Medicinal Chemistry
Medicinal Chemistry
Pharmaceutics
Pharmaceutics
Pharmacology
Medicinal Chemistry
Medicinal Chemistry
Pharmaceutics
Pharmacology
Pharmacology
Medicinal Chemstry
Medicinal Chemistry
Medicinal Chemistry
Pharmaceutics
Medicinal Chemistry
Pharmaceutics
Pharmaceutics
Pharmaceutics
Medicinal Chemistry
Advisor
Dalton, James
Dalton, James
Chen, Ching-Shih
Lee, Robert
Chan, Kenneth
Brueggemeier, Robert
Chen, Ching-Shih
Wientjes, Guillaume
Dalton, James
Bauer, John
Chen, Ching-Shih
Chen, Ching-Shih
Au, Jessie
Young, Anthony
Hoyt, Dale
Werbovetz, Karl
Chen, Ching-Shih
Chen, Ching-Shih
Lee, Robert
Chen, Ching-Shih
Au, Jessie Au
Au, Jessie
Dalton, James
Chen, Ching-Shih
Bussard, Beth Elaine
Candy, Timothy Alan
Chen, Chang-Shi
Guan, Na
Landini, Serena
McKenzie, Quovadis
Miller, Heather
Pandit, Bulbul
Ramga, Stacy
Su, Bin
Swiderski, Samantha M
Valluri, Satish
Vrontos, Jr., John
Yang, Chih-Cheng
M.S.
M.S.
M.S.
M.S.
M.S.
M.S.
M.S.
M.S.
M.S.
M.S.
M.S.
M.S.
M.S.
M.S.
Hospital Pharmacy
Hospital Pharmacy
Medicinal Chemistry
Pharmaceutics
Medicinal Chemistry
Hospital Pharmacy
Medicinal Chemistry
Medicinal Chemistry
Hospital Pharmacy
Medicinal Chemistry
Hospital Pharmacy
Pharmacy Admin
Hospital Pharmacy
Medicinal Chemistry
Pedersen, Craig
Schneider, Phillip
Chen, Ching-Shih
Dalton, James
Brueggemeier, Robert.
Seoane-Vazquez, E.
Sun, Duxin
Li, T
Schneider, Phillip
Pedersen, Craig
Seoane-Vazquez, E.
Schneider, Phillip
Chen, Ching-Shih
MS and PhD Graduates in 2006:
Name
Byun, Youngjoo
Lu, Dan
Su, Bin
Wei, Xiaohui
Xin, Yan
Yang, Yating
Yu, Bei
Degree
Ph.D.
Ph.D.
Ph.D.
Ph.D.
Ph.D.
Ph.D.
Ph.D.
Abraham, Divya A
M.S.
Barreto Hernandez, Janinah M.S.
Bellebaum, Katherine Louise M.S.
Chen, Ping
M.S.
Delfin, Dawn Athelsia
M.S.
Heitz, Ronald Douglas
M.S.
Inquilla, Carmen
M.S.
Kinsella (Hendrick), Erin
M.S.
Smith, Stephanie Nichole M.S.
Tong, Liyue
M.S.
Area
Medicinal Chemistry
Pharmaceutics
Medicinal Chemistry
Pharmaceutics
Pharmaceutics
Medicinal Chemistry
Pharmaceutics
Advisor
Tjarks, Werner
Wientjes, Guillaume
Chan, K & Marcucci, G
Wientjes, Guillaume
Chen, Ching-Shih
Au, Jessie
Hospital Pharmacy
Hospital Pharmacy
Pharmacy Admin
Medicinal Chemistry
Medicinal Chemistry
Pharmacy Admin
Hospital Pharmacy
Hospital Pharmacy
Hospital Pharmacy
Pharmacology
Schneider, Phillip
Seoane-Vazquez, E
Pedersen, Craig
Li, T
Werbovetz, Karl
Pedersen, Craig
Szeinbach, Sheryl
Pedersen, Craig
Seoane-Vazquez, E
Bauer, John
19
Summary of Student Enrollment and Graduates, 2005/2006
Current Enrollments (Autumn 2005):
Residential PharmD program
Non-traditional PharmD (NTPD)
Graduate Programs
BS Pharmaceutical Sciences
TOTAL
442
91
100
421
1,054
Graduates (includes Winter ’05 through Summer ’06 quarters):
Residential PharmD program
210
Nontraditional PharmD (NTPD)
27
Graduate Programs
55
BS Pharm Sci
168
TOTAL
Student Enrollment Trends
faculty
20
460
Faculty
Faculty
T
he College of Pharmacy faculty are truly outstanding, providing excellent teaching and learning
opportunities to students in both large lectures and small group and clinical settings. They are engaged
in exciting scholarship and state-of-the-art research in pharmacy and the pharmaceutical sciences. Our
faculty and staff serve the University and profession at regional and national levels and are involved in
stimulating outreach and engagement activities. The high quality of our faculty is reflected in this
impressive statistic: two-thirds of our pharmacy senior faculty have been honored by their peers and
elected as Fellows of scientific organizations or professional pharmacy organizations.
The total number of tenure-track faculty, regular clinical faculty, and instructional staff in Autumn
2005 was 61. Recent faculty additions are listed here and a complete list of the faculty by Division is
provided at the end of this section.
New Faculty
The College recruited six new faculty to our ranks, bringing the total number of tenure-track faculty,
regular clinical faculty, and instructional staff to 61.
Pictured below, from left to right:
Dr. Keli Hu, Assistant Professor, Pharmacology. Dr. Hu studies the role of regulated ion channel
function and trafficking in cellular protection against ischemia and/or apoptosis. Her current work
focuses on the molecular signaling mechanisms that cause ATP-regulated potassium channels to
accumulate in mitochondria following exposure of heart cells to brief periods of diminished oxygen.
Dr. Stuart Beatty, Clinical Assistant Professor, Pharmacy Practice and Administration. Dr. Beatty
is teaching, coordinating case conferences in the pathophysiology and therapeutics courses, and
practicing at a general medicine clinic at OSU Medical Center.
Dr. Esperanza Carcache de-Blanco, Assistant Professor, Medicinal Chemistry and Pharmacognosy,
and Pharmacy Practice and Administration. Dr. Carcache de-Blanco is involved in research to
elucidate the mechanism of action of constituents derived from plants using different bioassays.
Dr. Chenglong Li, Assistant Professor, Medicinal Chemistry and Pharmacognosy. Dr. Li specializes
in structure-based/computer-aided drug design to design drugs for cancer and Type II diabetes. He
utilizes X-ray crystallography to determine the three dimensional structures of biologically
important proteins/DNAs/RNAs.
Dr. Wenqing Gao, Assistant Research Professor, Pharmaceutics. Dr. Gao's research interests
include structural biology and molecular pharmacology of selective nuclear receptor modulators,
and the expression regulation of drug metabolizing enzymes by nuclear receptors.
Dr. Raj Balkrishnan, Merrell Dow
Professor, Pharmacy Practice and
Administration. Dr. Balkrishnan’s
research includes diverse topics
related to economic evaluation of
pharmaceuticals, risk adjustment of
health outcomes, quality of primary
care, medication and patient safety,
applied statistical methodology in health
services evaluation, and patient-centered
outcomes evaluation (specifically focused on
patient satisfaction, and medication
adherence behavior).
21
Retired Faculty
C
ongratulations to our faculty who retired from the College in 2005 and 2006. The OSU Board of
Trustees approved the title of Faculty Emeritus for two of our esteemed colleagues.
Dr. John M. Cassady, former dean of the College of Pharmacy and
professor of medicinal chemistry, retired March 2005 and is currently
the Vice President for Research at Oregon State University. Dr.
Cassady's research focuses on the discovery and design of potential
cancer drugs. He is a Fellow of the American Association for the
Advancement of Science (AAAS) and the American Association of
Pharmaceutical Sciences (AAPS) and received an Honorary Doctor
of Science degree from DePauw University and the Research
Achievement Award in Natural Products Chemistry from the
American Pharmaceutical Association.
Dr. Popat Patil, professor of pharmacology, retired June 2005 after
38 years of service to Ohio State and the College of Pharmacy. Dr.
Patil is interested in the details of the interaction of
neurotransmitters and drugs with receptors and how these
interactions produce a change in molecular conformation leading to
a drug effect. Although officially retired, Professor Patil is active on
nearly a full time basis. He is teaching classes and writing various
pieces on the history of pharmacology. He is also evaluating effects
of newly discovered chemicals using a variety of intact organ
models.
Diversity
T
he College of Pharmacy is strongly committed to enhancing diversity among our faculty, staff and student
populations, as we believe a climate for success must be welcoming of difference. We have made significant
progress toward our diversity goals.
Persons-of-color (African-American; Asian/Pacific Islander; Hispanic and Native-American) are represented
in our college community:
Entry-Level Professional Students:
17.3%
BSPS Students:
21.5 %
Graduate Students:
11.0%
Faculty:
37.0% * (national average is 18%)
Staff:
19.0%
To acknowledge our faculty and staff who celebrate diversity in their dealings with students, we awarded
the John M. Cassady Diversity Enhancement Award to Drs. Dennis McKay and Jerry Siegel in 2005 and Ms.
Jennifer Pecora in 2006. They represent the best efforts of our faculty and staff in creating a welcoming and
open atmosphere for everyone in our College and University.
22
Faculty Awards and Recognitions
National Awards
2005
Marialice Bennett
Bennett, Marialice
ASHP Best Practice Award, with C. Green, S. Cook, M. Medow
Beatty, Stuart
Mehta, Bella
APhA-APPM Presentation Merit Award, with Rodis JL, Bellebaum K, Bennett M
Cable, Jerry
Fellow, American Pharmacists Association
Knoell, Daren
Career Development Award, American College of Clinical Pharmacy
Pedersen, Craig
Fellow, American Pharmacists Association
Pruchnicki, Maria
AACP Innovations in Teaching Award, with M. Bennett, J. Legg and D. Mungall,
American Distance Education Consortium Excellence in Distance Education
Award with D. Mungall, A. Khurma and B. Skunza
Wientjes, Guilliame
Fellow, American Association of Pharmaceutical Scientists
Graig Pedersen
2006
Guilliame Wientjes
Buerki, Robert
Pellegrino Medal by the Healthcare Ethics and Law (HEaL) Institute, Samford
University, Birmingham, Alabama
Murphy, Christine
Humanitarian Award, Ohio Society of Health-System Pharmacists
Nahata, Milap
Rho Chi Lecture Award, National Rho Chi Honor Society
Schneider, Phillip
Donald E. Francke Medal, American Society of Health-System Pharmacists
A. Douglas Kinghorn
Fellow, The School of Pharmacy, University of London
College/University Awards
2005
Milap Nahata
Brackett, Cari
Miriam R. Balshone Distinguished Teaching Award, OSU College of Pharmacy
Dasta, Joseph
Jerry Siegel Clinical Service Achievement Award, OSU Medical Center
Pai, Vinita
Preceptor of the Year Award, OSU College of Pharmacy
Werbovitz, Karl A
Bachelor of Science in Pharmaceutical Sciences (BSPS) Teacher of the Year
2006
Phillip Scheinder
A. Douglas Kinghorn
Bennett, Marialice
Miriam R. Balshone Award for Distinguished Teaching, OSU College of Pharmacy
Havard, Patty
Distinguished Faculty Award on Diversity, OSU Multicultural Center
Whetstone, Jennifer
Bachelor of Science in Pharmaceutical Sciences (BSPS) Teacher of the Year
23
Faculty, National Honors
24
7 faculty
Fellows, American Association for the Advancement of Science (AAAS)
Jessie L.-S. Au
Ching-Shih Chen
Milap C. Nahata
M. Guillaume Wientjes
John M. Cassady (emeritus)
Popat N. Patil (emeritus)
14 faculty
Fellows, American Association of Pharmaceutical Sciences (AAPS)
Jessie L.-S. Au
Kenneth K.-H. Chan
Sylvan G. Frank
William L. Hayton
A. Douglas Kinghorn
M. Guillaume Wientjes
John M. Cassady (emeritus)
Louis Malspeis (emeritus)
Robert E. Notari (emeritus)
Dev S. Pathak (emeritus)
Richard H. Reuning (emeritus)
Theodore D. Sokoloski (emeritus)
Albert H. Soloway (emeritus)
3 faculty
Fellows, American College of Clinical Pharmacy (ACCP)
Joseph F. Dasta
Daren L. Knoell
Milap C. Nahata
1 faculty
Fellow, American College of Clinical Pharmacology
Milap C. Nahata
5 faculty
Fellows, American Pharmacists Association (APhA)
Marialice S. Bennett
Gerald L. Cable
George H. Hinkle
Milap C. Nahata
Craig A. Pedersen
4 faculty
Fellows, American Society of Health-System Pharmacists (ASHP)
George H. Hinkle
Milap C. Nahata
Philip J. Schneider
Jerry Siegel
1 faculty
Member, Académie Internationale d'Histoire de la Pharmacy (AIHP)
Robert A. Buerki
Academic Divisions, 2005-06
Division of Medicinal Chemistry and Pharmacognosy
Li, Pui-Kai
Brueggemeier, Robert W.
Carcache de-Blanco, Esperanza
Chen, Ching-Shih
Curley, Robert W.
Kinghorn, A Douglas
Li, Chenglong
Tjarks, Werner
Werbovetz, Karl A.
Whetstone, Jennifer L.
Associate Professor and Interim Chair
Professor and Dean
Assistant Professor (joint, Pharmacy
Practice and Administration)
Professor
Professor
Professor and Jack L. Beal Chair
Assistant Professor
Assistant Professor
Assistant Professor
Visiting Assistant Professor
Cassady, John M.
Doskotch, Raymond
Jagadeesh, Jogikal
Olson, Carter
Robertson, Larry
Soloway, Albert
Emeritus Professor and Dean
Professor Emeritus
Professor Emeritus
Professor Emeritus
Professor Emeritus
Emeritus Professor and Dean
Pui-Kai (Tom) Li
The Division of Medicinal Chemistry and Pharmacognosy is composed of faculty members with diversified
research interests representing synthetic organic, natural products, and biological chemistry. The research areas
focus on the interdisciplinary application of chemical and biochemical principles to the identification and
development of therapeutic agents. Research in medicinal chemistry emphasizes drug design and includes the
synthesis of organic medicinal products, elucidation of the biochemistry of medicinal agents, examination of
the relationship of chemical structure to biological activity, qualitative and quantitative analysis of drugs and
related products, and application of computational
chemistry to drug design. Research in pharmacognosy
emphasizes drug discovery and encompasses the isolation
and structure determination of pharmacologically active
natural products from plants and microbes, studies on
the structure and biochemistry of biological products,
examination of the biosynthesis of natural products, and
evaluation of the biochemical effects of these active
constituents.
Faculty productivity is reflected in scholarly activities
and graduate education, both of which continue at an
accelerated pace. Graduate programs are organized
around faculty expertise into three disciplines medicinal chemistry, biomedical and natural products.
Currently, there are 47 graduate students in the division. Three students from the Ohio
State Biochemistry Program and three students from Electrical Engineering are directed
by Medicinal Chemistry faculty. These students are involved in medicinal chemistry
research, natural products chemistry, biosynthesis and pharmacognosy research.
25
Division of Pharmaceutics
Hayton, William L.
Au, Jessie L.-S.
Chan, Kenneth K.-H.
Dalton, James T.
Frank, Sylvan G.
Gao,Wenqing
Johnston, Jeffrey S.
Kvaratskhelia, Mamuka
Lee, Robert J.
Schmittgen, Thomas D.
Sun, Duxin
Wientjes, M. Guillaume
Professor, Associate Dean and Interim Chair
Distinguished University Professor
Professor
Professor
Professor and Associate Dean
Research Assistant Professor
Visiting Assistant Professor
Assistant Professor
Associate Professor
Associate Professor
Assistant Professor
Professor
Malspeis, Louis
Notari, Robert E.
Sokoloski, Theodore D.
Staubus, Alfred
Professor Emeritus
Professor Emeritus
Professor Emeritus
Associate Professor Emeritus
William Hayton
Pharmaceutics is the science of drug delivery and has a multidisciplinary emphasis. Areas of
pharmaceutics include the preparation and stability of suitable dosage forms, design and evaluation of
dosing regimens and dosage forms (delivery systems) that overcome barriers and optimize drug action
(and minimize adverse effects), understanding of barriers that influence drug absorption and prevent
drug reaching its site of action, quantitative characterization of both the drug concentration-effect
relationship and the concentration-time profile of the drug after it enters the body. Faculty research in
the Division of Pharmaceutics focuses on cancer chemotherapy, drug delivery systems,
pharmacokinetics, pharmacodynamics, and physical pharmacy.
Thirty-four graduate students in the division continue to be competitive for positions in the
pharmaceutical industry. The trend for international student enrollment has been increasing since 2001.
The division awarded seventeen graduate degrees in 2005-06. The Ph.D. graduation rate was the highest
recorded for the division and represents nearly half of the Ph.D degrees awarded by the college during
2005-06. Employment prospects for graduating graduate students remain outstanding with recent
graduates accepting positions in major pharmaceutical companies immediately after graduation.
The division is distinguished by the balanced involvement in both major areas of pharmaceutics:
pharmacokinetics-pharmacodynamics and drug delivery. The faculty is internationally known for cancer
drug pharmacokinetics-pharmacodynamics and establishing a successful model for
translational research in cancer chemotherapy. These researchers are critical to the
cancer program on the Ohio State campus. In addition, faculty in pharmaceutics
discovered, patented and are commercializing inventions from their research. These
discoveries formed the bases for ongoing
clinical trials in the University and
emerging pharmaceutical companies.
Pharmaceutics faculty have strong
collaborative research projects with
faculty in the College, and
interdepartmental collaborative research
projects with faculty across the campus.
26
Division of Pharmacology
Wallace, Lane J.
Elton, Terry S.
Hoyt, Dale G.
Hoyt, Kari R.
Hu, Keli
Keshvara, Lakhu M.
McKay, Dennis B.
Young, Anthony P.
Professor and Chair
Professor
Associate Professor
Assistant Professor
Assistant Professor
Assistant Professor
Professor
Professor
Burkman, Allan
Feller, Dennis
Gerald, Michael
Patil, Popat N.
Uretsky, Norman J.
Professor Emeritus
Professor Emeritus
Professor Emeritus
Professor Emeritus
Professor Emeritus
Lane Wallace
Pharmacology includes the study of drug effects in biological systems, the determination of the
mechanisms by which drugs produce their effects, and optimization of therapeutic regimens. An
understanding of the nature of drug action and the vulnerability of living systems to alterations by
chemicals serves as the basis on which new therapeutic agents are developed and toxic consequences of
chemical exposure are alleviated. Since drugs are chemical substances that modify biological or
physiological processes, pharmacology involves many diverse and inter-related scientific disciplines.
These include chemistry, biochemistry, pathophysiology, cellular and molecular biology, and others.
Pharmacology is a diverse and interdisciplinary field that ranges from the design and evaluation of drug
effects at the cellular and subcellular levels (biochemical and molecular pharmacology) to the study of
drug effects in intact animal models and in humans (experimental and clinical pharmacology).
Pharmacology faculty are experts in a wide range of
pharmacological methods, including intact animal
experimentation (particularly cardiovascular and
neuropharmacology) isolated organ studies, cellular signal
transduction and molecular biology and are funded by major
granting agencies, such as the National Institutes of Health, the
American Heart Association, among others. Our multi-level
approach is an excellent environment for the training of wellrounded pharmacologists. Nine graduate students are currently
pursuing degrees and five completed their graduate degree
during the 2005-06 academic year. A number of undergraduate
students in pharmacology enriched their educational experience
by participating in research projects with faculty advisors.
27
Division of Pharmacy Practice and Administration
Nahata, Milap C.
Balkrishnan, Rajesh
Knoell, Daren L.
Legg, Julie E.
Mehta, Bella H.
McAuley, James W.
Murphy, Christine C.
Pai, Vinita B.
Pedersen, Craig A.
Pruchnicki, Maria C.
Rodis, Jennifer L.
Schneider, Philip J.
Seoane-Vazquez, Enrique C.
Siegel, Jerry
Szeinbach, Sheryl L.
Professor and Chair
Associate Professor and Merrell Dow
Professor
Assistant Professor of Clinical Pharmacy
Professor of Clinical Pharmacy
Associate Professor of Clinical Pharmacy
Professor
Clinical Assistant Professor and Director,
Experiential and Outreach Programs
Associate Professor
Professor
Milap C. Nahata
Clinical Assistant Professor
Clinical Associate Professor and
Assistant Dean
Associate Professor
Associate Professor
Clinical Assistant Professor and Director of Assessment and
Educational Strategies
Associate Professor
Associate Professor
Associate Professor
Clinical Professor and Director, Latiolais Leadership Program
Assistant Professor
Clinical Professor and Assistant Dean, Medical Center Affairs
Professor
Pathak, Dev S.
Reuning, Richard H.
Visconti, James A.
Emeritus Professor
Emeritus Professor
Emeritus Professor
Beatty, Stuart
Bennett, Marialice S.
Brackett, Carolyn C.
Buerki, Robert A.
Cable, Gerald L.
Carnes, Cynthia A.
Casper, Kristin A.
Coyle, James D.
Dasta, Joseph F.
Emptage, Ruth E.
Hale, Kenneth M.
Hall, Laura E.
Havard, Patty F.
Hinkle, Jr., George H.
Huston, Jeffery L.
Kelley, Katherine A.
Faculty in Pharmacy Practice and Administration are involved in teaching, research and delivery of
pharmaceutical care services in various area hospitals, clinics, and ambulatory/community practice settings.
Teaching and scholarship activities include identifying new therapeutic strategies and optimizing therapeutic
outcomes for patients, improving medication use, reducing adverse drug events and drug interactions, and
increasing patient adherence or compliance to therapies. The faculty in pharmaceutical administration teach
and conduct research in assessing medication related health outcomes, effectiveness of health care delivery,
drug policy, technology, pharmacy workforce and patient safety. The active interaction of faculty members and
students within the programs allows students to develop and maintain high standards of professionalism, and
provide the capacity of adapting to the changing pharmaceutical and health care environment. Division
28
faculty have been important participants in the development, implementation, and revision of the Entry Level
and Non-Traditional PharmD programs and the provision of leadership to the overall College planning via the
Curriculum Committee and Pharm.D Program Committee.
There are 24 graduate students in three graduate programs; MS in Health-System Pharmacy
Administration, MS in Pharmaceutical Administration and Ph.D. in Pharmaceutical Administration. The MS
and PhD program in pharmaceutical administration emphasizes evaluation of the medication use systems and
health outcomes, and development of health policy. The MS in health-system pharmacy administration
program focuses on leadership development by educating and training pharmacists to conceptualize, plan,
coordinate, and evaluate the medication use system in organized health care settings. This graduate program is
offered as a combined graduate study-residency program in cooperation with five Columbus hospitals (Grant
Medical Center, Mount Carmel West Hospital, The Ohio State University Medical Center, Riverside
Methodist Hospital, and Columbus Children’s Hospital). The Residency and Fellowship programs remain
strong with 8 trainees. Those who graduated acquired faculty or clinical specialist positions. We continue to
add new partner sites, e.g., Palliative Care Consultant Group, to our Residency program. Our faculty mentor
residents and fellows in teaching through Teaching Mentors and Roundtable Program.
In the area of service, the Division of Pharmacy Practice and Administration provided excellent leadership
to the College, the University, and to national and international professional organizations. Service to student
organizations, College committees, University committees indicates a strong role of the Division at all levels of
University life. Service to hospitals, clinics and several community settings, including substantial clinical
pharmacy service, is an added dimension. Faculty leadership in national professional organizations is an
important projection of Ohio State influence and visibility at the national level.
29
Department of Pharmacy, OSU Medical Center 2006
The College of Pharmacy and the OSU Medical Center Department of Pharmacy have a symbiotic
relationship. Many pharmacy practice and administration faculty and department of pharmacy clinical faculty
collaborate in teaching and research endeavors. OSU Medical Center is the primary site for our experiential
rotations. Senior Director Jerry Siegel, Assistant Dean at the College, and Pharmacy Practice and
Administration Chair, Milap Nahata, also Associate Director, Department of Pharmacy, work closely to
accomplish the missions of the College and the Medical Center.
Siegel, Jerry
Miller, Alicia S.
Griffith, Niesha
Smeenk, David
Haas, Dan
Jordan, Trisha
Tubbs, Crystal
Eskander, Natosha
Forrey, Ryan
Keating, Ellen
Mavko, Lou
Seth, Shiv K.
Gerlach, Anthony
Tschampel, Marva M.
Parbhoo, Rupal
Mirtallo, Jay M.
Shirk, Mary Beth
Pickworth, Kerry K.
Votolato, Nicholas
Pell, Lindsay J.
Edwards, Cowan
Fudge, Robert
Hawksworth, Kim
Gardner, Debra K.
Turowski, Robert
Goff, Debra
Bechtel, Thomas
McPherson, Elizabeth
McNulty, Robert
Pultz, Jr., Andrew J.
Chalupa, Donald L.
Schieber, Ariane
Kemper, Dorothy
30
Senior Director, Pharmaceutical Services, Clinical Associate
Professor, Assistant Dean
Associate Director of Pharmacy
Associate Director, Residency Program Coordinator
Associate Director of Pharmacy
Associate Director of Pharmacy, Director of Pharmacy University
Hospital East
Associate Director, Residency Program Coordinator
Assistant Director, Clinical Pharmacy Services, Residency
Coordinator
Assistant Director
Assistant Director
Medication Utilization Evaluation Coordinator
Staff Pharmacist, Ross Heart Hospital
Specialty Practice Pharmacist, Internal Medicine/transplant
Specialty Practice Pharmacist, Critical Care, Clinical Assistant
Professor
Specialty Practice Pharmacist
Specialty Practice Pharmacist Drug Information Specialist
Specialty Practice Pharmacist, Nutrition Support/Surgery, Clinical
Assistant Professor
Specialty Practice Pharmacist, Critical Care, Clinical Assistant
Professor
Specialty Practice Pharmacist - Cardiology, Clinical Instructor
Specialty Practice Pharmacist, Neuropsychiatry
Specialty Practice Pharmacist, Critical Care and Rehabilitation,
Specialty Practice Pharmacist Nuclear
Specialty Practice Pharmacist & Medication Utilization Evaluation
Coordinator
Specialty Practice Pharmacist, James Cancer Hospital
Specialty Practice Pharmacist, Women and Infants, Assistant
Clinical Professor
Specialty Practice Pharmacist, Infectious Disease Specialist,
Clinical Associate Professor
Specialty Practice Pharmacist- Bone Marrow Transplantation,
Clinical Generalist
Specialty Practice Pharmacist - Hematology/Oncology, James
Cancer Hospital
Clinical Pharmacy Specialist, Investigational Drug Service
Specialty Practice Pharmacist in Internal Medicine, OSU East,
Office Associate
Administrative and Professional Staff 2005-06
Office of the Dean
Brueggemeier, Robert W.
Eshbaugh, Susan B.
Frank, Sylvan G.
Hayton, William L.
Hale, Kenneth M.
Siegel, Jerry
Simon, Mary K.
Professor and Dean
Office Associate
Associate Dean, Professional Programs
Associate Dean, Graduate and Research Studies
Assistant Dean, Student Affairs
Assistant Dean, Medical Center Affairs
Assistant to the Dean
Office of Professional Programs
Frank, Sylvan G.
Hegler, Barbara A.
Kelley, Katherine A.
Associate Dean, Professional Programs and Interim Director,
Non-Traditional Doctor of Pharmacy Program
Program Manager
Director of Assessment
Office of Professional Experience Programs
Cable, Gerald L.
Blight, Thallia
Makarich, Joseph
Murphy, Christine
Director, Experiential and Outreach Programs
Associate Program Coordinator
Coordinator, Introductory Practice Experiences
Intermediate Practice Experiences
Office of Graduate and Research Studies
Hayton, William L.
Brooks, Kathleen I.
Eshbaugh, Susan B.
Wray, Dawn A.
Associate Dean, Graduate and Research Studies
Graduate Program Coordinator
Office Associate
Laboratory Supervisor
Office of Student Affairs
Hale, Kenneth M.
Agresta, Heather S.
Cacioppo, Rose
Evans, June A.
Orozco, Joe
Pecora, Jennifer L.
Assistant Dean, Student Affairs
Director of Admissions
Office Associate
College Registrar
Academic Counselor and Staff Assistant
Director of Undergraduate Programs
Central Business Office
Mead, Marie
Blakemore, Brian
Emmenegger, Linda S.
Malone, Jodi
Sharp, Suzanne F.
Vornholt, Gail
College Fiscal/Personnel Officer
Building Coordinator
College Procurement Coordinator
Grants Manager
Business Services Officer
Human Resources Manager
31
Development and Alumni Affairs
Weiher, Shannon
Marcy, Louis W.
McDay, Tanya R.
Director of Development
Director of Alumni Affairs
Development and Alumni Affairs Coordinator
Computers and Instrumentation
Fowble, John W.
Beranek, Edward
Gladden, Jonathan E.
Hoerig, Casey
Khurma, Anand
Logan, James
Posey, Bruce C.
Director, Senior Systems Manager
Systems Developer/Engineer
Systems Specialist
Systems Manage
Division Coordinators and Staff
Bulgrin, Betsy
Camm, Carol A.
Kivel, Mary
Noble, Emily
Schaner, Tina
Scott, Joy E.
Turner, Sara
Division of Pharmacology
Division of Medicinal Chemistry and Pharmacognosy
Council of Ohio Colleges of Pharmacy
The Council of Ohio Colleges of Pharmacy, the consortium of Ohio’s four colleges of pharmacy, was
established on October 19, 1966, “to work with the pharmacists in Ohio through their various state and
local associations in the planning and implementation of continuing education activities and other vital
activities to the advancement of the profession of pharmacy in Ohio”.
Brusadin, Ronald
Oyler, Julia A.
Smyers, Tammy J.
32
Executive Director
Program Coordinator
Office Administrative
College of Pharmacy
Administrative Organization, 2005
33
Research and Scholarship
R
esearch is a fundamental mission of the College of Pharmacy.
Faculty, students, and research staff are extensively involved in the
discovery and contribution of knowledge to the pharmaceutical
sciences, which cover all aspects of the discovery, development,
and use of medicines. The research mission is inextricably
intertwined with the education of students in all programs of the
college and in particular with the graduate programs. The four
major focus areas of pharmaceutical research are organized by PhD
specialties. Medicinal chemistry and pharmacognosy involves design
and discovery of new drugs via synthetic medicinal chemistry,
natural products chemistry and molecular modeling.
Pharmaceutics focuses on drug delivery and targeting systems to
optimize the therapeutic utility of drugs. Pharmacology examines
William Hayton
the biochemical and physiological mechanisms by which drugs
exert their therapeutic activity. Pharmacy practice and
administration involves the determination of optimal therapies and dosage regimens of
drugs, examination of economic issues related to use of drugs, study of patients'
behaviors relative to use of medicines, and the study of medication use safety.
This past academic year was very productive for our research and scholarship,
achieving unparalleled levels for the College. These accomplishments are the reflection
of the high-quality research being performed on a daily basis by faculty, students,
postdoctoral scholars, and research staff. The number of refereed publications totaled
164 in 2004, an increase of approximately 64% from 2003. The College's research
portfolio includes research grants and contracts from NIH, NSF, US Army Breast
Cancer and Prostate Cancer
Research Programs, other federal
agencies, the State of Ohio, the
pharmaceutical industry, and
private foundations and donors.
Figures 6 and 7 illustrate the
distribution of the total research
funding and the NIH funding.
34
Figure 6. Distribution of Research Funding by Source
Figure 7. Distribution of Research Funding by NIH Agency
35
College Research Day
On May 11, 2006 the College hosted an inaugural event, The College of Pharmacy
Research Day 2006. Research Day 2006 is one of the many new College activities that
promote interdisciplinary discussion and interactions for knowledge exchange relating to
drug discovery, development and therapeutics. The Patil Symposium was held in the
afternoon in honor of emeritus professor, Dr. Popat Patil, Division of Pharmacology, who
retired June 2005. The event recognized Dr. Patil’s distinguished research career and
featured lectures from distinguished alumni who studied under Dr. Patil. College faculty
and students presented 70 posters showcasing their research efforts.
College Distinguished Lecture Series
The Distinguished Lecture Series is designed to bring outstanding pharmaceutical
scientists and educators to the College of Pharmacy to present a lecture of current topical
interest to students and faculty. The lectures are general and aim to inform the College
community at large. The lecturers also interact with faculty and students in their
disciplinary area of interest. Lecturers are nominated by division faculty through the
division chairs. The nominations are reviewed by the Graduate and Research Committee,
which recommends lecturers to the Executive Committee for its approval.
Speakers for the 2005-06 Distinguished Lecture Series were:
Dr. Mansukh C. Wani, Research Triangle Institute
“Plant-Derived Anticancer Agents, Taxol and Camptothecin: From Bench to Bedside”.
Dr. Wani, in partnership with the late Dr. Monroe Wall, discovered two compounds,
camptothecin and Taxol, which since 1992 have been instrumental in the fight against
cancer and whose derivatives today represent nearly one-third of all anti-cancer
medications on the market.
Dr. Neal Castagnoli, Peters Professor of Chemistry, Virginia Polytechnic Institute and
State University
"Mechanistic Studies on the Enzyme-Catalyzed Oxidations of Amines", Dr. Castagnoli is
an expert in molecular mechanisms of drug metabolism and pharmacological
processes including monoamine oxidase and cytochrome P-450 and a noted mass
spectrometrist. His research has been particularly noted for nicotine related
neurotoxicity and neuroprotection and areas that relate to Parkinson's Disease. He
was special assistant to the Commissioner of the Food and Drug Administration and on
editorial boards of reputable journals including the Journal of Pharmacology and
Experimental Therapeutics.
Dr. Daria Hazuda, Vice President, Virus and Cell Biology Research, Merck Research
Laboratories
“HIV-1 Integrase Inhibitors: Past, Present and Future?”. Dr. Hazuda's scientific
interests focus on drugs that target HIV/AIDS and Alzheimer's Disease. Internationally
renowned for her studies on HIV integration, Dr. Hazuda is particularly credited for
discovery of the first authentic HIV integrase inhibitors, which have recently
successfully completed Phase II clinical trials.
Dr. J. Steven Leeder, Marion Merrell Dow Endowed Chair in Pediatric
Pharmacogenomics, The University of Missouri-Kansas City
"Prenatal Pharmacogenetics and the Promise of Developmental Pharmacogenomics".
Dr. Leeder conducts a renowned research program in pharmacogenetics and
pharmacogenomics, with regard to the ontogeny of drug metabolism in children.
Specific emphasis is placed on pharmacogenetic determinants of drug-induced birth
defects and adverse drug reactions in children.
36
College Publications 2005-06
2005 Division of Medicinal Chemistry and Pharmacognosy
J.C. Hackett, R.W. Brueggemeier, and C.M. Haddad, The final catalytic step of cytochrome P450 aromatase: A
density functional theory study. J. Am. Chem. Soc., 127, 5224-5237 (2005).
E.S. Diaz-Cruz, C.L. Shapiro, and R.W. Brueggemeier, Cyclooxygenase inhibitors suppress aromatase expression
and activity in breast cancer cells. J. Clin. Endocrinol. Metab., 90, 2563-2570 (2005).
R.W. Brueggemeier, J.C. Hackett, and E.S. Diaz-Cruz, Aromatase Inhibitors for the Treatment of Breast Cancer.
Endocrine Reviews, 26, 331-345 (2005).
J.C Hackett, Y.-W. Kim, B. Su, and R.W. Brueggemeier, Synthesis and characterization of azole isoflavone
inhibitors of aromatase. Bioorg. Med. Chem., 13, 4063-4070 (2005).
R.W. Brueggemeier, E.S. Díaz-Cruz, P.-K. Li, Y. Sugimoto, Y.C. Lin, C.L. Shapiro, Translational studies on
aromatase, cyclooxygenases, and enzyme inhibitors in breast cancer. J. Steroid Biochem. Molec. Biol., 95, 129-136
(2005).
B. Su, J.C Hackett, E.S. Díaz-Cruz, Y.-W. Kim, and R.W. Brueggemeier, Lead optimization of 7-benzyloxy 2(4’-pyridylmethylthio) isoflavone aromatase inhibitors. Bioorg. Med. Chem., 13, 6571-6577 (2005).
R.W. Brueggemeier, “Sex Hormones (Male), Analogs, and Antagonists” in Encyclopedia of Molecular Cell Biology
and Molecular Medicine, Volume 13, R.A. Meyers, Editor-in-Chief, Wiley-VCH Verlag GmbH & Co., Weinheim,
Germany, 1-69, 2005.
J.-W. Huang, C.-W. Shiau, Y.-T. Yang, K.-F. Chen, S. K. Kulp, R. W. Brueggemeier, C. L. Shapiro, and C.-S.
Chen (2005) “Peroxisome Proliferator-Activated Receptor g-Independent Ablation of Cyclin D1 by
Thiazolidenediones and Their Derivatives in Breast Cancer Cells” Mol Pharmacol, 67, 1342-1348
A. J. Johnson, L. L. Smith, J. Zhu, N. A., Heerema, S. Jefferson, M. R. Grever, C.-S. Chen, J. C. Byrd (2005) “A
novel celecoxib derivative inducesapoptosis in primary CLL cells and transformed B-cll lymphoma via a caspaseand Bcl-2-independent mechanism” Blood, 105, 2504-2509
H. Ding, C. Han, J. Zhu, C.-S. Chen, and S. M. D'Ambrosio (2005) “Celecoxib derivatives induce apoptosis via
the disruption of mitochondrial membrane potential and activation of caspase 9” Int. J. Cancer, 113, 803-810.
C.-W. Shiau, C.-C. Yang, K.-F. Chen, J.-W. Huang, and C.-S. Chen (2005) “Thiazolidenediones mediates
apoptosis in prostate cancer cells, in part, via the inhibition of Bcl-xL/Bcl-2 functions independently of PPARg”
Cancer Res., 65, 1561-1569.
P.-H. Tseng, H.-P. Lin, K.-F. Chen, J. Zhu, J.C C. Byrd, M. R. Grever, B. J. Druker, and C.-S. Chen (2005)
“synergistic interactions between imatinib and the novel phosphoinositide-dependent kinase-1 inhibitor OSU03012 in overcoming imatinib resistance” Blood, 105, 4021-4027.
O.S. Gardner, C.-W. Shiau, C.-S. Chen, and L.M. Graves (2005) “PPARg-independent activation of p38 MAPK
by thiazolidebediones involves calcium/calmodulin-dependent protein kinase II and protein kinase R: correlation
with endoplasmic reticulum stress” J. Biol. Chem., 280, 10109-10118.
C,-S, Chen, S.-C. Weng, P.-H. Tseng, H.-P. Lin, and C.-S. Chen (2005) “Nonepigenetic effects of histone
deacetylase inhibitors on Akt through reshuffling protein phosphatae-1 complexes” J. Biol. Chem, 280, 3887938887.
Q. Lu, D.-S. Wang, C.-S. Chen, Y.D. Hu, and C.-S. Chen (2005) “Structure-based optimization of
phenylbutyrate-derived histone deacetylase inhibitors” J. Med. Chem. 48, 5530-5535.
S. K. Kulp, K.-F. Chen, and C.-S. Chen (2005) “Chemotherapy for prostate cancer” in Prostate Cancer. Basic
mechanisms and Therapeutic Approaches (Ed., C. Chang) World Scientific, New Jersey, pp. 365-82
J.E. Kucab, C. Lee, C.-S. Chen, J. Zhu, C. B. Gilks, M. Cheang, D. Huntsman, E. Yorida, J. Emerman, M.
Pollak, S. E. Dunn (2005) Celecoxib analogues disrupt Akt signaling, which is commonly activated in primary
breast tumours <http://breast-cancer-research.com/content/7/5/R796> Breast Cancer Research 2005, 7:R796-R807
37
Z. Tong, X. Wu, D. Ovcharenko, J. Zhu, C.-S. Chen, J. P. Kehrer (2005) Neutrophil gelatinase associated
lipocalin as a survival factor. Biochem. J. 391, 441-448
Alshafie, G.A.; Walker, J.R.; Curley, R.W., Clagett-Dame, M.; Highland, M.A.; Nieves, N.J.; Stonerock, L.A.;
Abou-Issa, H., “Inhibition of Mammary Tumor Growth by a Novel Non-toxic Retinoid: Chemotherapeutic
Evaluation of a C-Linked Analog of 4-HPR Glucuronide”, Anticancer Res. 2005, 25, 2391-2398.
Rivero-Cruz, J. F.; Lezutekong, R.; Lobo-Echeverri, T.; Ito, A.; Mi, Q.; Chai, H.-B.; Soejarto, D. D.; Cordell, G.
A.; Pezzuto, J. M.; Swanson, S. M.; Morelli, I.; Kinghorn, A. D. Cytotoxic constituents of the twigs of Simaruba
glauca. Phytother. Res., 19,136-140, 2005.
Lobo-Echeverri, T.; Rivero-Cruz, J. F.; Su, B.-N.; Chai, H.-B.; Cordell, G. A.; Pezzuto, J. M.; Swanson, S. M.;
Soejarto, D. D.; Kinghorn, A. D. Constituents of the leaves and twigs of Calyptranthes pallens collected from an
experimental plot in southern Florida. J. Nat. Prod., 68, 577-580, 2005.
Lee, D.; Li, C.; Graf, T. N.; Schunke Vigo, J.; Graham, J. G.; Cabieses, F.; Farnsworth, N. R.; Cordell, G. A.;
Kinghorn, A. D.; Kroll, D. J.; Wani, M. C.; Oberlies, N. H. Diterpene glycosides from Egletes viscosa. Planta
Med., 71, 794-796, 2005.
Jones, W. P.; Lobo-Echeverri, L.; Mi, Q.; Chai, H.; Lee, D.; Soejarto, D. D.; Cordell, G. A. Pezzuto, J. M.;
Swanson, S. M.; Kinghorn, A. D. Antitumor activity of 3-chlorodeoxylapachol, a naphthoquinone from
Avicennia germinans collected from an experimental plot in southern Florida. J. Pharm. Pharmacol., 57, 10011008, 2005. (Special issue devoted to medicinal plants of neotropical origin).
Su, B.-N., Pawlus, A. D.; Jung, H.-A.; Keller, W. J.; McLaughlin, J. L.; Kinghorn, A. D. Chemical constituents
of the fruits of Morinda citrifolia (Noni) and their antioxidant activity. J. Nat. Prod. 68:592-595, 2005.
Mi, Q.; Lantvit, D.; Reyes-Lim, E.; Chai, H.; Pfiher, S.S.; Wani, M.C.; Wall, M. E.; Tan, G. A.; Cordell, G. A.;
Farnsworth, N. R.; Kinghorn, A. D.; Swanson, S. M. Apoptotic anticancer effect of alvaradoin E isolated from
Alvaradoa haitensis. Anticancer Res., 25, 779-788, 2005.
Jang, D. S.; Su, B.-N.; Pawlus, A. D.; Jones, W. P.; Kleps, R. A.; Bunyapraphatsara, N.; Fong, H. H. S.; Pezzuto,
J. M.; Kinghorn, A. D. Limnophilospiroketone, a highly oxygenated phenolic derivative from Limnophila
geoffrayi. J. Nat. Prod. 68, 1134-1136, 2005.
Pawlus, A. D.; Su, B.-N.; Keller, W. J.; Kinghorn, A. D. An anthraquinone with potent quinone reductaseinducing activity and other constituents of the fruits of Morinda citrifolia (Noni). J. Nat. Prod. 68, 1720-1722,
2005. (Rapid communication).
Kim, S; Su, B-N.; Riswan, S., Kardono, L. B. S.; Afriastini, J. J.; Gallucci, J. C.; Chai, H.; Farnsworth, N. R.;
Cordell, G. A.; Swanson, S. M.; Kinghorn, A. D. Edulisones A and B, two epimeric benzo[b]oxepine derivatives
from the bark of Aglaia edulis. Tetrahedron Lett. 46, 9021-9024, 2005.
Li, C.; Lee, D.; Graf, T. N.; Phifer, S.S.; Nakanishi, Y.; Burgess, J. P.; Riswan, S.; Setyowati, F. M.; Saribi, A. M.;
Soejarto, D. D.; Farnsworth, N. R.; Falkinham III, J. O.; Kroll, D. J.; Kinghorn A. D.; Wani, M. C.; Oberlies,
N. H. A hexacyclic ent-trachylobane diterpenoid possessing an oxetane ring from Mitrephora glabra. Org. Lett., 7,
5709-5712, 2005.
Pezzuto, J. M.; Kosmeder II, J. W.; Park, E.J.; Lee, S.K.; Cuendet, M.; Gills, J.; Bhat, K.; Grubhesic, S.; Park,
H.-S.; Mata-Greenwood, E.; Tan, Y.; Yu, R.; Lantvit, D. D.; Kinghorn, A. D. Characterization of natural product
cancer chemopreventive agents. In Cancer Chemoprevention. Vol. 2. Strategies for Cancer Chemoprevention;
Kelloff, G. J., Hawk, E. T., Sigman, C. C., Eds.; Humana Press, Inc.: Totowa, NJ, 2005, pp. 3-37.
Gu, J.; Kinghorn, A. D. Bioactive constituents of plants in the genus Hernandia. In Studies in Natural Products
Chemistry. Vol. 30. Bioactive Natural Products (Part K); A.-ur-Rahman, Ed.; Elsevier Scientific Publications:
Amsterdam, 2005, 559-602.
Pawlus, A. D.; Su, B.-N.; Kinghorn, A. D. Noni (Morinda citrifolia L.). In The Encyclopedia of Dietary
Supplements; Coates, P. M., Blackman, M. R., Cragg, G. M., Levine, M., Moss, M., White J. D., Eds; Marcel
Dekker: New York, 2005, pp. E1-E8. (Published electronically).
38
Jones, W. P.; Kinghorn, A. D. Extaction of plant secondary metanolites. In Natural Products Isolation, 2nd
Edit. (Methods of Biotechnology, No. 20); Sarker, S. D., Latif, Z., Gray, A. I., Eds.; Humana Press, Inc.: Totowa,
NJ, 2005, pp. 323-351.
Thomas MJ,; Mameli M,; Carta M,; Valenzuela CF,; Li PK,; Partridge LD. Neurosteroid paradoxical
enhancement of paired-pulse inhibition through paired-pulse facilitation of inhibitory circuits in dentate granule
cells. Neuropharmacology 2005 Mar;48(4):584-96.
Brueggemeier RW, Diaz-Cruz ES. Li PK, Sugimoto Y, Lin YC, Shapiro CL. Translational studies on aromatase,
cyclooxygenases, and enzyme inhibitors in breast cancer. J Steroid Biochem Mol Biol. 2005 May;95(1-5):129-36.
Li, P. K.; Xiao, Z.; Hu, Z.; Pandit, B.; Sun, Y.; Sackett, D. L.; Werbovetz, K.; Lewis, A.; Johnsamuel, J
Conformationally restricted analogs of Combretastatin A-4 derived from SU5416 Bioorg Med Chem Lett 2005,
15, (24), 5382-5.
Byun, Y.; Yan, J.; Al-Madhoun, A.S.; Johnsamuel, J.; Yang, W.; Barth, R.F.; Eriksson; S.; Tjarks, W.; Synthesis
and Biological Evaluation of Neutral and Zwitterionic 3- Carboranyl Thymidine Analogues for Boron Neutron
Capture Therapy; J. Med. Chem. 48, 1188-1198, 2005.
Bandyopadhyaya, A.K.; Johnsamuel, J.; Al-Madhoun, A.S.; Eriksson; S.; Tjarks, W.; Comparative Molecular Field
Analysis and Comparative Molecular Similarity Indices Analysis of Human Thymidine Kinase 1 Substrates;
Bioorg. Med. Chem., 13, 1681-1689, 2005.
Johnsamuel, J.; Eriksson, E.; Oliveira, M.; Tjarks, W.; Docking simulation with a purine nucleoside specific
homology model of deoxycytidine kinase, a target enzyme for anticancer and antiviral therapy; Bioorg. Med.
Chem., 13, 4160-4167, 2005.
Backer, M.V.; Gaynutdinov, T.I.; Patel, V.; Bandyopadhyaya, A.K.; Thirumamagal, B.T.S.; Tjarks, W.; Barth,
R.F.; Claffey, K.; Backer, J.M.; Vascular endothelial growth factor selectively targets boronated dendrimers to
tumor vasculature, Molecular Cancer Therapeutics, 4, 1423-1429, 2005.
M. Salem and K. Werbovetz. Antiprotozoal compounds from Psorothamnus polydenius, Journal of Natural
Products, 68: 108-111, 2005.
G. Bhattacharya, L. Gerena, S. Jiang, and K. Werbovetz. Activity of amidine-containing diphenylureas against P.
falciparum, Letters in Drug Design & Discovery, 2: 162-164, 2005.
P. Li, Z. Xiao, Z. Hu, B. Pandit, Y. Sun, D. Sackett, K. Werbovetz, A. Lewis, J. Johnsamuel. Conformationally
restricted analogs of Combretastatin A-4 derived from SU5416, Bioorganic and Medicinal Chemistry Letters, 15:
5382-5385, 2005.
2005 Division of Pharmaceutics
Wei, Y. and Au, J.L.-S. Role of tumor microenvironment in mediating chemoresistance. In: Cancer Growth and
Progression. In: Integration/Interaction of Oncologic Growth. (Meadows, G., ed). Kluwer Academic Publishers.
2005. Vol. 15, pp. 285-321, 2005.
Wei, Y. and Au, J.L.-S. Role of tumor microenvironment in mediating chemoresistance. In: Cancer Growth and
Progression. In: Integration/Interaction of Oncologic Growth. (Meadows, G., ed). Kluwer Academic Publishers.
2005. Vol. 15, pp. 285-321, 2005.
Au, J.L.-S., and Wientjes, M.G. Intravesical chemotherapy of superficial bladder cancer: optimization and novel
agents. In: Textbook on bladder cancer. Lerner, S., Schoenberg, M.P., and Sternberg, C., eds., Martin Dunitz
Publishers, 2006, pp. 341-352.
Marcucci G, Stock W, Dai G, Klisovic RB, Liu S, Klisovic MI, Blum W, Kefauver C, Sher DA, Green M,
Moranm M, Maharry K, Novic B, Zwiebel JA, Larson RA, Grever MR, Chan KK, and Byrd JC. Phase I Study of
Oblimersen Sodium, an Antisense to Bcl-2, in Untreated Older Patients with Acute Myeloid Leukemia:
Pharmacokinetics, Pharmacodynamics and Clinical Activity. J of Clin Oncology, 23 (15): 3404-3411, 2005.
39
Otterson GA, Lavelle J, Villalona-Calero MA, Shah M, Wei X, Chan KK, Fischer B, and Grever M. A Phase I
clinical and pharmacokinetic study of fenretinide combined with paclitaxel and cisplatin for refractory solid
tumors. Invest New Drugs 23(6):555-562, 2005.
Xiao JJ, Huang Y, Dai Z, Liu S, Chen J, Covey JM, Wright JM, Byrd J, Marcucci G, Sadée W and Chan KK.
Chemo-resistance to depsipeptide FK228 is mediated by reversible MDR1 induction in human cancer cell lines.
Journal of Pharmacology and Experimental Therapeutics 314(1):467-475, 2005.
Byrd JC, Marcucci G, Parthun MR, Xiao JJ, Klisovic RB, Moran M, Lin TS, Liu S, Wickham J, Davis ME, Lucas
DM, Fischer B, Shank R, Binkley B, Wright J, Chan KK, and Grever MR. A phase 1 study of Depsipeptide
(FK228) in chronic lymphocytic leukemia and acute myeloid leukemia. Blood 105: 959-967, 2005.
Liu Z, Floss HG, Cassady JM, and Chan KK. Metabolism studies of the anti-tumor gent maytansine and its
analog ansamitocin P-3 using liquid chromatography/tandem mass spectrometry. J Mass Spectrom. 40: 389-399,
2005.
Huang Y, Blower PE, Yang C, Barbacioru C, Dai Z, Zhang Y, Xiao JJ, Chan KK, and Sadée W. Correlating gene
expression with chemical scaffolds of cytotoxic agents: ellipticines as substrates and inhibitors of MDR1. The
Pharmacogenomics Journal 5:112-125, 2005.
Liu Z, Chan KK, and Wang JJ. Tandem mass spectrometric analysis of cyclophosphamide, ifosfamide and their
metabolites. Rapid Commun Mass Spectrom, 19 (18): 2581-2590, 2005.
Dai G, Wei X, Liu Z, Liu S, Marcucci G, and Chan KK. Characterization and quantification of Bcl-2 antisense
G3139 and metabolites in plasma and urine by ion-pair reversed phase HPLC coupled with electrospray ion-trap
mass spectrometry. J Chromatog B, 825 (2): 201-213, 2005.
Dai G, Chan KK, Shen TS, Hoyt D, Klisovic M, Caliguri MA, Byrd J, Grever M, and Marcucci, G. Cellular
uptake and intracellular levels of the Bcl-2 antisense G3139 in cultured cells and treated patients with acute
myeloid leukemia. Clinical Cancer Research, 11(8): 2998-3008, 2005.
Xiao JJ, Foraker AB, Swaan PW, Liu S, Huang Y, Dai Z, Chen J, Sadee W, Byrd J, Marcucci G, and Chan KK.
Efflux of depsipeptide FK228 (FR901228, NSC-630176) is mediated by P-glycoprotein and Multidrug
Resistance-Associated Protein 1. J Pharmacol Exp Thera. 313(1): 268-276, 2005.
Miller DD, Brueggemeier RW, and Dalton JT. Adrenocorticoids. In: Principles of Medicinal Chemistry, 5th
Edition. Foye WO, Lemke Tl, and Williams DA (Eds.), Williams and Wilkins, Baltimore, MD.
Miller DD, Brueggemeier RW, and Dalton JT. Men's Health. In: Principles of Medicinal Chemistry, 5th Edition.
Foye WO, Lemke Tl, and Williams DA (Eds.), Williams and Wilkins, Baltimore, MD.
Bohl CE, Miller DD, Chen J, Bell CE, and Dalton JT. Structural Basis for Accomodation of Nonsteroidal
Ligands in the Androgen Receptor. Journal of Biological Chemistry, 280(45):37747-37754, 2005.
Bohl CE, Gao W, Miller DD, Bell CE, Dalton JT. Structural Basis for Antagonism and Resistance of
Bicalutamide in Prostate Cancer. Proc Natl Acad Sci U S A. 102(17): 6201-6206, 2005.
Chen J, Kim J, and Dalton JT. Discovery and Therapeutic Promise of Selective Androgen Receptor Modulators.
Molecular Interventions, 5(3):173-188, 2005.
Phelps MA, Foraker AB, Gao W, Dalton JT, Swaan PW. A novel rhodamine-riboflavin conjugate probe exhibits
distinct fluorescence resonance energy transfer that enables riboflavin trafficking and subcellular localization
studies. Molecular Pharmaceutics, 1(4):257-66, 2005.
Chen J, Hwang DJ, Chung K, Bohl CE, Fisher SJ, Miller DD, Dalton JT. In vitro and in vivo structure-activity
relationships of novel androgen receptor ligands with multiple substituents in the B-ring. Endocrinology,
146(12):5444-54, 2005.
Nair V, Mustafa SM, Mohler ML, Fisher SJ, Dalton JT, and Miller DD. Synthesis of irreversibly binding
bicalutamide analogs for imaging studies. Tetrahedron Letters, 46:4821-4823, 2005.
40
Chen J, Hwang DJ, Bohl CE, Miller DD, and Dalton JT. A Selective Androgen Receptor Modulator (SARM)
for Hormonal Male Contraception. Journal of Pharmacology and Experimental Therapeutics, 312(2): 546-553,
2005.
Gao W, Reiser PJ, Coss CC, Phelps MA, Kearbey JD, Miller DD, and Dalton JT. Selective Androgen Receptor
Modulator (SARM) Treatment Improves Muscle Strength and Body Composition, and Prevents Bone Loss in
Orchidectomized Rats. Endocrinology, 146(11):4887-4897, 2005.
Gao W, Bohl CE, and Dalton JT. Chemistry and structural biology of androgen receptor. Chemical Reviews,
105(9):3352-70, 2005.
Gududuru V, Hurh E, Dalton JT, Miller DD. Discovery of 2-Arylthiazolidine-4-carboxylic acid Amides as a New
Class of Cytotoxic Agents for Prostate Cancer. J Med Chem. 48(7):2584-2588, 2005.
Gududuru V, Hurh E, Sullivan J, Dalton JT, and Miller DD. SAR Studies of 2-Arylthiazolidine-4-carboxylic
Acid Amides: A Novel Class of Cytotoxic Agents for Prostate Cancer. Bioorganic Medicinal Chemistry Letters,
15(18): 4010-4013, 2005.
Kim J, Wu D, Hwang DJ, Miller DD, and Dalton JT. The 4-Para-Substituent of S-3-(Phenoxy)-2-hydroxy-2methyl-N-(4-nitro-3-trifluoromethyl-phenyl)-propionamides is a Major Strcutural Determinant of In Vivo
Disposition and Activity of Selective Androgen Receptor Modualtors. Journal of Pharmacology and Experimental
Therapeutics, 315(1):230-239, 2005.
Ekins S, Johnston JS, Bahadduri P, D'Souza VM, Ray A, Chang C, and Swaan PW, In vitro and pharmacophorebased discovery of novel hPEPT1 inhibitors. Pharm Res 22:512-517, 2005.
Yong C, and Frank SG. Isothermal Crystallization Kinetics of Lidocaine in Supersaturated Lidocaine/Polyacrylate
Pressure Sensitive Adhesive Systems, J. Pharm. Sci., 94, 2039-2048, 2005.
Shell SM, Hess S, Kvaratskhelia M, Zou Y. Mass spectrometric identification of lysines involved in the
interaction of human replication protein A with single-stranded DNA. Biochemistry. 25:971-8, 2005.
Williams KL, Zhang Y, Shkriabai N, Karki RG, Nicklaus MC, Kotrikadze N, Hess S, Le Grice SF, Craigie R,
Pathak VK, Kvaratskhelia M. Mass spectrometric analysis of the HIV-1 integrase-pyridoxal 5'-phosphate complex
reveals a new binding site for a nucleotide inhibitor. J. Biol. Chem. 280:7949-55, 2005.
Liu Y, Kvaratskhelia M, Hess S, Qu Y, Zou Y. Modulation of replication protein A function by its
hyperphosphorylation-induced conformational change involving DNA binding domain B. J. Biol. Chem.
280(38):32775-83, 2005.
Liu Q, and Lee, RJ. Folate Receptor Targeted Liposomes Drug Design Reviews - Online, Vol. 2, No. 7.Nov., pp.
547-552, 2005.
Pan XQ and Lee RJ. In vivo antitumor activity of folate receptor-targeted liposomal daunorubicin in a murine
leukemia model. Anticancer Res. 25: 343 - 346, 2005.
Schmittgen TD, Gissel KA, Zakrajsek BA, Lawrence BP, Liu Q., Jupe ER, Lerner ML, Do SV, and Brackett DJ.
Diverse gene expression pattern during 5-fluorouridine-induced apoptosis. Int. J. Oncol., 27:297-306, 2005.
Jiang J., Lee EJ, Gusev Y, and Schmittgen TD. Real-time expression profiling of microRNA precursors in human
cancer cell lines. Nucleic Acids Res., 33:5394-5403, 2005.
Cheng H, Cao, X, Xian M, Fang L, Cai TB, Tunac JB, Sun D, Wang GP. Synthesis and enzyme-specific
activation of carbohydrate-geldanamycin conjugates with potent anticancer activity. J Med Chem, 48: 645, 2005.
Zhang G, Shen J, Cheng H, Zhu L, Luo S, Muller MT, Sun D, and Wang PG. Syntheses and biological activities
of rebeccamycin analogues with uncommon sugar. Journal of Medicinal Chemistry, 48(7); 2600-261, 2005.
Xiao JJ, Cao X, Fang J, Hinkle GH, Horst SN, Kocak E, Young D, Agnese DM, Sun D, and Martin Jr EW.
Pharmacokinetics and clinical evaluation of 125-I Radiolabeled Humanized CC49 Monoclonal Antibody
41
(HuCC49DeltaCH2) in Recurrent and Metastatic Colorectal Cancer Patients. Cancer Biotherapy and
Radiopharmaceuticals, 20(1); 16, 2005
Zhu L, Cao X, Chen W, Zhang G, Sun D, Peng Wang PG. Syntheses and Biological Activities of Daunomycin
Analogs with Uncommon Sugars. Bioorganic and Medicinal Chemistry 13: 6381-6387, 2005.
Cao X, Yu LX, Barbaciru C, Landowski CP, Shin H-C, Amidon GL, and Sun D. Permeability Dominates In
Vivo Intestinal Absorption of P-gp Substrate with High Solubility and High Permeability. Molecular Pharmaceutics
2(4); 329-340, 2005.
Zhang G, Fang L, Zhu L, Aimiuwu JE, Shen J, Cheng H, Muller MT, Lee GE, Sun D, and Wang PG. Syntheses
and Biological Activities of Disaccharide Daunorubicins. Journal of Medicinal Chemistry 48, 5269-78, 2005.
Zhou R, Moench P, Heran C, Lu X, Mathias N, Faria T, Wall DA, Hussain MA, Smith RL, and Sun D. pHDependent Dissolution In Vitro and Absorption In Vivo of Weakly Basic Drugs: Development of a Canine
Model. Pharmaceutical Research, 22: 188, 2005
Bolanos-Meade J., Jacobsohn DA, Margolis J, Ogden A, Wientjes MG, Byrd JC, Lucas DM, Anders V, Phelps
M, Grever MR, and Vogelsang GB. Pentostatin in steroid-refractory acute graft-versus-host disease. J Clin. Oncol.,
23:2661-2668, 2005.
Wientjes MG, Zheng JH, Hu L, Gan Y, and Au JL-S. Intraprostatic chemotherapy: Kinetics and mechanisms of
doxorubicin transport. Clin. Cancer Res., 11:4204-4211, 2005.
Xin Y, Song SH, Lyness G, Chen D, Jang S, Wientjes MG, and Au JL-S. Low-dose suramin as achemosensitizer
of bladder cancer to mitomycin C. J Urol, 174:322-327, 2005.
Lu Z, Wientjes MG, and Au JL-S. Nontoxic suramin treatments enhance docetaxel activity in chemotherapypretreated nonsmall cell lung xenograft tumors. Pharm. Res, 22:1069-1078, 2005.
Xin Y, Song SH, Lyness G, Chen D, Jang S, Wientjes MG, and Au JL-S. Low-dose suramin as a chemosensitizer
of bladder cancer to mitomycin C. J Urol, 174:322-327, 2005.
Yeh TK, Lu Z, Wientjes MG, and Au JL-S. Formulation of paclitaxel alters its disposition. Pharm. Res, 22:867874, 2005.
2005 Division of Pharmacology
Baliga, R. S., Chaves, A. A., Jing, L., Ayers, L. W., and Bauer, J. A. “AIDS-related vasculopathy: evidence for
oxidative and inflammatory pathways in murine and human AIDS.” American Journal of Physiology-Heart and
Circulatory Physiology 289, H1373-H1380; 2005.
Poladia, D. P. and Bauer, J. A. “Functional, structural, and neuronal alterations in urinary bladder during
diabetes: Investigations of a mouse model.” Pharmacology 74, 84-94; 2005.
Soucy, N. V., Mayka, D., Klei, L. R., Nemec, A. A., Bauer, J. A., and Barchowsky, “A. Neovascularization and
angiogenic gene expression following chronic arsenic exposure in mice.” Cardiovascular Toxicology 5, 29-41; 2005.
Speth, R.C., Kwan, H.K., Elton, T.S. and Simasko, S. “Sarcosine1, Glycine8 Antiotensin II is a functional AT1
angiotensin receptor antagonist.” Endocrine 26: 83-87, 2005.
Dai, G.W., Chan, K.K., Liu, S.J., Hoyt, D., Whitman, S., Kilsovic, M., Shen, T.S., Caligiuri, M.A., Byrd, J.,
Grever, M. and Marcucci, G. “Cellular uptake and intracellular levels of the Bcl-2 antisense G3139 in cultured
cells and treated patients with acute myeloid leukemia.” Clinical Cancer Research 11(8): 2998-3008, 2005.
Rose, J.L., Huang, H., Wray, S.F. and Hoyt, D.G. “Integrin engagement increases histone H3 acetylation and
reduces histone H1 association with DNA in murine lung endothelial cells.” Molecular Pharmacology 68(2): 439446, 2005.
42
Lee, B., Butcher, G.Q., Hoyt, K.R., Impey, S. and Obrietan, K. “Activity-dependent neuroprotection and
CREB: kinase coupling, stimulus intensity, and temporal regulation of CREB phosphorylation at Serine 133.”
Journal of Neuroscience 25: 1137-1148, 2005.
Huang, Y.C., Shah, V., Liu, T.Z. and Keshvara, L. “Signaling through Disabled 1 requires phosphoinositide
binding.” Biochemical And Biophysical Research Communications 331(4): 1460-1468, 2005.
Free, R.B., McKay, S.B., Gottlieb, P.D., Boyd, R.T. and McKay, D.B. “Expression of native alpha 3 beta 4*
neuronal nicotinic receptors: Binding and functional studies investigating turnover of surface and intracellular
receptor populations.” Molecular Pharmacology 67(6): 2040-2048, 2005.
Hong, S.S., Bavadekar, S.A., Lee, S.I., Patil, P.N., Lalchandani, S.G., Feller, D.R. and Miller, D.D. “Bioisosteric
phentolamine analogs as potent alpha-adrenergic antagonists.” Bioorganic & Medicinal Chemistry Letters 15(21):
4691-4695, 2005.
Poladia, D.P., Schanbacher, B., Wallace, L.J. and Bauer, J.A. “Innervation and connexin isoform expression
during diabetes-related bladder dysfunction: early structural vs. neuronal remodelling.” Acta Diabetologica 42(3):
147-152, 2005.
2005 Division of Pharmacy Practice and Administration
Kulkarni AS, Balkrishnan R, Richmond DW, Pearce DJ, Feldman SR. Medication related factors affecting health
care outcomes and costs in patients with psoriasis in the United States. Journal of the American Academy of
Dermatology - 52(1):27-31, 2005.
Balkrishnan R, Nelsen LM, Kulkarni AS, Pleasants RA, Whitmire JT, Schechter MJ. Outcomes associated with
initiation of different controller therapies in a Medicaid asthmatic population: a retrospective data analysis.
Journal of Asthma - 42(1):39-44, 2005.
Carroll CL, Clarke J, Camacho FT, Balkrishnan R, Feldman SR. Topical Tacrolimus Ointment Combined with
6% Salicylic Acid Gel for Plaque Psoriasis Treatment. Archives of Dermatology - 141(1):43-46, 2005.
Barshes NR, Lee TC, Goodpastor SE, Balkrishnan R, Schock AP, Mote A, Brunicardi FC, Alejandro R, Ricordi
C, Goss JA. Transaminitis following pancreatic islet transplantation. Journal of the American College of Surgeons 200(3):353-361, 2005.
Balkrishnan R, Jurgensmeyer JC, Shenolikar RA, Fleischer AB, Feldman SR. Prescribing Patterns for Topical
Retinoids within NAMCS Data. Journal of Drugs in Dermatology - 4(2):172-179, 2005.
Hite RD, Seeds MD, Bowton DL, Grier BL, Safta AM, Balkrishnan R, Waite BM, Bass DA. Surfactant
Phospholipid changes after Antigen Challenge: A Role for Phosphatidylyglycerol in Dysfunction. American
Journal of Physiology - 288(4):L610-L617, 2005.
Balkrishnan R, McMichael AJ, Hu JY, Camacho FT, Kaur M, Bouloc A, Rapp SR, Feldman SR. Corrective
Cosmetics Improve the Quality of Life of Women with Facial Pigmentary Disorders. Cutis - 75(3):181-187, 2005.
Balkrishnan R, Rasu RS, Rajagopalan R. Physician and patient determinants of the pharmacological treatment of
sleep difficulties in outpatient settings in the United States. Sleep - 28(6):715-719, 2005.
McCall BP, Horwitz IB, Feldman SR, Balkrishnan R. Incidence rates, costs, severity, and work related factors of
occupational dermatitis: A workers compensation analysis of Oregon 1990-97. Archives of Dermatology 141(6):713-718, 2005.
Venkat AV, Kulkarni AS, Scheinfeld NS, Balkrishnan R, Feldman SR. Health insurance benefit limits: An
analysis of the impact on psoriasis treatment. Journal of the American Academy of Dermatology - 53(1):140-142,
2005.
Barshes NR, Vanatta JC, Inman S, Mote A, Schock AP, Balkrishnan R, Brunicardi FC, Goss JA. Health-related
quality of life after pancreatic islet transplantation: a longitudinal study. Transplantation - 79(12):1727-1730,
2005.
43
Cayce KA, Krowchuk DP, Feldman SR, Camacho FT, Balkrishnan R, Fleischer AB. Healthcare Utilization for
Acute and Chronic Diseases of Young, School-age Children in the Rural and Non-rural Setting. Clinical Pediatrics
- 44(6):491-498, 2005.
Coldiron B, Fisher AH, Adelman E, Yelverton CB, Balkrishnan R, Feldman MA, Feldman SR. Adverse event
reporting: lessons learned from 4 years of Florida office data. Dermatologic Surgery. 31(9):1079-1092, 2005.
Hancox JG, Balkrishnan R, Battle J, Housman TS, Fleischer AB Jr, Feldman SR. Limited availability of psoriasis
and phototherapy care: an analysis of advertisements. Dermatology Online Journal. 11(2):6, 2005 (Online
publication).
Barshes ND, Lee TC, Balkrishnan R, Karpen SJ, Carter BA, Goss JA. Orthotopic Liver Transplantaton for
Biliary Atresia: the US Experience. Liver Transplantation - 11(10):1193-1200, 2005.
Graham GF, Camacho FT, Rosenborough I, Taylor S, Gratton B, Balkrishnan R, Feldman SR, Graham JH.
Patients with solar keratoses of the trunk and lower extremity are at high risk of development of skin cancer.
Clinical and Experimental Dermatology - 30(6): 717-718, 2005.
Thevarajah S, Balkrishnan R, Camacho FT, Feldman SR, Fleischer AB. Trends In Prescription Of Acne
Medication In The US: Evidence For Effects Of Microbial Resistance On Prescribing Behavior. Journal of
Dermatological Treatment - 16(4):224-228, 2005.
Balkrishnan R, Camacho FT, Pearce DJ, Kulkarni AS, Spencer L, Fleischer AB, Feldman SR. Factors influencing
prescription of ultra high potency topical corticosteroids for psoriaisis treatment in US outpatient settings. Journal
of Drugs in Dermatology. 4(6): 699-706, 2005.
Ziel K, Yelverton CB, Balkrishnan R, Feldman SR. Cumulative Irritation Potential of Metronidazole Gel
Compared to Azelaic Acid Gel after Repeated Applications to Healthy Skin. Journal of Drugs in Dermatology. 4(6):
727-731, 2005.
Pearce DJ, McGowan J, Balkrishnan R, Richmond D, Chen GJ, Feldman SR. The skinny on psoriasis and
obesity. Archives of Dermatology - 141(12):1601-1602, 2005.
Pearce DJ, Morrison AE, Higgins KB, Crane MM, Balkrishnan R, Fleischer AB Jr, Feldman SR. The comorbid
state of psoriasis patients in a university dermatology practice. Journal of Dermatological Treatment - 16(5/6): 319323, 2005.
Balkrishnan R. The Importance of Medication Adherence in Improving Chronic-disease related Outcomes: What
we know and what we need to further know. Medical Care - 43(6):517-520, 2005. (Peer reviewed editorial)
Beatty SJ, Mehta BH, Rodis JL. Decreased Warfarin Effect after Initiation of High-Protein, Low-Carbohydrate
Diets. Annals of Pharmacotherapy 2005;39:744-7
Dasta J, Kim SR, McLaughlin TP, Mody S, Piech CT. Incremental daily cost of mechanical ventilation in patients
receiving treatment in an intensive care unit. Crit Care Med 2005;33:1266-71
Kane SL, Dasta JF, Schneider PJ, Pathak DS, Cook C. Monitoring abnormal laboratory values as antecedents to
drug-induced injury. J Trauma 2005:59:1457-62.
LeBlanc J, Dasta JF. The scope of international pharmacy practice: A review. Ann Pharmacother 2005;30;183191.
Schetz M, Dasta J, Goldstein S, Golper T. Drug-induced acute kidney failure. Curr Opin Crit Care 2005:11:55565
Dasta JF, Durtschi AJ, Kane-Gill SL. Pharmacoeconomics in Critical Care. Grenvik, A (Editor) Textbook of
Critical Care, 5th Edition, 2005 pp 1732-1739.
Emptage RE. Providing homebound patients with pharmaceutical services. Am J Health Syst Pharm 2005;
62(14):1491-3.
44
Joy S, Poi M, Hughes L, Brady MT, Koletar SL, Para MF, and Fan-Havard P. Third trimester maternal
toxicity with nevirapine use in pregnancy. Obstet & Gynecol 2005; 106:1032-1038.
Fan-Havard P. Vision of Life: A lesson learned from a 98-year old artist on World AIDS Day. Annals of
Pharmacotherapy 2005; 39; 2111-3
Fan-Havard P. CMV Retinitis. In: Pharmacotherapy Casebook A Patient-Focused Approach, 6th Edition.
McGraw-Hill, Company, Inc., New York, 2005: pp:352-354.
Fan-Havard P. CMV Retinitis. In: Pharmacotherapy Casebook: Instructor's Guide, 6th Edition. McGraw-Hill
Company, Inc., 2005 (ISBN: 0-07145771-2).65)
Fan-Havard P and Zabawski EJ. Cidofovir. In: Antimicrobial Therapy and Vaccines: Volume II: Antimicrobial
Agents, 2nd Edition. Eds Yu VL, Edwards G, McKinnon PS, Peloquin C, Morse G. ESun Technologies, LLC.,
Pittsburg, PA. 2005: pp:731-745.
Xiao J, Horst S, Hinkle G, Cao X, Kocak E, Fang J, Young D, Khazaeli M, Agnese D, Sun D, Martin Jr. E.
Pharmacokinetics and Clinical Evaluation of I-125 Radiolabeled Humanized CC49 Monoclonal Antibody
(HuCC49_CH2) in Recurrent and Metastatic Colorectal Cancer Patients. Cancer Biother Radiopharm
2005;20:16-26.
Yearsley M, Knoell DL, Diaz PT, Nuovo G. Correlation of HIV-1 detection and histology in AIDS-associated
emphysema Diagnostic Molecular Pathology. 2005;14 (1):48-52.
Sweeney P., Wang Y., Chaudhuri A., Doseff AI., Marsh CB., Knoell DL. Keratinocyte Growth Factor induces Akt
kinase and inhibits Fas-mediated apoptosis in A549 lung epithelial cells. Amer J Phys Lung Cell Mol Physiol.
2005;288: L36-42.
Bahadduri P, D’Souza R, Pinsonneault J, Sadee W, Knoell D, Swaan P. Functional characterization of PepT2
transporter in primary human lung epithelial cells. Amer J Resp Cell Mol Biol. 2005:32:1-7. (Impact 4.175; Rank 3
out of 33 in Respiratory)Role: Co-investigator.
Long L, McAuley JW, Shneker B, Moore JL. The Validity and Reliability of the Knowledge of Women’s Issues
and Epilepsy (KOWIE) Questionnaires I & II. Journal of Neuroscience Nursing 37:88-91, 2005.
Shneker BF, McAuley JW. Pregabalin: A New Neuromodulator with Broad Therapeutic Indications. Annals of
Pharmacotherapy 2005;39:2029-37.
McAuley JW. Complex Partial Seizures: A Lifelong Pattern. In: Schwinghammer TL, ed. Pharmacotherapy: A
patient-focused approach. Stamford, CT: Appleton & Lange, 6th Edition 2005 (171-173) [Note: this is a case
presentation/answer guide in a casebook that accompanies a Therapeutics textbook]
Mehta BH, Rodis JL, Nahata MC, Bennett MS. Advancing Patient Care through Innovative Practice: The
Clinical Partners Program. AJHP 2005;62:2501-7.
Mehta BH, Rodis JL, Nahata MC, Bennett MS. Advancing Patient Care through Innovative Practice: The
Clinical Partners Program. AJHP 2005;62:2501-7.
Benavides S, Striet J, Germak J, Nahata MC*. Efficacy and safety of hypoglycemic drugs in patients with type 2
diabetes mellitus. Pharmacotherapy 25:803-809, 2005.
Rasu R, Shenolikar RA, Nahata MC, Balkrishnan R. Physician and Patient Factors Associated With Prescribing
of Sleep Disorder Medications in United States Outpatient Settings: An Analysis of the NAMCS 1996-2001.
Clinical Therapeutics - 27(12): 1970-1979, 2005.
Nash JD, Nahata MC. Improving access to prescription drugs for indigent and uninsured populations. Journal of
Applied Therapeutic Research 5:9-15, 2005.
Caballero J, Koranyi K, Brady M, Nahata MC. Depression in children with HIV infection. Journal of Pediatric
Pharmacology and Therapeutics 10: 51-60, 2005.
45
Spiker E, Giannamore M, Nahata MC*. Medication use patterns and health outcomes among patients utilizing a
subsidized prescription program. Journal of American Pharmacists Association 45(6): 714-719, 2005.
Robinson RF, Nahata MC, Sparks E, Daniels C, Batisky DL, Hayes JR, Mahan JD. Relationship of abnormal left
ventricular mass and aortic distensibility in pediatric dialysis patients. Pediatric Nephrology 2005;20:64-68.Epub
2004 Oct 27.
Robinson RF, Batisky DL, Hayes JR, Nahata MC, Mahan JD. Significance of heritability in primary and
secondary pediatric hypertension. Am J Hypertens. 2005 Jul;18(7):917-21.
Nahata MC. Pediatrics. In: Pharmacotherapy: A Pathophysiological Approach, 6th edition. DiPiro, Talbert, Yee et
al (editors), McGraw Hill, New York, 91-101, 2005.
Caballero J, Nahata MC. Use of selective serotonin-reuptake inhibitors in the treatment of depression in adults
with HIV. Annals of Pharmacotherapy 39:141-145, 2005.
Weise K, Nahata MC. EMLA for painful procedures in infants. Journal of Pediatric Health Care 19:42-47, 2005.
Mistry R, Nahata MC. Ketamine for conscious sedation in pediatric emergency care. Pharmacotherapy 25:11041111, 2005.
Carr R, Nahata MC. Complementary and alternative medicine for upper respiratory tract infection in children.
American Journal of Health-System Pharmacy 63:33-39, 2005.
Rasu R, Balkrishnan R, Shenolikar RA, Nahata MC. Treatment of insomnia: a review and update. Expert Review
of Pharmacoeconomics and Outcomes Research 5(6):733-740, 2005.
Robinson RF, Nahata MC, Batisky DL, Mahan JD. Pharmacologic treatment of chronic pediatric hypertension.
Pediatric Drugs 7(1): 27-40, 2005.
Nahata MC, O’Mara N. Benavides S. Viral infections. In: Applied Therapeutics: The Clinical Use of Drugs, 8th
edition. Koda-Kimble et al (editors). Lipincott Williams & Wilkins, 1-20, 2005
Pai, V, Nahata MC. Drug dosing in pediatric patients. In: Clinical Pharmacokinetics, 3rd edition. Murphy
(editor), 413-430, 2005.
Savage S, Schneider PJ, Pedersen CA. “Utility of an Online Medication-Error-Reporting System.” American
Journal of Health-System Pharmacy 2005; 62:2265-70.
Pedersen CA, Schneider PJ, Scheckelhoff DJ. “ASHP national survey of pharmacy practice in hospital settings:
prescribing and transcribing-2004.” American Journal of Health-System Pharmacy 2005; 62(4):378-90.
Pedersen CA. “Pharmacists and the U.S. Health Care System.” In Wertheimer AI and Smith MI, Pharmacy and
the US Health Care System. Pharmaceutical Products Press, 2005.
Joy MS, DeHart RM, Gilmartin C, Hachey DM, Hudson JQ, Pruchnicki M, et al. Clinical pharmacists as
multidisciplinary healthcare providers in the management of CKD: a joint opinion by the Nephrology and
Ambulatory Care Practice and Research Networks of the American College of Clinical Pharmacy. Am J Kidney Dis
2005;45:1105-18.
Kane-Gill, SL, Feng, Y, Bobek, MB, Bies, RR, Pruchnicki, MC, Dasta, JF: Administration of enoxaparin by
continuous infusion in a naturalistic setting: Analysis of renal function and safety. J Clin Pharm Ther
2005:30:207-213
Pruchnicki MC, Bennett MS, Legg JE, Mungall D. Development and Implementation of a Web-Based
Advanced Teaching Experience. Am J Pharm Educ. 2005; 69(2):article 22
Zillich AJ, Saseen JJ, DeHart RM, Dumo P, Grabe DW, Gilmartin C, Hachey DM, Hudson JQ, Pruchnicki
MC, and Joy MS. Caring for patients with chronic kidney disease: a joint opinion of the Ambulatory Care and
Nephrology Practice and Research Networks of the American College of Clinical Pharmacy. Pharmacotherapy
2005;24:123-43.
46
Savage SW, PJ Schneider, CA Pedersen. Utility of an online medication-error-reporting system. Am J HealthSyst Pharm. 2005;62: 2265-2270.
Schneider PJ, CA Pedersen, K Nagel, C Curran, S Harpe, W Bohenek, B Perrato, T J Swaim, K Wellman.
Improving the Safety of Medication Administration Using an Interactive CD ROM Program. Am J Health-Syst
Pharm. 2005;63:59-64.
Schneider PJ. Equipment for Compounding Sterile Preparations. In: Compounding Sterile Preparations.
Bethesda, MD: American Society of Health-System Pharmacists; 2005:27-34.
Schneider PJ. Documentation of Compounded Sterile Preparations. In: Compounding Sterile Preparations.
Schneider PJ. Compounding and Sterilization of Batch Preparations. In: Compounding Sterile Preparations.
Schneider PJ. Batch Compounding Documentation. In: Compounding Sterile Preparations. Bethesda, MD:
American Society of Health-System Pharmacists; 2005:135-151.
Schneider PJ. Pharmacist Education. In: Compounding Sterile Preparations. Bethesda, MD: American Society of
Health-System Pharmacists; 2005:153-58.
Ulrika Enemark, Anita Alban, Enrique C. Seoane, Andreas Seiter. “Purchasing Pharmaceuticals.” In Alexander S.
Preker (Editor). Spending Wisely: Buying Health Services For the Poor. ISBN: 0821359185. World Bank:
Washington, DC, June 2005. pp. 251-266.
Allison, Temtayo, Szeinbach, Sheryl L., Schneider Phillip. Accuracy of Verbal Orders: An Exploratory Study,
Journal of Health-System Pharmacy, 62:78-83, 2005.
Szeinbach SL, Williams PB, Kucukarslan S., Elhefni H. Influence of Patient Care Provider on Patient Health
Outcomes in Allergic Rhinitis. Annals of Allergy Asthma & Immunology, 95: 167-174, August 2005
Sheryl L. Szeinbach and Earlene E. Lipowski, Drug Distribution In Pharmacy and the U.S. Health Care System,
Third Edition, Editors: Smith, Wertheimer, Fincham, 2005.
2006 Medical Chemistry
B. Su, E.S. Díaz-Cruz, S. Landini, and R.W. Brueggemeier, Novel sulfonanilide analogs suppress aromatase
expression and activity in breast cancer cells independent of COX-2 inhibition. J. Med. Chem., 49, 1413-1419
(2006).
R.W. Brueggemeier and E.S. Diaz-Cruz, Relationship between aromatase and cyclooxygenases in breast cancer:
Potential for new therapeutic approaches. Minerva Endocrinol., 31, 13-26 (2006).
E.S. Diaz-Cruz and R.W. Brueggemeier, Interrelationships between cyclooxygenases and aromatase: Unraveling
the relevance of cyclooxygenase inhibitors in breast cancer. Anticancer Agents in Med. Chem., 6, 221-232 (2006).
M.J. Balunas, B. Su, S. Landini, R.W. Brueggemeier, and A.D. Kinghorn, Interference by naturally occurring
fatty acids in a non-cellular, enzyme-based aromatase bioassay. J. Nat. Prod., 69, 700-703 (2006).
H.-Y. Lin, C.-S. Chen, S.-P. Lin, J.-R. Weng, and C.-S. Chen (2006) _Targeting Histone Deacetylase in Cancer
Therapy_ Med. Res. Rev., 26, 26, 397-413
J.-R. Weng, C.-Y. Chen, J. Pinzone, M.D. Ringel, and C.-S. Chen (2006) _Beyond PPAR-gamma Signaling. The
Multi-Facets of the Antitumor Effect of Thiazolidinediones_ Endocrine-Related Cancer, 13, 401-413
C.-W. Shiau, J.-W. Huang, D.-S. Wang, J.-R. Weng, C.-C. Yang C. Li, and C.-S. Chen (2006) “a-Tocopheryl
Succinate Induces Apoptosis in Prostate Cancer Cells in part through Inhibition of Bcl-xL/Bcl-2 Function”, J.
Biol. Chem, 281, 11819-11825
47
C.-C. Yang, C.-Y. Ku, S. Wei, C.-W. Shiau, C.-S. Chen, J. Pinzone, M.D. Ringel, and C.-S. Chen (2006)
“Peroxisome Proliferator-Activated Receptor g-Independent Repression of Prostate-Specific Antigen Expression by
Thiazolidinediones in Prostate Cancer Cells”, Mol Pharmacol, 69, 1564-1570
R. E. Teresi, C.-W. Shiau, C.-S. Chen, V. K. Chatterjee, K. A. Waite, and C. Eng (2006) “Increased PTEN
expression due to transcriptional activation of PPARg by Lovastatin and Rosiglitazone” Int. J. Cancer, 118, 23902398
Walker, J.R.; Alshafie, G.; Nieves, N.; Ahrens, J.; Clagett-Dame, M.; Abou-Issa, H.; Curley, R.W. Jr., “Synthesis
and Preliminary Chemotherapeutic Evaluation of the Fully C-Linked Glucuronide of N-(4Hydroxyphenyl)retinamide”, Bioorg. Med. Chem. 2006, 14, 3038-3048.
Villani, M.G.; Appierto, V.; Cavadini, E.; Bettiga, A.; Prinetti, A.; Clagett-Dame, M.; Curley, R.W.; Formelli, F.,
“4-Oxo-Fenretinide, a Recently Identified Fenretinide Metabolite, Induces Marked G2-M Cell Cycle Arrest and
Apoptosis in Fenretinide-Sensitive and Fenretinide-Resistant Cell Lines”, Cancer Res. 2006, 66, 3238-3247.
Su, B.-N.; Mi, Q.; Chai, H.; Riswan, S.; Farnsworth, N. R.; Cordell, G. A.; Swanson, S. M.; Kinghorn, A. D.
Activity-guided isolation of cytotoxic glabretal triterpenoids from Aglaia crassinervia. Bioorg. Med. Chem., 14,
960-972, 2006.
Fang, L.; Ito, A.; Chai, H.-B.; Mi, Q.; Jones, W. P.; Madulid, D. R.; Oliveros, M. B.; Gao, Q.; Orjala, J.;
Farnsworth, N. R.;, Cordell, G. A.; Swanson, S. M.; Kinghorn, A. D. Cytotoxic constituents from the stem bark
of Dichapetalum gelonioides collected in the Philippines. J. Nat. Prod., 69, 332-337, 2006. (In issue dedicated to
Professor Norman R. Farnsworth).
Chin, Y.-W.; Jones, W. P.; Waybright, T. J.; McCloud, T. G.; Rasoanaivo, P.; Cragg, G. M., Cassady, J. M.;
Kinghorn, A. D. Tropane aromatic ester alkaloids from a large-scale recollection of Erythroxylum pervillei stem
bark obtained in Madagascar. J. Nat. Prod., 69, 414-417, 2006. (In issue dedicated to Professor Norman R.
Farnsworth).
Chin, Y.-W., Jones, W. P.; Rachman, I.; Riswan, S.; Kardono, L. B. S.; Chai, H.-B.; Farnsworth, N. R.; Cordell,
G. A.; Swanson, S. M.; Cassady, J. M.; Kinghorn, A. D. Cytotoxic lignans from the stems of Helicteres hirsuta
collected in Indonesia. Phytother. Res., 20, 62-65, 2006.
Jung, H.-A.; Su, B.-N.; Keller, W. J.; Mehta, R. G.; Kinghorn, A. D. Antioxidant xanthones from the pericarp of
Garcinia mangostana (Mangosteen). J. Agric. Food Chem., 54, 2077-2082, 2006.
Carcache-Blanco, E. J.; Cuendet, M.; Park, E. J.; Su, B.-N.; Rivero-Cruz, J. F.; Farnsworth,N. R.; Pezzuto, J. M.;
Kinghorn, A. D. Potential cancer chemopreventive agents from Arbutus unedo. Nat. Prod. Res. B. Biol. Act. Nat.
Prod., 20, 327-334, 2006.
Balunas, M. J.; Su, B.; Landini, S.; Brueggemeier, R. W.; Kinghorn, A. D. Interference by naturally occurring
fatty acids in a non-cellular enzyme-based aromatase bioassay. J. Nat. Prod., 69, 700-703, 2006.
Mi, Q.; Su, B.-N.; Chai, H.; Farnsworth, N. R.; Kinghorn, A. D.; Swanson, S. M. Rocaglaol induces apoptosis
and cell-cycle arrest in LNCaP cells. Anticancer Res., 26 (2A), 947-952, 2006.
Jones, W.P.; Chin, Y.-W; Kinghorn, A.D. The role of pharmacognosy in modern medicine and pharmacy. Curr.
Drug Targ., 7, 247-264, 2006.
Chin, Y.-W.; Balunas, M. J.; Chai, H.-B.; Kinghorn, A. D. Drug discovery from natural sources. AAPS J., 8 (2),
article #28, E239-E253, 2006. (Published electronically)
Li, P. K.; Pandit, B.; Sackett, D. L.; Hu, Z.; Zink, J.; Zhi, J.; Freeman, D.; Robey, R. W.; Werbovetz, K.; Lewis,
A.; Li, C. A thalidomide analogue with in vitro antiproliferative, antimitotic, and microtubule-stabilizing activities
Mol Cancer Ther 2006, 5, (2), 4
Wu, G.; Barth, R.F.; Yang, W.; Lee, R.J.; Tjarks, W.; Backer, M.V.; Joseph M. Backer, J.M.; Boron Containing
Macromolecules and Nanovehicles as Delivery Agents for Neutron Capture Therapy; Anti-Cancer Agents in
Medicinal Chemistry, 6, 167-184, 2006.
48
Byun, Y.; Narayanasamy, S.; Johnsamuel, J.; Bandyopadhyaya, A.K.; Tiwari, R.; Al- Madhoun, A.S.; Barth,
R.F.; Eriksson, S.; Tjarks, W. 3-Carboranyl Thymidine Analogues (3CTAs) and other Boronated Nucleosides for
Boron Neutron Capture Therapy; Anticancer Agents Med. Chem., 6, 127-144, 2006.
M. Salem and K. Werbovetz. Isoflavonoids and Other Compounds from Psorothamnus arborescens with
Antiprotozoal Activities, Journal of Natural Products, 69: 43-49, 2006.
P. Li, B. Pandit, D. Sackett, Z. Hu, J. Zink, J. Zhi, D. Freeman, R. Robey, K. Werbovetz, Lewis, and C. Li. A
thalidomide analogue with in vitro antiproliferative, antimitotic, and microtubule-stabilizing activities. Molecular
Cancer Therapeutics, 5: 450-456, 2006.
K. Werbovetz. Diamidines as Antitrypanosomal, Antileishmanial, and Antimalarial Agents, Current Opinion in
Investigational Drugs, 7: 147-157, 2006.
2006 Pharmaceutics
Au, J.L.-S., and Wientjes, M.G. Intravesical chemotherapy of superficial bladder cancer: optimization and novel
agents. In: Textbook on bladder cancer. Lerner, S., Schoenberg, M.P., and Sternberg, C., eds., Martin Dunitz
Publishers, 2006, pp. 341-352.
Fang L, Zhang G, Li C, Zheng X, Zhu L, Xiao JJ, Szakacs G, Nadas J, Chan KK, Wang PG, and Sun D.
Discovery of a Daunorubicin Analog that Exhibits Potent Antitumor Activity and Overcomes P-gp-mediated
Drug Resistance. J Med Chem, 49: 932-941, 2006.
Bekaii-Saab TS, Mortazavi AS, Hicks LG, Zalupski M, Pelley R, Chan KK, and Kraut EH. A Phase II Study of
Chloroquinoxaline Sulfonamide (CQS) in Patients with Metastatic Colorectal Carcinoma (MCRC) Investigational
New Drugs, 28 January, 2006.
Liu Z, Marcucci G, Byrd JC, Grever M, Xiao J, and Chan KK. Characterization of Decomposition Products and
Preclinical and Low Dose Clinical Pharmacokinetics of Decitabine (5-aza-2’-deoxycytidine) by a New LC-MS/MS
Quantification Method. Rapid Commun Mass Spectrom 20(7): 1117-1126, 2006.
O'Connor O, Smith EA, Toner LE, Feldstien J, Frankel S, Rolfe M, Wei X, Liu S, Marcucci G, Chan KK, and
Chanan-Khan A. The Combination of the Proteasome Inhibitor Bortesomib and the Bcl-2 Antisense Molecule
Oblimersen Sensitizes Human B Cell Lymphomas to Cyclophosphamide. Clin Cancer Res 12(19): 2902-2911,
2006.
Segal S, Narayanan R, Dalton JT. Therapeutic potential of the SARMs: revisiting the androgen receptor for drug
discovery. Expert Opinion in Investigational Drugs. 15(4):377-87, 2006.
Taneja SS, Smith MR, Dalton JT, Raghow S, Barnette G, Steiner M, Veverka KA. Toremifene--a promising
therapy for the prevention of prostate cancer and complications of androgen deprivation therapy. Expert Opinion
in Investigational Drugs. 15(3):293-305, 2006.
Gao W, Johnston JS, Miller DD, Dalton JT. Inter-Species Differences in Pharmacokinetics and Metabolism of S3-(4-acetylamino-phenoxy)-2-hydroxy-2-methyl-N-(4-nitro- 3-trifluoromethyl-phenyl)-propionamide: The Role
of N-Acetyltransferase. Drug Metabolism and Disposition, 34(2):254-260, 2006.
Gao W, Wu Z, Bohl CE, Yang J, Miller DD, Dalton JT. Characterization of the In vitro Metabolism of Selective
Androgen Receptor Modulator (SARM) Using Human, Rat and Dog Liver Enzyme Preparations. Drug
Metabolism and Disposition, 34(2):243-253, 2006.
Wu D, Wu Z, Yang J, Nair VA, Miller DD, Dalton JT. Pharmacokinetics and metabolism of a selective androgen
receptor modulator (SARM) in rats–implication of molecular properties and intensive metabolic profile to
investigate ideal pharmacokinetic characteristics of a propanamide in preclinical study. Drug Metabolism and
Disposition, 34(3):483-494, 2006.
Yang J, Bohl CE, Nair VA, Mustafa SM, Hong SS, Miller DD, Dalton JT. Preclinical pharmacology of a
nonsteroidal ligand for androgen receptor mediated imaging of prostate cancer. Journal of Pharmacology and
Experimental Therapeutics, 317(1):402-408, 2006.
49
George TG, Johnsamuel J, Delfin DA, Yakovich A, Mukherjee M, Phelps MA, Dalton JT, Sackett DL, Kaiser M,
Brun R, Werbovetz KA. Antikinetoplastid antimitotic activity and metabolic stability of dinitroaniline
sulfonamides and benzamides. Bioorganic and Medicinal Chemistry. 2006 May 2; [Epub ahead of print]
Gao W, Johnston JS, Miller DD, and Dalton JT. Interspecies differences in pharmacokinetics and metabolism of
S-3-(4-acetylamino-phenoxy)-2-hydroxy-2-methyl-N-(4-nitro-3-trifluoromethylphenyl)-propionamide: the role of
N-acetyltransferase, Drug Metab. Dispos., 34:254-260, 2006.
Wu D, George TG, Hurh E, Werbovetz KA, Dalton JT. Pre-systemic metabolism prevents in vivo
antikinetoplastid activity of N1,N4-substituted 3,5-dinitro sulfanilamide, GB-II-150. Life Sciences. 2006 Mar 28;
[Epub ahead of print]
Yong C and Frank SG. Characterization of Supersaturated Lidocaine/Polyacrylate Pressure Sensitive Adhesive
Systems: Thermal Analysis and FT-IR, J. Pharm. Sci., 95, 701-713, 2006.
Kim J, Bronson CL, Hayton WL, Radmacher MD, Roopenian DC, Robinson JM, and Anderson CL. Albumin
turnover: FcRn-mediated recycling saves as much albumin from degradation as the liver produces. Am. J. Physiol.
290:G352-G360, 2006.
Shkriabai N, Datta SA, Zhao Z, Hess S, Rein A, Kvaratskhelia M. HIV-1 Gag interactions with assembly
cofactors. Biochemistry 45:4077-83, 2006.
X G. Wu, R.F. Barth, W. Yang, R. J. Lee, W. Tjarks, M.V. Backer, and J.M. Backer, Nanoparticles and High
Molecular Weight Boron Delivery Agents. (2006) in Nanotechnology for Cancer Therapy, Ed. M.M. Amiji, Taylor
and Francis/CRC Press, Chapter 6
J. Guan, X. Pan, L. J. Lee, R.J. Lee. Viral, Non-Viral, and Physical Methods for Gene Delivery (2006) in
Biopharmaceutical Drug Design and Development, Ed. S. Wu-Pong, Humana Press.
X.B. Zhao, N. Muthusamy, J.C. Byrd, R.J. Lee, Folate Receptor-Targeted Liposomes for Cancer Therapy (2006)
in Nanotechnology for Cancer Therapy, Ed. M.M. Amiji, Taylor and Francis/CRC Press, Chapter 33
Zhang Z-Y, Ugwu S, Zhang A, Ahmad MU, Ahmad I, Chiu S, Lee RJ. A novel cationic cardiolipin analogue for
gene delivery, Pharmazie 1, 2006.
Chiu S-J, Marcucci G, Lee RJ. Efficient delivery of an antisense oligodeoxyribonucleotide formulated in folate
receptor-targeted liposomes, Anticancer Res. 26:1049-1056, 2006
Chiu S-J, Liu S, Perrotti D, Marcucci G, and Lee RJ. Efficient delivery of a Bcl-2-specific antisense
oligodeoxyribonucleotide (G3139) via transferrin receptor targeted liposomes, J. Control. Release 112:199-207,
2006.
Wu J, Liu Q, Lee R.J. A Folate Receptor-Targeted Liposomal Formulation for Paclitaxel. Int. J. Pharm. 316:148153, 2006.
Liu J, Levine AL, Mattoon JS, Yamaguchi M, Lee RJ, Pan X, and Rolsol TJ. Nanoparticles as image enhancing
agents for ultrasonography. Phys. Med. Biol. 51:2179-2189, 2006.
Wu XG, Barth RF, Yang W, Lee RJ, Tjarks W, Backer MV, and Backer JM, Nanoparticles and High Molecular
Weight Boron Delivery Agents. in Nanotechnology for Cancer Therapy, Ed. M.M. Amiji, Taylor and Francis/CRC
Press, Chapter 6, 2006
Zhao XB, Muthusamy N, Byrd JC, Lee RJ. Folate Receptor-Targeted Liposomes for Cancer Therapy in
Nanotechnology for Cancer Therapy, Ed. M.M. Amiji, Taylor and Francis/CRC Press, Chapter 33, 2006.
Guan J, Pan X, Lee LJ, Lee RJ. Viral, Non-Viral, and Physical Methods for Gene Delivery in Biopharmaceutical
Drug Design and Development, Ed. S. Wu-Pong, Humana Press, 2006.
50
X G. Wu, R.F. Barth, W. Yang, R. J. Lee, W. Tjarks, M.V. Backer, and J.M. Backer, Nanoparticles and High
Molecular Weight Boron Delivery Agents. (2006) in Nanotechnology for Cancer Therapy, Ed. M.M. Amiji, Taylor
and Francis/CRC Press, Chapter 6
X.B. Zhao, N. Muthusamy, J.C. Byrd, R.J. Lee, Folate Receptor-Targeted Liposomes for Cancer Therapy
(2006) in Nanotechnology for Cancer Therapy, Ed. M.M. Amiji, Taylor and Francis/CRC Press, Chapter 33
J. Guan, X. Pan, L. J. Lee, R.J. Lee. Viral, Non-Viral, and Physical Methods for Gene Delivery (2006) in
Biopharmaceutical Drug Design and Development, Ed. S. Wu-Pong, Humana Press.
Schmittgen, T.D., Quantitative gene expression by real-time PCR: A complete protocol, in Real-time PCR, M.T.
Dorak, Editor. 2006, Taylor and Francis: New York. p. 127-137.
Jiang J, Lee RJ, and Schmittgen TD Increased expression of microRNA-155 in Epstein-Barr Virus transformed
lymphoblastoid cell lines. Gene Chromosome Cancer, 45:103-106, 2006.
Martin MM, Lee EJ, Buckenberger JA, Schmittgen TD, and Elton TS. MicroRNA-155 regulates human
angiotensin II type 1 receptor expression in fibroblasts. J. Biol. Chem., M601496200, May 4, 2006.
Schmittgen, T.D., Quantitative gene expression by real-time PCR: A complete protocol, in Real-time PCR, M.T.
Dorak, Editor. 2006, Taylor and Francis: New York. p. 127-137.
Fang L, Zhang G, Zheng X, Jim J, Xiao P, Wang G, and Sun D. Discovery of a daunorubicin analogue that
exhibits potent antitumor activity and overcomes MDR-mediated drug resistance. J Med Chem; 49: 932-941,
2006.
Zhang G, Fang L, Zhu L, Zhong Y, Wang G, Sun D. Syntheses and Biological Activities of 3'-Azido Disaccharide
Daunorubicins against drug-resistant leukemia, J Med Chem, 49(5): 1792-1799, 2006.
Zhang G, Fang L, Zhu L, Sun D, and Wang PG. Syntheses and Biological activities of Novel Bisdaunorubicins
through Click Chemistry. Bioorganic and Medicinal Chemistry, 14: 426-434, 2006.
Gan Y, Walsh C, Wientjes MG, and Au JL-S. Expression of basic fibroblast growth factor correlates with
resistance to paclitaxel in human tumors. Pharm. Res., In press publication date June 8, 2006.
Chen D, Song SH, Wientjes MG, Yeh TK, Villalona-Calero M, Otterson G, Jensen R, Grever M, Murgo A, and
Au JL-S. Nontoxic suramin as a chemosensitizer in patients: Dosing nomogram development. Pharm. Res., In
Press, May 25, 2006.
Chen D, Song SH, Wientjes MG, Yeh TK, Villalona-Calero M, Otterson G, Jensen R, Grever M, Murgo A, and
Au JL-S. Nontoxic suramin as a chemosensitizer in patients: Dosing nomogram development. Pharm. Res., In
Press, May 25, 2006.
2006 Pharmacology
Chaves, A.A., Baliga, R.S., Mihm, M.J., Schanbacher, B.L., Basuray, A., Liu, C., Cook, A.C., Ayers, L.W. and
Bauer, J.A. “Bacterial lipopolysaccharide enhances cardiac dysfunction but not retroviral replication in murine
AIDS - Roles of macrophage infiltration and toll-like receptor 4 expression.” American Journal Of Pathology
168(3): 727-736, 2006.
Zhao, Q., Wang, X.X., Nelin, L.D., Yao, Y.X., Matta, R., Manson, M.E., Baliga, R.S., Meng, X.M., Smith, C.V.,
Bauer, J.A., Chang, C.H. and Liu, Y.S. “MAP kinase phosphatase 1 controls innate immune responses and
suppresses endotoxic shock.” Journal Of Experimental Medicine 203(1): 131-140, 2006.
Joshi, M.S., Julian, M.W., Huff, J.E., Bauer, J.A., Xia, Y. and Crouser, E.D. “Calcineurin regulates myocardial
function during acute endotoxemia.” American Journal Of Respiratory And Critical Care Medicine 173(9): 9991007, 2006.
Martin, M.M., Buckenberger, J.A., Knoell, D.L., Strauch, A.R. and Elton, T.S. “TGF-beta(1) regulation of
human AT(1) receptor mRNA splice variants harboring exon 2.” Molecular And Cellular Endocrinology 249(1-2):
21-31, 2006.
Martin, M.M., Lee, E.J., Jiang, J., Buckenberger, J.A., Schmittgen, T.D. and Elton, T.S. “MicroRNA-155
regulates human antiotensin II type 1 receptor expression in fibroblasts.” Journal of Biological Chemistry, 2006.
51
Free, R.B., Kaser, D.J., Boyd, R.T. and McKay, D.B. “Receptor protection studies comparing recombinant and
native nicotinic receptors: Evidence for a subpopulation of mecamylamine-sensitive native alpha 3 beta 4*nicotinic
receptors.” Neuroscience Letters 392(1-2): 135-139, 2006.
2006 Pharmacy Practice and Administration
Balkrishnan R, McMichael AJ, Hu JY, Camacho FT, Shew KR, Bouloc A, Rapp SR, Feldman SR. Correlates of
Health-related Quality of Life in Women with Severe Facial Blemishes. International Journal of Dermatology 45(2): 111-115, 2006.
Yelverton CB, Kulkarni AS, Balkrishnan R, Feldman SR. Home UVB Phototherapy is a Less Costly Alternative
for Treating Patients with Severe Psoriasis. Managed Care Interface - 19(1): 33-39, 2006.
Barshes NR, Lee TC, Balkrishnan R, Karpen SJ, Quiros-Tejeira RE, Carter BA, Goss JA. Risk stratification of
patients undergoing orthotopic liver transplantation for fulminant hepatic failure. Transplantation - 81(2): 195201, 2006.
Balkrishnan R, Bhosle MJ, Camacho FT, Anderson RT. Predictors of Medication Adherence and Associated
Health Care Costs in an Older Population With Overactive Bladder Syndrome: A Longitudinal Cohort Study.
Journal of Urology - 175(3): 1067-1071, 2006.
Balkrishnan R, Rajagopalan R, Shenolikar RA, Camacho FT, Anderson RT. Outcomes associated with
introduction of thiazolidinedione therapy in Medicaid enrolled patients with type 2 diabetes: An updated and
expanded retrospective analyses. Current Medical Research and Opinion - 22(3): 551-559, 2006.
Pearce DJ, Singh S, Balkrishnan R, Kulkarni AS, Fleischer AB, Feldman SR. The negative impact of psoriasis on
the workplace. Journal of Dermatological Treatment - 17(1): 24-28, 2006.
Pearce DJ, Nelson AA, Fleischer AB, Balkrishnan R, Feldman SR. The cost-effectiveness and cost of treatment
failures associated with systemic psoriasis therapies. Journal of Dermatological Treatment - 17(1): 29-37, 2006.
Durant RH, Wolfson M, Lafrance B, Balkrishnan R, Altman D. An Evaluation of a Mass Media Campaign to
Encourage Parents of Adolescents to Talk to Their Children About Sex. Journal of Adolescent Health - 38(3):
298e1-298e9, 2006.
Balkrishnan R, Kulkarni AS, Richmond DA, Cayce KA, Feldman SR. Predictors of health care outcomes and
costs related to medication use in patients with acne in the United States. Cutis - 77(4):251-255, 2006.
Pearce DJ, Stealey KH, Balkrishnan R, Fleischer AB, Feldman SR. Psoriasis Treatment in the U.S. at the end of
the 20th Century. International Journal of Dermatology - 45(4): 370-374, 2006.
Krejci-Manwaring J, McCarty MA, Camacho F, Carroll CL, Johnson K, Manuel J, Balkrishnan R, Hartle J,
Fleischer A Jr, Feldman SR. Adherence with topical treatment is poor compared with adherence with oral agents:
implications for effective clinical use of topical agents. Journal of the American Academy of Dermatology
54(5):S235-236, 2006.
Munar MY, Singh H, Belle D, Brackett CC, Earle, SB. The Use of Wireless Laptop Computers for ComputerAssisted Learning in Pharmacokinetics. Am J Pharm Educ. 2006; 70:1-7.
Brock KA, Casper KA, Green TR, Pedersen CA. Documentation of Patient Care Services in a Community
Pharmacy Setting. J Am Pharm Assoc 2006;46:378-84.
Zierler-Brown SL, VanAmburgh JA, Casper KA, Krypel LL, Salcido AL, Padron VA, Pray WS, Wall AL, Sobotka
JL, Engle JP. Current Status and Recommendations for Self-Care Instruction in U.S. Schools and Colleges of
Pharmacy, 2006: A White Paper. AJPE 2006.
MacLaren R, Devlin JW, Martin SJ, Dasta JF, Bond CA. A National Survey Characterizing the Practice of
Critical Care Pharmacists. Ann Pharmacother 2006;40:612-17
52
Sesti AM, Jacobi JJ, McLaughlin T, Dasta JF. A Large Administrative hospital database for health outcomes
research; Sedative use in the real-world setting. Pharmacotherapy 2006;26:798-805.
LeBlanc J, Dasta JF, Kane-Gill SL. The role of bispectral index monitoring in the ICU. Ann Pharmacother
2006:40:490-500
Ng T, Singh AK, Dasta J, Feldman D, Mebaaza A. Contemporary issues in the pharmacologic management of
acute heart failure. Critical Care Clinics of North America 2006;22:199-219
Dasta JF. Special 40th year anniversary issue: Perspectives on critical care pharmacy. Ann Pharmacother
2006;40:736-7.
Martin S, Dasta JF (Guest editors). Pharmacotherapy of critical illness. Critical Care Clinics of North America
2006;22:187-382 (April)
Colombo DF, Lew JL, Pedersen CA, Johnson JR and Fan-Havard P. Optimal timing of ampicillin administration
to pregnant women for establishing bactericidal levels in the prophylaxis of Group B Streptococcus. Am J Obstet
Gynecol; 2006;194:466-70.
Bao S., Knoell D. Zinc Modulates airway epithelium susceptibility to death receptor-mediated apoptosis. Amer J
Phys Lung Cell Mol Physiol. 2006;290:L433-441. (Impact 4.051; Rank 4 out of 33 in Respiratory Role: Project
Leader and Corresponding Author.
Martin M., Buckenberger JA., Knoell DL., Strauch AR., Elton TS. TGF-b1 regulation of human AT1
receptor mRNA splice variants harboring exon 2. Molecular and Cellular Endocrinology. 2006; 249:21-31. (Impact
2.626; Rank 36 out of 87 in Endocrinology) Role: Co-investigator.
Hoyt D., Knoell DL. Respiratory pharmacology In defense of the lung: innovations to bolster or prevent acute
and chronic lung diseases. Curr Opin Pharmacol. 2006;6(3):227-229. (Impact 4.593; Rank 19 out of 187 in
Pharmacology and Pharmacy).
Chan M, Mehta BH. New Drugs and Agents Pending FDA Approval. In: Rakel R, Bope E, editors. Conn’s
Current Therapy. Philadelphia: Saunders; 2006
Mehta BH. OTC Product: Today Sponge. JAPhA 2006; 46(2): 304
Stojanovski SD, Robinson RF, Baker SD, Casavant MJ, Hayes JR, Nahata MC. Children and adolescent
exposures to atomoxetine hydrochloride reported to a poison control center. Clinical Toxicology 44(3):243-7,
2006.
Nahata MC, O’Mara N. Benavides S. Viral infections. In: Applied Therapeutics: The Clinical Use of Drugs, 8th
edition. Koda-Kimble et al (editors). Lipincott Williams & Wilkins, 1-20, 2005.
Nahata MC. Evolution of pediatric pharmacotherapy. Annals of Pharmacotherapy 40: 1109-110, 2006.
Corvino TF, Nahata MC, Angelos MG, Tschampel MM, Morosco RS, Zerkle J, Nelson RN. Availability,
Stability, and Sterility of Pralidoxime for Mass Casualty Use. Annals of Emergency Medicine 47(3):272-277, 2006.
Nahata MC, Morosco RS, Brady MT. Extemporaneous sildenafil citrate oral suspensions for the treatment of
pulmonary hypertension in children. American Journal of Health-System Pharmacy 63:254-257, 2006.
Seres D, Sacks GS, Pedersen CA, Canada TW, Johnson D, Kumpf V, Guenter P, Petersen C, and Mirtallo J.
“Parenteral Nutrition Safe Practices: Results of the 2003 American Society for Parenteral and Enteral Nutrition
Nutrition Survey.” Journal of Parenteral and Enteral Nutrition. 2006;30:259-65.
Brock KA, Casper KA, Green TR, Pedersen CA. “Documenting Patient Care Services in a Community
Pharmacy.” Journal of the American Pharmacists Association 2006; 46(3):378-384.
Mott DA, Doucette WR, Gaither CA, Kreling DK, Pedersen CA, Schommer JC. “Pharmacist Participation in
the Workforce: 1990, 2000, 2004.” Journal of the American Pharmacists Association 2006; 46(3):322-330.
Doucette WR, Kreling DK, Schommer JC, Gaither CA, Mott DA, Pedersen CA. “An Evaluation of Community
Pharmacy Service Mix.” Journal of the American Pharmacists Association 2006; 46(3):348-355.
53
Schommer JC, Pedersen CA, Gaither CA, Doucette WR, Kreling DK, Mott DA. “Pharmacists’ Time in Work
Activities (Desired, Actual, and Gaps): Evidence from the 2004 National Pharmacist Workforce Study.” Journal of
the American Pharmacists Association 2006; 46(3):340-347.
Kreling DK, Doucette WR, Mott DA, Gaither CA, Pedersen CA, Schommer JC. “Community Pharmacists’
Work Environments: Evidence from the 2004 National Pharmacist Workforce Study.” Journal of the American
Pharmacists Association 2006; 46(3):331-339.
Schommer JC, Pedersen CA, Worley MM, Brown LM, Hadsall RS, Ranelli PL, Stratton TP, Uden DL,
Chewning BA. “Provision of Risk Management and Risk Assessment Information: The Role of the Pharmacist.”
Research in Social and Administrative Pharmacy (June 2006).
Colombo DF, Lew JL, Pedersen CA, Johnson JR, Fan-Havard P. “Optimal timing of ampicillin administration to
pregnant women for establishing bactericidal levels in the prophylaxis of Group B Streptococcus.” American
Journal of Obstetrics and Gynecology 2006; 194:466-70.
Pedersen CA, Schneider PJ, Scheckelhoff DJ. “ASHP National Survey of Pharmacy Practice in Hospital Settings:
Dispensing and Administration–2005.” American Journal of Health-System Pharmacy 2006; 63(4):327-45.
Schneider PJ, Pedersen CA, Montanya KR, Curran CR, Harpe SE, Bohenek W, Perratto B, Swaim TJ, Wellman
KE. “Improving the safety of medication administration using an interactive CD-ROM program.” Am J Health
Syst Pharm. 2006; 63(1):59-64.
Schneider PJ. Nutrition Support Teams - An Evidence Based Practice. Nutr Clin Pract. 2006:21:62-67.
Pedersen CA, PJ Schneider, DJ Scheckelhoff. ASHP national survey of pharmacy practice in hospital settings:
Dispensing and administration - 2005. Am J Health-Syst Pharm. 2006;63:327-45.
Schneider PJ and E CBuchanan. Chapter 28 - “Sterile Preparations and Admixture Programs.” In: TR Brown,
ed. Handbook of Institutional Pharmacy Practice, 4th edition.Bethesda, MD: American Society of Health-System
Pharmacy; 2006:393-404.
54
NIH Grants Awarded FY2005
NIH, Principal Investigator
Name
Au, Jessie L.-S.
Institute* Grant Number
NCI
R01CA93871-04
NCI
R01CA097067-04
Brueggemeier,
Robert W.
Chan, Kenneth K
NCI
Chen, Ching-Shih
NCI
NCI
NCI
NCI
Curley, Robert W.
NCI
Dalton, James T.
NIDDK
Elton, Terry
NHLBI
Knoell, Daren L.
NHLBI
Lee, Robert J.
NCI
Schmittgen, Thomas D. NCI
Werbovetz, Karl A.
NIH
Wientjes, M. Guillaume NCI
Wientjes, M. Guillaume NCI
Project Title
Chemoresistance in renal cell cancer
FGF: a mechanism of acquired
multidrug resistance
R01CA073698-07
Estrogen biotransformations and
breast cancer etiology
N01CM52205-01
Preclinical pharmacological study of
antitumor and other agnts
R01CA094829-05
Apoptosis regulation by lipid signals
in prostate cancer
R21CA104776-02
Novel Celecoxib Derivatives as
Chemopreventive Agents
R01CA112250-01
Targeting Akt and Bcl-2 in prostate
cancer prevention
R01CA049837-12
Analog studies of 4-HPR and its
glucuronide
R01DK059800-06
Pharmacology of nonsteroidal
androgen receptor ligands
R01HL048848-13
Human angiotensin II receptor gene
regulation
K08HL004462-04
Cytolytic attack against lung
parenchyma in emphysema
R01CA095673-03
Targeted liposomal doxorubicin
delivery to leukemia
R21CA107435-01
Micro RNA Expression and Cancer
R01AI061021-02
Simple, Selective Antimitotic
Antiparasitic Agents
R01CA100922-02
Enhanced Chemosensitivity of
Pancreatic Cancer
R21CA111770-01A1 Tumor priming to promote
nanoparticle gene delivery
Subtotal
FY04 Award
$269,848
$245,219
$277,300
$340,098
$199,125
$134,550
$295,263
$297,510
$326,318
$224,250
$126,942
$296,904
$134,550
$334,645
$272,138
$192,855
$3,967,515
NIH, via subprojects and subcontracts:
Name
Brueggemeier,
Robert W.
Carnes, Cynthia
Dalton, James T.
McKay, Dennis B.
Tjarks, Werner
Institute* Grant Number
NCI
5 P30 CA16058-27
Project Title
Cancer Center Core grant
NHLB via
Cleveland
Clinic
NIH via
Univ of
Tennessee
NIH via
Ohio
University
NIH via
OSU
subproject
R01HL65412-01
Oxictive stress and atrial fibrillation
KD065227-02
Novel irreversible SARMs for prostate
cancer
$128,409
1R01DA13939
Analogues of methyllycaconitine
as selective nicotinic agents
$149,295
R01CA098945
Molecular targeting of EGFR for the
treatment of gliomas
Subtotal
Subtotal for NIH
FY04 Award
$125,826
$75,000
$39,383
$517,913
$4,485,428
*National Institutes of Health (NIH); National Cancer Institute (NCI): National Institute of Diabetes & Digestive & Kidney
Disease (NIDDK); National Heart Lung Blood Institute (NHLBI)
55
Other Federal Agencies, Associations, or Foundations
Name
Balkrishnan, Rajesh
Chen, Ching-Shih
Dalton, James T.
Nahata, Milap C.
Agency*
Wake Forest
University
Susan G. Komen Breast
Cancer Fndn.
Army Medical Research
& Material Command
Army Medical Research
& Material Command
NSF Div. Engn., Ed., and
Centers
Univ. of Tennessee
Merck Foundation
Elton, Terry
American Heart
Association
Hoyt, Kari
The Parkinson's Disease
Fndn.
Schmittgen, Thomas D. Army Medical Research
& Material Command
Sun, Duxin
FDA
FDA
PhRMA Foundation
Werbovetz, Karl A.
American Assoc. Coll.
Pharm.
Univ. of North Carolina
(Gates Fndn. Award)
United Negro College
Fund
United Negro College
Fund
Project Title
Center for Dermatology research
Sensitizing ER-nagative breast cancer cells
to tamoxifen- …
Novel molecularly targeted agents for
prostate cancer treatment
Riboflavin carrier protein and riboflavin
in breast tumor targeting
CANPBD: evaluation of nanoscale gene
delivery devices …
Targeting calpain for novel anticancer agents
Impact of pharmaceutical and clinical
services in older adults
Hyperglycemic regulation of the human
angiotensin …
Chronic biguanide exposure as a new mouse
model of P.D.
Aptimer drug conjugates for prostate
cancer therapy
In vitro cell systems and in vivo animal
models….
Effect of excipients on permeability of
transporter …
Site specific activation of geldanamycin
prodrug …
Glucose transporters and targeted
delivery …
Development of novel drug candidates for the
treatment of human African trypanosomiasis
and leishmaniasis
Parallel synthesis, identification and
evaluation of novel …
Parallel synthesis, identification and
evaluation of novel …
Subtotal
FY04 Award
$185,112
$125,000
$186,875
$41,888
$38,812
$60,000
$40,000
$60,500
$40,000
$95,838
$25,000
$25,000
$30,000
$10,000
$44,000
$10,000
$30,000
$1,008,025
Other Local Agencies, Associations, or Foundations
Name
Havard, Patty
Sun, Duxin
56
Agency*
Children's Research
Institute
Ohio Cancer Research
Associates
Project Title
Family-centered, community-based,
coordinated HIV care program
FY04 Award
$10,000
Targeted prodrug delivery for cancer therapy
$25,000
Subtotal
$35,000
Industry Sponsored
Name
Balkrishnan, Rajesh
Industry
GSK
Balkrishnan, Rajesh
Centrocor, Inc.
Dalton, James T.
Eli Lilly & Co.
Dasta, Joseph
Aspect Medical Systems
Project Title
Prevalence and impact of poor treatment
adherance in PD
Costs and outcomes associated with
introduction of …
Intercellular trafficking of receptor mediated
endocytosis of riboflavin
A prospective analysis of the association
between lorazepam..
Subtotal
Grand Total
FY04 Award
$24,000
$40,000
$35,400
$7,000
$106,400
$5,634,853
Pharmacy Practice Contracts:
Laura Hall/Milap Nahata/
Columbus Neighborhood Health Ctrs
Pharmacy services for an indigent population
$124,000
Kristen Casper/Milap Nahata
/Kroger Pharmacies
Pharmaceutical care in community pharmacies
$ 50,000
Ruth Emptage/Milap Nahata/
Lifecare Alliances/Cardinal Health
Pharmacy services in home care setting
$ 46,000
57
Outreach and Engagement
C
ontinued partnerships involving faculty and staff include
OSU Extension, Columbus Neighborhood Health Center
(CNHC), Kroger, Cardinal Health-Life Care Alliance, Columbus
Public Health Department, Life-Care Alliance, Columbus Public
Schools, Central Ohio Poison Center and Catholic Social Services.
Dr. Jen Rodis partnered with OSU Community Development
on a Faculty Support Grant and an Excellence in Engagement
Grant. Dr. Laura Hall continues her faculty practice sites at
Columbus Neighborhood Health Center, where she engages in
experiential education and ambulatory residency training. Kroger
partners with the College on experiential and residency training
(Dr. Kristin Casper and Dr. Tara Green) and training Kroger
pharmacists for expanded/effective patient care. Dr. Ruth Emptage
Gerald Cable
continues her practice site with Cardinal Health involving research
on home-based pharmacists services. Jerry Cable was involved in
an inter-professional elective course in partnership with Crestview Middle School. Christine Murphy
developed educational partnerships with Capital Park (Mt. Carmel Outreach) and Physicians ‘Free
Clinic’.
Pharmacy students (in partnership with Columbus Public Health Department) engaged in
immunization education and experiential education. Students supported visiting nurses who
administered over 5,300 doses of influenza vaccine during the 2005 flu season and engaged in senior
outreach activities at various senior retirement communities (Meals on Wheels, Heartburn Awareness
Program and Brown-bag medication reviews). APhA-ASP Student Chapter held patient events related
to diabetes, hypertension and heartburn. The students also enhanced a diabetes education program for
6th-grades and expanded the program to include a Hilliard, Ohio middle school, and Crestview Middle
School, part of the Columbus Public Schools. Over 500 students benefited from this educational
experience. Pharmacy students contributed service hours to our community through health related
events (i.e. health fairs, diabetes screenings, etc.), community-based programs for underserved people,
brown-bag medicine reviews, tutoring, and the like. Medicare Part-D plan came into existence in 2005
and pharmacy students contributed volunteer hours assisting senior citizens in choosing the plan best
suited to them. Recognition for the fine efforts of the APhA-ASP chapter included an Ohio State
University “Award for Excellence in Community Service Programming” in both 2005 and 2006 and the
APhA “Most Improved Chapter” award, a national recognition in 2005.
Current relationships with professional associations include Ohio Pharmacists Association (OPA)
and Ohio Society of Health-System Pharmacists (OSHP) Professional Affairs Division. Jerry Cable
served on the OPA Board of Directors, Public & Professional Relations Committee and the
Preparedness Task Force and Emergency Response Team. Professor Cable, Christine Murphy and Dean
Ken Hale maintain the relationship with the OSHP through involvement in division committee
activities, by assisting with the annual Residency Showcase and in
planning OSHP annual meetings in 2005 and 2006.
Professional continuing education is administered by Jerry
Cable, Director of Outreach and Experiential Programs. ACPE
continuing education included the 3rd Annual Autumn
Symposium College CE Program, September 2005, in association
with the Alumni football tailgate event, CE support to PDM
Healthcare and to the National Hospice and Palliative Care
Organization. The Ohio State Board of Pharmacy CE included 27
Ohio CE programs delivered by College Faculty to preceptors,
residents and other central Ohio pharmacists.
58
Alumni Affairs
A
lumni regularly contribute their time, expertise and effort in
many ways to support the mission of the College. They serve on
important committees related to the Alumni Governing Board
business, participate in hosting alumni and college-wide events,
interview prospective students and act as recruiters, and serve as
preceptors in our critically important experiential programs. They
are integral to our development efforts as their contributions to
scholarship and research funds are vital to our academic mission.
The OSU College of Pharmacy Alumni Society Annual
Meeting and 22nd Alumni Awards Ceremony was held on May
6, 2005 at the Fawcett Center. This is the culminating event of
the Alumni Society year at which the College and Society honor
outstanding College alumni. The banquet was attended by 109
Lou Marcy
alumni, faculty and guests. The Alumni Relations Committee,
Chaired by Professor Marialice Bennett, selected an outstanding
group of honorees. The 23rd Annual Alumni Awards Banquet and Annual Meeting of the Pharmacy
Alumni Society Governing Board was held on May 5, 2006 at the Blackwell Hotel. Over 130 alumni,
faculty, students and their guests attended the awards banquet to help honor the outstanding group of
alumni award recipients.
Distinguished Alumni Award recipients must have a professional degree (BS, MS, PharmD) from the
OSU College of Pharmacy, have made distinguished contributions in the fields of public health and
public service, have performed outstanding activities in the interest of the College and its students, and
have an outstanding record in the profession of pharmacy.
Distinguished Alumni Award Recipients:
2005: Kathleen D. Donley, B.S. ’77, M.B.A.,
Debra K. Gardner, Pharm.D. ’87,
Mark A. Gerhardt, B.S. ’86, M.D., Ph.D.,
Julie A. Johnson, B.S. ’85, Pharm.D.
2006: Ashok K. Chawla, B.S., 1981, M.S., 1983
Lemont B. Kier, B.S., 1954, Ph.D.
Frank J. Krivanek, B.S., 1983, M.S., 1985
Karl S. Pappa, B.S., 1979, Pharm.D.
The Jack L. Beal Postbaccalaureate Alumni Award is named in honor of the late Jack L. Beal, PhD,
1952, Professor Emeritus of Medicinal Chemistry and Pharmacognosy at The Ohio State University.
The recipient of the Jack Beal Award must have a postbaccalaureate degree (MS, PhD, or PharmD)
from The Ohio State University College of Pharmacy and shall have contributed significantly to research
and scholarships in the pharmaceutical sciences and/or contributed outstanding service to the
professional practice of pharmacy.
Jack L. Beal Postbaccalaureate Alumni Award Recipients:
2005: David A. Kvancz, M.S. ’81,
2006:
Patrick L. McKercher, Ph.D. ’74,
David P. Rotella, Ph.D. ’85,
Arnold Schwartz, M.Sc. ’57, Ph.D.
Jeffrey J. Ares, Ph.D., 1986
Appavu Chandrasekaran, Ph.D., 1986
Joseph J. Lynch, Ph.D., 1982
Jerome F. Pierson, B.S., 1980, Ph.D. 1997
The Josephine Sitterle Failer Alumni Award recipient is named in honor of Josephine Sitterle Failer,
BS, 1939 (d. 1987), a long-time College benefactor who contributed service to the College for nearly
five decades. The award recognizes an alumnus who has received a professional degree from the College
of Pharmacy within the past ten years and has made outstanding contributions to community or
professional service.
Josephine Sitterle Failer Alumni Award Recipients:
2005: Susan Crist Downard, B.S. ’96
2006: Scott M. Mark, Pharm.D., M.S., 1997,
FASHP
59
GOVERNING BOARD ROSTER of PHARMACY ALUMNI SOCIETY
THE OHIO STATE UNIVERSITY COLLEGE OF PHARMACY
2005-06
Officer
President
President-Elect
Name
Linda F. Bendinelli
Donald L. Bennett
Degree, Year
B.S. '80
B.S. '70
Location
Columbus, OH
Westerville, OH
Pharmacy Practice Site
Hospital/Consulting
Hospital
Vice President
Larry C. Schieber
B.S. '81
Circleville, Ohio
Community
Secretary
Kimberly Like McDevitt
B.S. '81
Columbus, OH
Community/Hospital
Treasurer
Col. John J. Coughlin
B.S. '56
Westerville, OH
Community
Immediate Past
President
Roberta M. Armstrong
B.S. '63
Albion, MI
Community
Alumni
Representative
to the OSUAA
Alumni Advisory
Board
Thomas P. Sherrin
B.S. '65
Powell, OH
Health Care Org
Representative
District 1
District 2
District 3
District 4
District 5
District 6
Name
Dale A. Bertke
Cecilia "Ceil" Canestraro
Michael Scott Ferriell
Mark P. Mershon
Creg F. Stockwell
Lorrie L. Burns
Shirlyn Chaffin
Amira E. Del Tosto
Niesha Griffith
Robert S. Hayman
Mary Beth Kanatas
David H. "Doc" Lamberjack
John A. Lince,
Dale C. Lucas
Kathy Nameth
Janet Senek Robertson
Bonnie Croce Spiers
Marilyn Keish Wollett
Michele Balint Brammer
Christopher L. Hirt
Dr. Brian Frank George
Eric M. Hals
Benjamin A. “Andy” Black
Kenneth Lee Warman
Kenneth D. Crist
Jerry S. Marlowe
Degree, Year
B.S. '85
B.S. '81
B.S. '76
B.S. '89
B.S. '77
Pharm.D. '03
B.S. '59
B.S. '93
M.S. '96
B.S. '64
B.S. '80
B.S. '93
B.S. '64
B.S. '67
B.S. '80
B.S. '84
John A. Nees
Barry E. Klein
Virginia Lynn Beaty
Inga Becker-Gutarts
Scott G. Jamieson
Richard Alan Gray
Brent J. Swipas
B.S. '51
B.S. '88, M.S. '89
B.S. '96
B.S. '98
B.S. '82
B.S. '74
B.S. '90
District 7
District 8
District 9
District 10
District 11
District 12
District 13
District 14
District 15
District 16
District 17
District 18
60
Location
Minster, OH
Urbana, OH
Brookville, OH
Cincinnati, OH
Washington C.H.,OH
Blacklick, Ohio
Westerville, OH
Columbus, OH
Columbus, OH
Grove City, OH
Columbus, OH
Dublin, OH
Columbus, OH
Gahanna, OH
Dublin, OH
Columbus, OH
Westerville, OH
B.S. '65
Columbus, OH
B.S. '85
Sunbury, OH
B.S. '95
Fremont, OH
B.S. '96, Pharm.D.'98 Lexington, OH
B.S. '89
Pataskala, OH
B.S. '94
Pickerington, OH
B.S. '78
Portsmouth, OH
B.S. '80, Pharm.D. '83 Zanesville, OH
B.S. '61
Dover, OH
Louisville, OH
Hudson, OH
North Olmsted, OH
Solon, OH
Lexington, OH
Canfield, OH
Warren, OH
Long Term Care
Hospital
Hospital
Community
Hospital
Hospital
Community
Community
Hospital
Community
Community
Community
Community
Community
Dir., Cont. Ed.-OPA
Nuclear Pharmacy
Industry
Mail Order Rx
Industry
Hospital
Hospital
Community
Clinical
Community
Res/Clinical Practice
Long Term Care/
Compounding
Community
Community
Community
Community
Hospital
Community
Community
Out-of-State
Representatives
Name
Degree, Year
Location
Robert P. Henderson
B.S. '81,
Pharm.D., UT '03
B.S. '98,
Pharm.D. '00
B.S. '72
Birmingham, AL
Education
Leola, PA
Clinical Community
B.S. '80
Plymouth, MI
Waterford, MI
Red Bank, NJ
Hospital
Chain Executive
Oncology Sales Rep.
B.S. '59
Columbus, OH
Community
Cuyahoga Falls, OH
Cleveland, OH
Plain City, OH
Columbus, OH
Perrysburg, OH
Reynoldsburg, OH
Westerville, OH
Powell, OH
Westerville, OH
Frederick, MD
Portsmouth, OH
Indianapolis, IN
Hospital
Chain management
Palliative Care
Community
LT Care/ Infusion
Consultant Pharmacy
Health Care Org
Retired HS Admin
Chain management
US Army/Research
Community
Hospital
Andrew J. Irons
Douglas A. Miller
Laura Matchett Shaw
Karen Balcerzak
At-Large Appointee Shirlyn Chaffin
Board Appointees
Barbara J. Ague
Joel Arnold
Phyllis Grauer
Robert J. Dupont Sr.
Terry Light Fraker
Paul E. Herring
Jeffrey R. Legg
J David Luckhaupt
Frank Sainato
Col. Jerry F. Pierson
James W. Staker
Sara New St. Angelo
B.S. '77
B.S. '58
B.S. '77
B.S. '62
B.S. '69
B.S. '68
B.S. '91, M.S. '92
B.S. '50
B.S. '58
BS '80, Ph.D. '97
B.S. '56
B.S. '76
Lifetime Member
in Memoriam
Name
Jack L. Beal
Robert W. Jones
Josephine S. Failer
Richard I. Wells
Degree, Year
Ph.D.'52
B.S. '48
B.S. '39
B.S. '56
Lifetime Member
Name
Charles W. “Bill” Ague
Lt. Col. Ralph V. Foster
Daniel B. Waitzman
Degree, Year
B.S. '50
B.S.'56
B.S. '43
Location
N.E. Ohio
Columbus, OH
Columbus, OH
Retired
Industry (ret.)
Community (ret.)
Alumni Affairs
Director
Lou Marcy
B.S. '65
Columbus, OH
Clinical Partners
61
Development
F
iscal year 2005-06 was a time of transition in the College of
Pharmacy's Office of Development. The College hired Shannon
Weiher as Director of Development in January 2006.
During FY 2005, development efforts raised a total of
$1,072,824 in private funds, a 1% increase in total private support
over FY ’04. Some key relationships with new donors were
developed and led to significant gifts. Development events included
two Corporate Council meetings, participation at University
Development’s Winter College in Naples, FL with Dr. Christine
Murphy presenting on Medicare Part D, and a partnership with the
College's Student Affairs to host the inaugural Scholarship Recipient
reception prior to the annual Alumni Awards Banquet.
As of June 30, 2006 the College raised $1,017,624 in private
Shannon Weiher
support in the forms of cash, securities and gifts in kind, and
$1,390,862 through OSURF (OSU Research Foundation). Seven
pending endowment funds reached fully endowed status in 2006. Five of the funds focused
on student support, one specifically created the first fellowship in the division of
Pharmacology in honor of Dr. Patil. Support for scholarships
continues to be a priority for the College as they are an
important recruiting tool to attract a high-quality and
diverse student body.
FY ’06 included several major gifts. Wyeth
named the first Pharmacology fellowship in honor
of professor emeritus Dr. Popat Patil. Dr. Chih
Ming Chen endowed a fund, $250,000, to
support Dr. Sylvan Frank's drug research. The
College also received a $100,000 gift from the
Prostate Cancer Foundation for Dr. Ching Shih
Chen’s work in cancer research. In the eyes of this
foundation, this support moves Ohio State into
the playing field of other internationally
recognized cancer research institutions.
Development events in 2006 included a trip to Florida
around Winter College in Sarasota during which donor
discovery work found two potentially strong prospects for
the College. Long time friends and alumni Richard and
Karol Wells were honored (Mr. Wells posthumously)
with the University’s Reese Medal Award for their
campus wide support including the College of Pharmacy.
This event was held in Beverly Hills and Mrs. Wells
graciously accepted the award. The College's first Research
Day and Patil Symposium welcomed several alumni and emeritus
faculty back to campus to celebrate Dr. Patil’s career and highlighted
the research currently underway in the College. The 2nd annual Scholarship
Recipient Reception with the Office of Student Affairs was another success with a few donors
indicating they would like to do more to help our students. The inaugural Emeritus Faculty
Appreciation lunch hosted about half of the current emeriti at the Faculty Club to thank them
for their service and keep them connected.
62
College of Pharmacy Honor Roll for Calendar 2005
We are very grateful to the many generous benefactors who continued to support all areas of The Ohio
State University College of Pharmacy during the calendar year 2005. Although every effort was made to
insure the following list is complete and accurate, errors may be present. We would appreciate a note
from you if you find an error.
$5000 and above99
American Distance Education
Consortium
American Foundation For
Pharmaceutical Education
Amgen Inc
Astellas Pharma U S A Inc
Boehringer Ingelheim Roxane Inc
Pamela Lynne Boner
Bristol-Myers Squibb Company
Pharmaceutical Group
C V S Charitable Trust Inc
Cardinal Health - Centricity L L C Dba Sales Services
Children's Hospital
Genzyme
Giant Eagle Inc
Gerald and Jody Hudec
J D S W Family Foundation
Maryann & Lawrence Kennedy
Medco Health Solutions Inc &
Medco Health Affiliates
Merck & Company Inc
Nature's Sunshine Products Inc
College Of Pharmacy Alumni
Society
Pan American Health Org
Greg & Patricia Ream
Louise Orr Scott Foundation
Marilyn Keish Wollett
Jinn & Diana Wu
Robert Ruffolo, Jr./Wyeth
Pharmaceuticals Inc
Estate of Simon Yotive
$1000 - $4999
A And A Consultants Inc
Academy Of Pharmacy Of
Central Ohio (Scholarship)
Charles W. "Bill" and Elma Ague
Alvin & Louise Myerberg Family
Foundation Inc
American Pharmacists Association
Anonymous Donor
Barr Laboratories Inc
Floyd G & Betsy Bender
Howard Bockbrader
Boehringer Ingelheim
Pharmaceuticals Inc
Boeing Gift Matching Program
Robert & Susan Brueggemeier
Robert & Leslie Buerki
John & Nancy Cassady
Joseph Cusma Sr
Bruce Downey
Drake University
John E Fedyna
Gregory R Garner
Glaxo Smith Kline Foundation
Kim & Judy Hawksworth
Health Managemnt Solutions
Donald E Hill
Betty Ann Hoener
Hoffmann-La Roche Inc
The J M Long Foundation
Key Bank National Association
Barry E Klein
The Kroger Company - Columbus
Steven R Lefevre
Kelly B Lutz
Louis & Carol Marcy
David James Mc Lean
Medical Plaza Pharmacy
Larry & Beverly Moore
Jennifer Myerberg
National Association Of Chain
Drug Stores Foundation
Michael A Nameth
Nusgart Consulting
James A Odom Jr
Council of Ohio Colleges of
Pharmacy
The P & G Fund
P & G Pharma Inc
Paddock Laboratories
Pfizer Foundation
Pharmacia Foundation Inc
Pharmacists Mutual Insurance
Company
Pharmacy Fdn of Ohio Inc
Procter & Gamble Company
Erika P & Nicholas Ragaji
Douglas W Rose
Sam's Club # 6326
Sam's Club Foundation
Larry C & Kim Schieber
Jerry Siegel
Mark A Sirgo
David A Smeenk
Alfred & Angela Staubus
Mark D Szewczyk
Target Stores
University of Florida
Walgreen Corporation
Lane Wallace
Amie Travis Walter
Donald & Elaine Walter
Lisa Webster
Jennifer Weisburn
Wellpoint Foundation Associate
Giving Campaign
Karol & Richard* Wells
Christopher Wendling
Mary Whisler
Whiston Foundation
Thomas E Whiston
Don E. White
John Karshner White
White's Pharmacy II Inc.
Dianne Whitten
Teresa & Scott Wilcox
Christopher & Suzanne Widing
John & Ann Wolfe
Nancy Thompson Wood
Karen Wooten
The Wright Resource LLC
Wyeth
Douglas Yeager
Fred E. Yingling
Terry James Yingling
Jacqueline A. Young
Young's Family Market Groceries
& Meats
Harry Zake
David Zgarrick
Jason & Angela Zielinski
$1 - $999
Kathy Wilson Abfall
American College Of Clinical
Pharmacy
Larry Lee Addington
Joan Evelyn Alguire
Russell Raymond Allinson
S. William & Marilyn R. Alper
Arlington Court - Nursing Center
John H Artino
Scott David Amick
William J. & Nancy B. Anderies
William James Anderies
Ninna Wheeler Anderson
Raymond Carl Anderson, Jr.
Leigh Ann Thoroughman Annis
Nancy Scott Atcheson
Barbara Ann Austin
Janis C. Austin
Aventis Consulting
63
Heidi Sue Baehler-Morris
Mabel I. Baker
Matthew E. & Suki C. Baker
Michele Balint Brammer
Raymond A. Bame, Jr.
Eleanor Barstow
Audrey Bowser Bazler
Daniel C. & Judy G. Bear
John H. Bender
Donald & Amy Bennett
Marialice S Bennett
Doris Wolf Bennett
Jeffrey Scott Bennett
Kristen Vincente Berbari
Carol S. Bernardo
Sushil Harivadan Bhagat
Andrew Carl Bidinotto
Stephen W Birdwell
Benjamin Arthur Blackford
Danielle Marie Blais
John L. & Barbara G. Boggs
Boris Catz & Rebecca Debora
Catz Trust
James Elwood Braden
Christina Walters Brague
Eric David Brooker
Kelly Anne Brown
E. Clyde Buchanan
Carl Kenneth Buckner
Gary Woods Bumgarner
Gerald Alan Burch
Donna Michele Burke
J Lorrie Z Burns
John G. & Gunta E. Burt
Harold Bernard Bushman
Laura Ferryman Butler
Gerald L Cable
Carol Camm
Cardinal Health
John Ervin Carlin
Debora Roberts Carter
Kimberly Ann Cermak
James Martin Chapman
Helen C. Chappelear
Michael Sae-Yong Choe
Jeffrey James Christoff
James P. & Ann T. Clark
Bradley Alan Collins
Johanna & Richard Costic
Conexus Health LLC
Carolyn Louise Connor
John C. & Miranda N. Cook
64
Chasity Michelle Cooper
Corinne Shaevitz Covel
Otis Lee Crawford
Ted Michael Crum
Steven Lewis Davis
Benjamin F. De Hays, Jr.
Robert Joseph De Wees
Anna Marie Derrer
Christina Morris Detwiler
Sara M. Deyo
James Michael Di Renzo
Kerry Welch Diver
James M. & Bridget O. Dixon
John M. & Sandra B. Douds
Michael Joseph Drexler, Jr.
Thomas L. Easly
Brandon Mark Edgerson
Robert Howard Ehlers
Crystal Woestendiek Engle
Michael Joseph Enright
William Fagan
Kim Rachelle Farnstrom
Betty Little Farwick
Lee Ann Federanich
Myron Feinberg
Nancy Raimonde Felici
Stephen John Ferenchak
Fidelity Char Gift Fund - John K Koo
Med. Sci. Char. Fdn.
Anthony D Figliola
Maureen Malaney Fink
Suzanne Schwemley Fitzpatrick
Robert Howard Flowers
William J. Flynn
Stephen W. & Sandra L. Fogt
Mark R. & Heather R. Fondriest
Diane Wisniewski Ford
Ryan Alexander Forrey
Ralph & Ruth Foster
Richard Dale Fox
Tamara McAninch Fox
Sylvan G. & Bonita K. Frank
Robert Edward Franz
Randall Steven Frederick
Marjorie Shupala Fredrickson
Lori Christianson Friedstrom
Phillip M. & Shari M. Fronckel
Eric Fung
Michael Joseph Gabriel
Renae Rindler Gaerke
Ava Relle Gegenheimer
Laurin Neimayer Geib
Stephen Vincent George
Terri Duga Ghitman
Mark Edward Giangardella
Frederick William Giessler
Joanne Walton Giessler
Martha Randall Gill
Jeffrey D. & Amy C. Givens
Tad A. & Kerry H. Gomez
Michael David Graham
Philip Postle Gramlich
Arthur Lewis Grant
Dennis W. & Sharlyn A. Grauer
Lisa Huffman Gray
John Kenneth Greathouse
Philip Daniel Gressel
Niesha L. Griffith
Donna Jean Grove
Kelley Don & Tamara T. Grueser
H & R Block Foundation
Sherry Crawford Haberkern
Mark Alan Hadley
Virginia Sowizal Hall
Eric Martin Hals
Justin Patrick Hamper
Michael Henry Haney
Ellen Matlin Harrison
Marc W. Harrold
William C. Harrup, Jr.
Gary Brian Hasemeier
Megan Elizabeth Hauck
James Deloss Hawkins
The Haworth Press
Susan McIlvaine Hayes
Robert S. Hayman
Health Risk Concepts Inc
Elizabeth Cly Hedges
Barbara Hegler
Jacob Hugh Hendershot
Mary Tashdjian Henne
Holly Crist Herrick
Paul Eugene Herring
Karen Borgert Hickman
Edward C. & Shirley P. Higgins, Jr.
Alexander & Christine N. Hinko
Amy Wiseman Hoch
J Terrence & Mary Kay F. Hoffmann
William H. & Donna N. Hohman
Jacquelin Sue Holland
Alicia Ann Holtzapfel
Barbara Ann Hoover
Jeremy Howard Horn
James Robert Hostler
Karen Kiplinger Hostler
House of Fashion
Karen Lindway Houser
Harold Eugene Huber
Benjamin Philip Indick
Merrill Insley
Susan Jane Insley
Joy R. Irvin
Joel Katsumi Ito
Kristin Youstra Izenstark
The J. M. Clark Revocable
Living Trust
Victor Jackson
Mary Ann Janning
Nancy Mei Yuh Jao
Wenlei Jiang
Thomas Larry Jirles
Julie Ann Johnson
Molly Reader Johnson
Craig Tyrrell Johnston, Sr.
Iona N. Jones
Rebecca Hoffman Jones
Susan Ann Jones
Trisha Ann Jordan
The J. P. Morgan Chase Foundation
John Stephen Judin, Jr.
Connie Tom Jung
David Justin Kalis
John D. & Karen S. Kaskewsky
Alan S. & Sandra T. Katz
Robert T. Kelley
Patrick R. & Theresa C. Kelly
Sharon Ann Kennedy-Norris
Christopher S. & Charlotte J.
Kenreigh
Jacqueline Zywicz Kessler
Jeffrey Michael Ketz
Kristine Ann Kingsbury
Margaret A. Kirian
Tressa Walker Kneer
Helen Yen Koo
Lisa Darvanan Korandovich
Virginia Butterfield Krinn
Billy L. & Susan E. Latta
Scott Allen Lawler
Sue Johnston Lawler
Lawler's Pharmacy
William Kimball Lecain
Krista Stocklin Lehew
S. Frank Lemon
Karl F. Leupold
Amy Carver Lewis
Leyda Family Foundation- Nat'l
Heritage Fdn Char Trust
James P Leyda
Roger Hart L'hommedieu Jr
Eleanor Lieptz
James Aloysius Logue, Jr.
Victor Nick Lombardi
Carl Joseph Lorubbio
William Charles Lubawy
June Ann Ludden
Mary Kathleen Lundy
Nicholas Arthur Lungociu
Mark Alan Manfresca
Jacqueline Alfonso Marowitz
Thomas M. & Claire J. Marshall
Lawrence L. & Arlene S. Martin
Susan Marx Mashni
Charles A. & Alice J. Matuszak
Vincent F. & Laurie S. Mauro
Jon Richard May
George M. McCann
Robert Henry McClanahan
Rhonda Osterwalder McCloy
Denise Vaselaney McCormick
Willis Edgar McGlone
Sarah Lynn McGreevy
Katie McGuire
Katie Jo McKillip
Kristine Joniak McQueen
Walter Adam Mendyka Jr
Jean Wrentmore Mewhinney
Harry R. & Kitty Minck, Jr.
Roman Oleh Mironovich
Jay Matthew Mirtallo
Barry Allan Moenter
Erinn Elizabeth Molnar
Mary Sasser Montenery
Cynthia Angela Murnyack
James W Munson
Mark M. & Linda W. Musgrave
Mylan Pharmaceuticals Inc
Kathleen & Randall Nameth
Jason William Nash
Cortney Blodgett Nauck
Douglas James Navarro
Stephen Samuel Navran, Jr.
Julie Trout Neff
Suzanne Amato Nesbit
Deborah Harstine Newman
OSU PharmD Class of 2005
William G. Oakley
Robert E. & Mary Ann E. Ober
Kyle F. Oelrichs
Jeanette Pauline O'Neal
Melvin Orchen
Kevin P. & Jill M. O'Reilly
Linda Wick Orthoefer
Mary Ellen Page
Keith A. & Corlis M. Pappa
Diana Paxton
Jessie V. Pergrin
Lawrence J. & Jean S. Pesko
Carl Thomas Peterson
Michael & Mary Piascik
Ming Jye Poi
Chester Paul Porembski
R. Ira & Susan S. Porterfield
Albert G. Powell
Jerry Richard Powell
Kenneth Stuart Prayzer
Andrew P. Preston
Anil Ralhan
Thomas George Reigle
Raymond Leo Reinhart
Allen J. & Berdina S. Reis
Judith B. Reuning
James & Carol Reynolds
Shirley C Robertson
James Michael Rice
Christine L Ritzman
Joseph E. & Melissa R. Richardson
William M. Ritchey
Miguel Hernandes Rivera
Jeffrey A. & Gina R. Rogers
Shelly Puthoff Ross
Samuel Lawrence Rotunna
Steven Robert Rudner
Brian James Sabol
L. Edward Salser
Marie Elizabeth Savini
Robert Mark Schaffner
Douglas John Scheckelhoff
Tiffany Austin Schmitt
Janet Wadolny Schmittgen
Clare R. Schmurr
Harold R. Schorr
Judy Beck Schultz
Schwieterman's Drug Store Inc
Thomas & Frances Coffey Scono
Shiv Kumar Seth
Thomas J. Shea
Kimberly Betz Sherman
H. D. Hollis Showalter
Warren G. Shriver
Jeri J. Sias
Gregory Allen Sierer
65
Bruce E. & Linda W. Sill, Jr.
Laura Ann Simerlink
Warren E. Sinkhorn
Kenneth A. & Kathleen C. Skau
Michael William Smar
Steven Bryan Smith
Charlotte McCarthy Smucker
Di Song
Earl Charles Soule, Jr.
Jennifer Sue Spidle
Jennifer Porembski Stanko
Michael Bryan Stebelton
Ellen Horwitz Stefancik
Jon F. Stefancik
Howard S. Stern
Lenore Heiman Stern
Gerard Augustine Stock, Jr.
John Robert Stone
Cathy Sweet Stricklen
Marc Alan Sweeney
Joseph V. Swintosky
Kimberly Leiby Swipas
Gabriel & Susan G. Tannenbaum
Steven Charles Taylor
66
Thomas Neil Taylor
Valerie E. Taylor
William John Taylor
Timothy J. & Barbara H. Thissen
Paul Michael Thomas
Carl Ferris Thornton
Mariko Thumm
James Byron Toohey
James Matthew Trapp
Nicholas Clair Trausch
Douglas W. & Wanda Tremblay
William & Barbara T. Tzagournis
James P. Vale
Kristin Winkler Vitou
Alan & Linda Vrable
Daniel B. & Rita F. Waitzman
John A. Waliga
Jeffrey A. & Elizabeth W. Wallace
Mark Edward Walters
Juan Wang
Mike Wascovich
Robert Joseph Weber
Lisa Blocher Webster
Jennifer Lloyd Weisburn
Jill Fridenmaker Wellmeier
Mary H. Wernersbach-Meemken
Bev Greene Weston
David Leith Wheeler
Lynn Roberts Whisler
Roger L. & Paula D. White
Sara J White
Clifford Crandall Williams
Kristen McFarland Williams
Jean Graf Windesheim
Norman A. Winston
Robin L. Wirtz
Lisa Elaine Wojtowicz
William David Wright
Mamdoh Sabry Yaakob
John C. & Jane B. Young
Kathryn A. Zalovcik
Jason T. & Angela J. Zielinski
* Deceased
Dean’s Corporate Council
T
he Dean’s Corporate Council provides primary interactions between leaders in academia and corporate entities
and addresses the challenges and opportunities of health care in the 21st century. The primary purpose of the
Council is to advise and counsel with the Dean and College administration on broad matters of policy, planning
and resource development at the College. Members serve as external reviewers and are involved in specific tasks
and important projects with the Dean, College Faculty, and Council members. The Council is composed of 25-30
leaders from small and large companies throughout the country. They are engaged in pharmaceutical research and
manufacturing, managed care, independent pharmacy, consulting, and chain pharmacy. Prior educational
affiliation with The Ohio State University is not a condition of Council membership. The term of membership is
two years and members may be reappointed for two additional consecutive terms. The Council annually elects its
Chair and the Council meets as a body twice each year. Additional meetings may be held at the request of either
the Chair of the Council or the Dean.
Members of the Dean's Corporate Council, 2005
Name
Pamela Bernadella
Carl T. Bertram
Paul Blower
Arne F. Brodin
Jeffrey L. Brown
Daniel L. Deem
Bruce L. Downey
Larry M. Games
Harold N. Godwin
Maryann Kennedy
Stephen B. Krinke
John J. Long
John A. MacDonald
Robert E. Martini
Rob Mains
Larry Moore
Michael Nameth
Marcia I. Nusgart
Robert Ruffolo, Jr.
William F. Sheridan, III
Mark A. Sirgo
Title
Manager Professional Serv.
Director Clinical Services
Chief Scientific Officer
Director Special Projects
Pharmacy Division Manager
Pharmacy Development Mgr
Chairman and CEO
Vice President
Professor, Associate Dean
Director, Medical Liaisons
Director, Pharm Affairs
President
President and CEO
Chairman
Corporate Clinical Affairs
Deputy General Counsel
Executive Vice President
President
President R&D
Pharmacy Merchandiser
President and CEO
James Staker
Allan K. Vrable
Mary Ann Wagner
President and CEO
President
VP Pharm Regulatory Affairs
Affiliation
Target Pharmacy
Walgreens Health Init.
Leadscope, Inc.
AstraZeneca
Wal-Mart Stores, Inc.
Rite Aid Corporation
Barr Laboratories, Inc.
P&G Pharmaceuticals
University of Kansas
Roche Laboratories, Inc.
Mylan Pharmaceuticals
J. Long & Assoc, LLC
Catalyst Oncology
AmerisourceBergen
Cardinal Health
American Red Cross
Medmark, Inc.
Nusgart Consulting
Wyeth
Kroger Food and Drug
BioDelivery Sciences
International
Staker's Service Drugs
Vrable Healthcare
NACDS
City, State
Minneapolis, MN
Deerfield, IL
Columbus, OH
Sweden
Bentonville, AR
Dayton, OH
Woodcliff Lake, NJ
Mason, OH
Kansas City, KS
Nutley, NJ
Morgantown, WV
Dublin, OH
Yarmouth, MA
Orange, CA
Stow, OH
Washington, DC
Carnegie, PA
Bethesda, MD
Collegeville, PA
Westerville, OH
Morrisville, NC
Portsmouth, OH
Powell, OH
Alexandria, VA
67
Financial Report
T
he financial outlook for the College of
Pharmacy remains strong. The decreased
funds available from state instructional
support for higher education are
counterbalanced by revenues from
increases in student enrollment,
tuition, extramural research
funding, and development. In
FY2006, our overall
Endowment &
expenditures from all funds
Development
were approximately $21.3
7%
million, with the majority
Private Grants
of the expenditures in the
categories of general funds
& Contracts
and sponsored research.
4%
Approximately 88% of the
general funds expenses are
related to personnel (salaries,
benefits, graduate student fee
Sponsored
authorizations).
FY2006 Expenditures
Sales &
Services
1%
Total = $21.3 M
General Funds
60%
Research
28%
FY2006 General Funds (PBA) Expenditures
Supplies &
Services
9%
Benefits
15%
$12.98 M
Fee Authorization
13%
Startup
7%
Salaries
56%
approximately 88% in personnel
68
Nonprofit Org.
COLLEGE OF
PHARMACY
The Ohio State University
College of Pharmacy
500 West 12th Avenue
Columbus,Ohio 43210-1291
U.S. Postage
P A I D
Columbus, Ohio
Permit No. 711

Org. age Ohio . 711 - College of Pharmacy

Transcription

Similar documents

Pharmacies

Link to presentation - Leslie Dan Faculty of Pharmacy, University of

Pharmacy Daily for 250712

PDF

Pharmacy Payroll Deduction Authorization

String Festival opens musical summer ,at UTD

Commencement Program

Pharmacy Guild Portal Instructions

Your Opportunity to Receive

Walgreen World

August 2012 - Columbus Square

View/Open - University of New Mexico